| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant Expression in Human Epithelial Cancers of the P2X5-Encoded Minor Histocompatibility Antigen LRH-1: Implications for Graft-Versus-Tumor Immunity Against Solid Tumors.
|
Dolstra, Harry
|
|
|
110 |
11 |
p. 1795
|
artikel
|
| 2 |
Aberrant Gene Promoter Methylation of Tumor Suppressor Genes in Plasma Cell Disorders.
|
Stanganelli, Carmen
|
|
|
110 |
11 |
p. 2487
|
artikel
|
| 3 |
Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.
|
Wang, Qiuju
|
|
|
110 |
11 |
p. 3582
|
artikel
|
| 4 |
Aberrant NK Receptor Signaling Associated with Large Granular Lymphoycte Leukemia and Primary Pulmonary Hypertension.
|
Epling-Burnette, P.K.
|
|
|
110 |
11 |
p. 4704
|
artikel
|
| 5 |
Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.
|
Alatrash, Gheath
|
|
|
110 |
11 |
p. 4900
|
artikel
|
| 6 |
Abnormal CD34 Positive Cells Are Present in NPM+ Acute Myeloid Leukemia (AML) Samples at Diagnosis.
|
Martinez, Clara M.
|
|
|
110 |
11 |
p. 4289
|
artikel
|
| 7 |
Abnormal Expression of Receptor Tyrosine Kinase Mer in Adult Acute Leukemia.
|
Fan, Lei
|
|
|
110 |
11 |
p. 4252
|
artikel
|
| 8 |
Abnormal Large Platelets Are Associated Not Only with von Willebrand Disease (VWD) Type 2B (Including Type 2B/1 New York) but Also with Severe Type 3: A Potential Role for von Willebrand Factor (VWF) in Megakaryocytopoiesis.
|
Nurden, Paquita
|
|
|
110 |
11 |
p. 101
|
artikel
|
| 9 |
Abnormally High Levels of Circulating CD34+CD38−, CD34+CD38+, and CD10+ Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.
|
Christopherson, Kent W.
|
|
|
110 |
11 |
p. 4711
|
artikel
|
| 10 |
Abnormal NT-ProBNP in AL Amyloidosis Patients without Cardiac Involvement at Diagnosis - A Predictor of Subsequent Cardiac Involvement.
|
Wechalekar, Ashutosh D.
|
|
|
110 |
11 |
p. 1500
|
artikel
|
| 11 |
Absence of CCR4 Enhances the Function of Expanded Regulatory T-Cells.
|
Coghill, James M.
|
|
|
110 |
11 |
p. 2172
|
artikel
|
| 12 |
Absence of E-Selectin at the Vascular Niche Delays Hematopoietic Stem Cell Turn-Over.
|
Winkler, Ingrid G.
|
|
|
110 |
11 |
p. 609
|
artikel
|
| 13 |
Absence of FLT3 Mutations in 181 Healthy Blood Donors.
|
Hopkins, Courtney K.
|
|
|
110 |
11 |
p. 4273
|
artikel
|
| 14 |
Absence of Oncogenic Transformation in Long-Term Culture Mesenchymal Cells from Bone Marrow of Children.
|
Choumerianou, Despoina M.
|
|
|
110 |
11 |
p. 4100
|
artikel
|
| 15 |
Absence of Residual Vein Thrombosis after an Episode of Idiopathic Deep Vein Thrombosis: Short-Term Anticoagulation Is Safe. The “Extended Dacus Study”.
|
Siragusa, Sergio M.
|
|
|
110 |
11 |
p. 301
|
artikel
|
| 16 |
Absence of the V617F JAK2 Mutation in 181 Healthy Donors.
|
Hopkins, Courtney K.
|
|
|
110 |
11 |
p. 4664
|
artikel
|
| 17 |
Absolute Lymphocyte Count Is Independent of the Anaplastic Lymphoma Kinase and Predicts Survival in Primary Anaplastic Large Cell Lymphoma.
|
Porrata, Luis F.
|
|
|
110 |
11 |
p. 1335
|
artikel
|
| 18 |
ABT-737 Is a Useful Component of Combinatory Chemotherapies for Chronic Myelogenous Leukemias with Diverse Drug Resistance Mechanisms.
|
Kuroda, Junya
|
|
|
110 |
11 |
p. 808
|
artikel
|
| 19 |
A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.
|
Fullerton, D.S. Pete
|
|
|
110 |
11 |
p. 3324
|
artikel
|
| 20 |
ABVD Versus VEPEMB in Elderly Hodgkin's Lymphoma Patients.
|
Levis, Alessandro
|
|
|
110 |
11 |
p. 2322
|
artikel
|
| 21 |
A Case of HPP with a Novel Combination of α and β Spectrin Mutations.
|
Natarajan, Kavita
|
|
|
110 |
11 |
p. 1736
|
artikel
|
| 22 |
A Case of Peripheral Neuropathy Combined with Leukoencephalopathy after Injection with Intrathecal Methotrexate and Vincristine.
|
Lee, Hae-sang
|
|
|
110 |
11 |
p. 4348
|
artikel
|
| 23 |
a-catenin Hypermethylation Correlates with AML Transformation in Patients with and without 5q Defects.
|
Ye, Ying
|
|
|
110 |
11 |
p. 2119
|
artikel
|
| 24 |
Accelerated Apoptosis and Aberrant Retention of Bone Marrow Cells in Myelokathexis Are Two Independent Pathways Triggered by Mutant CXCR4 and Normalized upon Treatment with Specific Inhibitors.
|
Makaryan, Vahagn
|
|
|
110 |
11 |
p. 3300
|
artikel
|
| 25 |
Accelerated Proliferation and Limited Differentiation, Mediated through Jak2, Exacerbate Ineffective Erythropoiesis in β-Thalassemia.
|
Guy, Ella
|
|
|
110 |
11 |
p. 275
|
artikel
|
| 26 |
Acceptability and Validity of Use of a Patient-Reported Cost Diary To Capture Health Resource Utilization and Costs Associated with Deep Venous Thrombosis and Post-Thrombotic Syndrome.
|
El-Hadi, Wissam
|
|
|
110 |
11 |
p. 5173
|
artikel
|
| 27 |
Accessory Splenectomy for Relapsed Idiopathic Thrombocytopenic Purpura.
|
Thanarajasingam, Gita
|
|
|
110 |
11 |
p. 3213
|
artikel
|
| 28 |
Accurate Detection of the microRNA Transcriptome in a Leukemia Progression Model.
|
Kuchenbauer, Florian
|
|
|
110 |
11 |
p. 866
|
artikel
|
| 29 |
A Cellular Proteome Map of Human Multiple Myeloma.
|
Drach, Johannes
|
|
|
110 |
11 |
p. 111
|
artikel
|
| 30 |
Acetylation of an Ets Transcription Factor PU.1 Suppresses Its Transcriptional Activity.
|
Mouri, Fumihiko
|
|
|
110 |
11 |
p. 2402
|
artikel
|
| 31 |
Acetylation of PML Plays a Key Role in Histone Deacetylase Inhibitor-Mediated Apoptosis through Enhanced PML Sumoylation.
|
Hayakawa, Fumihiko
|
|
|
110 |
11 |
p. 4164
|
artikel
|
| 32 |
A Chemical Genetic Screen Identified Small Molecules Modulating Zebrafish Vascular Development and Angiogenesis.
|
Xue, Rui
|
|
|
110 |
11 |
p. 3721
|
artikel
|
| 33 |
A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.
|
Kondo, Takeshi
|
|
|
110 |
11 |
p. 1820
|
artikel
|
| 34 |
A Chromatin-Associated Histone H3 Dementhylase Promotes the Immortalization of MEFs and the Cycling of HSC-Like Cells in Culture.
|
Pfau, Raymond
|
|
|
110 |
11 |
p. 96
|
artikel
|
| 35 |
Acidosis in Human Whole Blood Does Not Necessarily Impair the Coagulation and the Effect of RFVIIa.
|
Viuff, Dorthe
|
|
|
110 |
11 |
p. 3930
|
artikel
|
| 36 |
A Clinical Test for the Identification of Amyloid Proteins in Biopsy Specimens by a Novel Method Based on Laser Microdissection and Mass Spectrometry.
|
Vrana, Julie A.
|
|
|
110 |
11 |
p. 1480
|
artikel
|
| 37 |
A Comparative Investigation of Therapeutic Approaches for Primary Prostate Cancer and Risk of Acute Myeloid Leukemia.
|
Ojha, Rohit P.
|
|
|
110 |
11 |
p. 1816
|
artikel
|
| 38 |
A Comparative Proteomic Analysis of Platelets from Healthy Human Patients and Chronic ITP Patients Receiving AMG 531, a Thrombopoiesis-Stimulating Protein.
|
Sloan, John M.
|
|
|
110 |
11 |
p. 1313
|
artikel
|
| 39 |
A Comparative Study of Diffuse Large B-Cell Lymphoma (DLBCL) between African Americans and Caucasians: Single-Center Experience at the University of Alabama at Birmingham (UAB).
|
The, Angelina
|
|
|
110 |
11 |
p. 4430
|
artikel
|
| 40 |
A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants.
|
Patah, Poliana
|
|
|
110 |
11 |
p. 3051
|
artikel
|
| 41 |
A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC.
|
Shaw, B.E.
|
|
|
110 |
11 |
p. 46
|
artikel
|
| 42 |
A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS.
|
Gohring, Gudrun
|
|
|
110 |
11 |
p. 2452
|
artikel
|
| 43 |
A Comprehensive Genomic Approach Using Gain of Function Cell Models, Patient Specimens and ChIP-on-CHIP Technologies Identifies PLZF-RARα Target Genes with Potential Roles in t(11;17) Associated APL.
|
Licht, Jonathan D.
|
|
|
110 |
11 |
p. 3168
|
artikel
|
| 44 |
A Comprehensive Geriatric Assessment Is More Effective Than Clinical Judgement to Prospectively Identify Elderly Patients with Diffuse Large Cell Lymphoma Who Can Tolerate Full-Dose Anthracyclin-Based Treatment and Achieve the Same Outcome as Young Patients.
|
Tucci, Alessandra
|
|
|
110 |
11 |
p. 3441
|
artikel
|
| 45 |
A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.
|
Lyman, Gary H.
|
|
|
110 |
11 |
p. 372
|
artikel
|
| 46 |
A Conserved Mechanism of Transcription Factor Competition Controls Hematopoietic Progenitor Self-Renewal.
|
Horman, Shane R.
|
|
|
110 |
11 |
p. 91
|
artikel
|
| 47 |
A Constitutive Increase in Gamma Globin Gene Production during the Erythroid Differentiation of CD34+ Cells from Sickle Cell Disease Patients and Alterations in Cyclic Nucleotide Levels during This Differentiation.
|
Lanaro, Carolina
|
|
|
110 |
11 |
p. 3790
|
artikel
|
| 48 |
A Cost-Utility Analysis of Nilotinib for CML Patients Who Have Become Resistant to Imatinib.
|
Pilgrim, H.
|
|
|
110 |
11 |
p. 5175
|
artikel
|
| 49 |
Acquired Genetic Abnormalities in Acute Lymphoblastic Leukaemia in Patients with Down Syndrome.
|
Kearney, Lyndal
|
|
|
110 |
11 |
p. 984
|
artikel
|
| 50 |
Acquisition of New In Vivo Genomic Change over Time in Multiple Myeloma.
|
Tai, Yu-Tzu
|
|
|
110 |
11 |
p. 2481
|
artikel
|
| 51 |
A Critical Role for CCL Chemokines in the Immuno-Protection Induced by Type I Interferons and IRF8/ICSBP Against Bcr/Abl-Induced Leukemia.
|
Nardi, Valentina
|
|
|
110 |
11 |
p. 1001
|
artikel
|
| 52 |
A Critical Role for STAT-3 Dependent Induction of Indoleamine 2, 3 Dioxygenase in Histone Deacetylase Inhibitors Mediated the Regulation of GVHD.
|
Sun, Yaping
|
|
|
110 |
11 |
p. 351
|
artikel
|
| 53 |
A Cross-Sectional MRI T2* Study of Pancreatic and Pituitary Hemosiderosis in 180 Thalassemia Major Patients in Hong Kong.
|
Au, Wing Y.
|
|
|
110 |
11 |
p. 2771
|
artikel
|
| 54 |
Activated c-Jun N-Terminal Kinase Is a Therapeutic Target in Advanced Stage ALK-Negative Anaplastic Large Cell Lymphoma.
|
Nakamaki, Tsuyoshi
|
|
|
110 |
11 |
p. 1391
|
artikel
|
| 55 |
Activated CMRF-56 Selected Blood Dendritic Cells: A Potential Anti-Myeloma Vaccine.
|
Freeman, Jennifer L.
|
|
|
110 |
11 |
p. 2508
|
artikel
|
| 56 |
Activated Protein C Inhibits Lipopolysaccharide-Induced Anandamide and 2-Arachidonoylglycerol Generation In Vitro and In Vivo.
|
Maruyama, Ikuro
|
|
|
110 |
11 |
p. 1754
|
artikel
|
| 57 |
Activated T Cell-Mediated Immunotherapy with a Chimeric Receptor Against CD38 in B-Cell Malignancies.
|
Mihara, Keichiro
|
|
|
110 |
11 |
p. 2356
|
artikel
|
| 58 |
Activating JAK3 Mutations in Transient Myeloproliferative Disorder and Acute Megakaryoblastic Leukemia Accompanying Down Syndrome.
|
Sato, Tomohiko
|
|
|
110 |
11 |
p. 1620
|
artikel
|
| 59 |
Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.
|
Cooley, Sarah
|
|
|
110 |
11 |
p. 43
|
artikel
|
| 60 |
Activating Mutation of Heme Oxygenase (HO)-1: A Novel Disease Entity Characterized by Microcytic, Hemolytic Anemia, a Defect of Bilirubin Synthesis and Hereditary Hemophagocytic Lymphohistiocytosis.
|
Greil, Johann
|
|
|
110 |
11 |
p. 235
|
artikel
|
| 61 |
Activating PP2A Tumor Suppressor Activity as a Potential Therapy for Treating Jak2 V617F-Driven Myeloproliferative Disorders.
|
Oaks, Joshua J.
|
|
|
110 |
11 |
p. 3548
|
artikel
|
| 62 |
Activation of B-Cell Maturation Antigen (BCMA) on Human Multiple Myeloma Cells by a Proliferation-Inducing Ligand (APRIL) Promotes Myeloma Cell Function in the Bone Marrow Microenvironment.
|
Leiba, Merav
|
|
|
110 |
11 |
p. 1503
|
artikel
|
| 63 |
Activation of Integrin αIIbβ3 through Toll-Like Receptors in Platelets.
|
Yamanouchi, Jun
|
|
|
110 |
11 |
p. 3892
|
artikel
|
| 64 |
Activation of JAZ by Small Molecules in Human Leukemia Cells.
|
Yang, Mingli
|
|
|
110 |
11 |
p. 2652
|
artikel
|
| 65 |
Activation of Multiple Signal Transduction Pathways as a Prognostic Marker in Acute Myelogenous Leukemia.
|
Flandrin-Gresta, Pascale
|
|
|
110 |
11 |
p. 2395
|
artikel
|
| 66 |
Activation of MYC Pathway Is a Unifying Pathological Event in the Progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma (MM).
|
Chng, Wee J.
|
|
|
110 |
11 |
p. 241
|
artikel
|
| 67 |
Activation of Nuclear Factor KappaB in ETV6/FLT3-Transformed Ba/F3 Cells Depends on the FLT3 Tyrosine 591.
|
Vu, Hoang Anh
|
|
|
110 |
11 |
p. 4666
|
artikel
|
| 68 |
Activation of Nucleic Acid-Sensing Toll-Like Receptors Induces Proliferation, Cytokine Production, Immunogenic Phenotype, and Plasma Cell Differentiation of CLL Cells and Immunoglobulin Production.
|
Paul, Santanu
|
|
|
110 |
11 |
p. 1137
|
artikel
|
| 69 |
Activation of the Inflammatory Cytokine Genes by Intracellular Galectin-9 in Human Monocytes.
|
Matsuura, Ai
|
|
|
110 |
11 |
p. 2212
|
artikel
|
| 70 |
Activation of the JNK Pathway Mediates Chemoresistance in T-Cell Acute Lymphoblastic Leukemia by Phosphorylation and Proteosomal Degradation of BimEL.
|
Leung, Kam Tong
|
|
|
110 |
11 |
p. 2372
|
artikel
|
| 71 |
Activation of the mTOR Signaling Pathway in Multiple Myeloma Patients and Its Prognostic Significance.
|
Guglielmelli, Tommasina
|
|
|
110 |
11 |
p. 1493
|
artikel
|
| 72 |
Activation of Transforming Growth Factor β1 (TGF-β1) Released by Platelets Is Enhanced by Shear and Occurs in Platelet-Rich Thrombi In Vivo.
|
Ahamed, Jasimuddin
|
|
|
110 |
11 |
p. 3632
|
artikel
|
| 73 |
Active Immunotherapy with Mitumprotimut-T (FavId®, Id-KLH) Following Rituximab Induction in Patients (pts) with Follicular B-Cell Lymphoma (FL): Progression Free Survival (PFS) at 4-Year Follow Up.
|
Koc, Omer
|
|
|
110 |
11 |
p. 2567
|
artikel
|
| 74 |
Activity and Mechanism of Action of AS1411 in Acute Myeloid Leukemia Cells.
|
Chen, Weiwei
|
|
|
110 |
11 |
p. 1604
|
artikel
|
| 75 |
Activity and Regulation of Long-Acting Factor VIIa Analogs.
|
Ghosh, Samit
|
|
|
110 |
11 |
p. 3141
|
artikel
|
| 76 |
Activity of ARRY-614, an Inhibitor of p38 Map Kinase and Angiogenic Targets, in Hematologic Malignancies.
|
Winski, Shannon L.
|
|
|
110 |
11 |
p. 4798
|
artikel
|
| 77 |
Activity of CDK1/2 Inhibitor LCQ195 Against Multiple Myeloma Cells.
|
McMillin, Douglas W.
|
|
|
110 |
11 |
p. 1519
|
artikel
|
| 78 |
Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.
|
Ma, Wanlong
|
|
|
110 |
11 |
p. 4546
|
artikel
|
| 79 |
Activity of New Heat Shock Protein 90 (hsp90) Inhibitor NVP-AUY922 Against Myeloma Cells Sensitive and Resistant to Conventional Agents.
|
McMillin, Douglas W.
|
|
|
110 |
11 |
p. 1587
|
artikel
|
| 80 |
Activity of Tyrosine Kinase Inhibitors in Multiple Myeloma.
|
Munker, Reinhold
|
|
|
110 |
11 |
p. 4804
|
artikel
|
| 81 |
Acute Graft-Versus-Host Disease Following Umbilical Cord Blood Transplantation: Retrospective Survey Involving 2015 Japanese Patients.
|
Miyakoshi, Shigesaburo
|
|
|
110 |
11 |
p. 1070
|
artikel
|
| 82 |
Acute Graft Versus Host Disease Reduces Human Thymic T Cell Differentiation without Acting on Thymocyte Proliferation.
|
Clave, Emmanuel
|
|
|
110 |
11 |
p. 2184
|
artikel
|
| 83 |
Acute Myeloid Leukemia (AML) with 9q Aberrations Occuring within a Non-Complex Karyotype Is Highly Associated with CEBPA and NPM1 Mutations - A Joint Analysis of the German-Austrian AML Study Group (AMLSG) and Cancer and Leukemia Group B (CALGB).
|
Corbacioglu, Andrea
|
|
|
110 |
11 |
p. 762
|
artikel
|
| 84 |
Acute Myeloid Leukemia with Normal Karyotype: Analysis of FLT3, NPM1, MLL and CEBPA Gene Abnormalities.
|
Trigo, Fernanda
|
|
|
110 |
11 |
p. 4245
|
artikel
|
| 85 |
Acute Promyelocytic Leukemia Harboring STAT5b-RARα Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.
|
Iwanaga, Eisaku
|
|
|
110 |
11 |
p. 4227
|
artikel
|
| 86 |
Acyclovir To Prevent Herpes Zoster in Myeloma Patients Treated with Bortezomib.
|
Vickrey, Eric
|
|
|
110 |
11 |
p. 4807
|
artikel
|
| 87 |
A Cytoplasmic Fusion/Cell Division Model for Renewal of Hematopoietic Stem Cell.
|
Tao, Wen
|
|
|
110 |
11 |
p. 2225
|
artikel
|
| 88 |
ADAMTS13 Antigen, Activity, and Autoantibody and ADAMTS13/fXI Complex Levels in Patients with Venous Thromboembolism.
|
Fryer, Hugh J.L.
|
|
|
110 |
11 |
p. 1635
|
artikel
|
| 89 |
ADAMTS13 Antigen, Activity, Autoantibody and ADAMTS13/fXI Complex Levels May Be Useful Diagnostic Biomarkers for Patients with Sickle Cell Disease.
|
Fryer, Hugh J.L.
|
|
|
110 |
11 |
p. 3805
|
artikel
|
| 90 |
ADAMTS13 Antigen Levels and the Risk of Relapse during Long-Term Clinical Follow Up of Patients with Idiopathic Thrombotic Thrombocytopenic Purpura.
|
Cataland, Spero R.
|
|
|
110 |
11 |
p. 3204
|
artikel
|
| 91 |
ADAMTS-13 Levels Do Not Predict Outcome in Thrombotic Thrombocytopenic Purpura: Protein S Levels Are Maintained during Plasma Exchange with Solvent Detergent Treated Plasma.
|
Rock, Gail A.
|
|
|
110 |
11 |
p. 2895
|
artikel
|
| 92 |
Adaptation of Augmented Berlin-Frankfurt-Munster (ABFM) Therapy in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL).
|
Rytting, Michael
|
|
|
110 |
11 |
p. 4342
|
artikel
|
| 93 |
Adaptation of Coagulation and Fibrinolysis in Allogeneic Stem Cell Transplantation.
|
Pinomaki, Anne
|
|
|
110 |
11 |
p. 3023
|
artikel
|
| 94 |
Adapting Cyclosporine to Calcineurin Activity Rather Than to Cyclosporine Blood Levels: Toward a Functional Management of Graft-Versus-Host Disease Prophylaxis.
|
Sanquer, Sylvia
|
|
|
110 |
11 |
p. 4990
|
artikel
|
| 95 |
Adaptor Protein Lnk Binds to PDGFRA, PDGFRB and FIP1L1-PDGFRA, but Not to the TEL-PDGFRB Fusion Protein.
|
Gueller, Saskia
|
|
|
110 |
11 |
p. 2213
|
artikel
|
| 96 |
Adaptor Protein Lnk Negatively Regulates Mutant MPL and JAK2 Alleles Associated with Myeloproliferative Disorders
|
Gery, Sigal
|
|
|
110 |
11 |
p. 1531
|
artikel
|
| 97 |
Addition of ATRA to the Maintenance Protocol Did Not Improve Disease-Free Survival: Results of the Russian APL Trial.
|
Parovichnikova, Elena N.
|
|
|
110 |
11 |
p. 4374
|
artikel
|
| 98 |
Addition of Fresh Frozen Plasma to Rituximab Induces a Major Clinical and Laboratory Response in Patients with Refractory Advanced CLL.
|
Klepfish, Abraham
|
|
|
110 |
11 |
p. 4723
|
artikel
|
| 99 |
Addition of Oblimersen (Bcl-2 Antisense) to Fludarabine/Cyclophosphamide for Relapsed/Refractory Chronic Lymphocytic Leukemia Extends Survival in Patients Who Achieve CR/nPR: Results from a Randomized Phase 3 Study.
|
O'Brien, Susan
|
|
|
110 |
11 |
p. 751
|
artikel
|
| 100 |
Addition of PTK787/ZK 222584 Can Lower the Dosage of Amsacrine To Achieve Equal Amounts of AML Cell Death.
|
Weidenaar, Alida C.
|
|
|
110 |
11 |
p. 4199
|
artikel
|
| 101 |
Addition of Rituximab Improves Progression-Free and Overall Survival in Patients with B-Cell Lymphoma Receiving Doxorubicin-Containing Chemotherapy
|
Sakai, Tatsunori
|
|
|
110 |
11 |
p. 1292
|
artikel
|
| 102 |
Addition of Rituximab to CHOP Chemotherapy Does Not Improve Clinical Outcome in Patients with Localized Gastric Diffuse Large B-Cell Lymphoma: A Retrospective Study by Ganken Adult Lymphoma Study Group (Single Institute Analysis).
|
Yokoyama, Masahiro
|
|
|
110 |
11 |
p. 4449
|
artikel
|
| 103 |
Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.
|
Al-Tourah, Abdulwahab J.
|
|
|
110 |
11 |
p. 790
|
artikel
|
| 104 |
Additon of Low-Dose Interferon-alpha (LD-IFN-a) and Lenalidomide after Failure to a Combination of Thalidomide and Prednisone in Myelofibrosis with Myeloid Metaplasia (MMM).
|
Reale, Lisa
|
|
|
110 |
11 |
p. 4645
|
artikel
|
| 105 |
Adenoviral Vector-Mediated Transfer of the Indian Hedgehog Gene Modulates Lymphomyelopoiesis In Vivo.
|
Kobune, Masayoshi
|
|
|
110 |
11 |
p. 2205
|
artikel
|
| 106 |
Adenovirus and BK Virus Co-Infection in the Pediatric Recipient of Stem Cell Transplant with CMV Infection.
|
Hongeng, Suradej
|
|
|
110 |
11 |
p. 5010
|
artikel
|
| 107 |
Adenovirus-Mediated Gene Transfer to Mesenchymal Stem Cells: Comparison of the Cytomegalovirus- and Rous Sarcoma Virus-Promoter.
|
Deng, Weiwen
|
|
|
110 |
11 |
p. 5145
|
artikel
|
| 108 |
Adenovirus Specific T-Cell Lines Devoid of Alloreactivity Against Haploidentical Recipients Can Be Obtained Using a Set of Adenovirus Hexon Peptides.
|
Comoli, Patrizia
|
|
|
110 |
11 |
p. 3273
|
artikel
|
| 109 |
A Distal Single Nucleotide Polymorphism Disrupts Development-Dependent Long-Range Transcriptional Regulation of the PU.1 Gene through the Chromatin-Remodeling Protein SATB1 in Acute Myeloid Leukemia.
|
Steidl, Ulrich
|
|
|
110 |
11 |
p. 3175
|
artikel
|
| 110 |
Adjuvant Rituximab and/or Chemotherapy Improves Outcome of Thrombotic Thrombocytopenic Purpura: University of Cincinnati Experience.
|
Karim, Nagla F. Abdel
|
|
|
110 |
11 |
p. 3219
|
artikel
|
| 111 |
Administration of Rituximab Is Feasible and Does Not Affect Engraftment of Allograft Recipients with Advanced CD20+ Malignancies.
|
Kharfan-Dabaja, Mohamed A.
|
|
|
110 |
11 |
p. 3016
|
artikel
|
| 112 |
Adoptive Cellular Therapy for Follicular Lymphoma Using Genetically-Modified Autologous CD20-Specific T Cells.
|
Till, Brian G.
|
|
|
110 |
11 |
p. 499
|
artikel
|
| 113 |
Adoptive Immunotherapy with Autologous CD25-Depleted and CD3/CD28-Costimulated T-Cells (ACTC) Enhances Numeric and Functional Lymphocyte Recovery after Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma.
|
Schuster, Stephen J.
|
|
|
110 |
11 |
p. 126
|
artikel
|
| 114 |
A Dose and Schedule Finding Study of Maintenance Therapy with Low-Dose 5-Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High-Risk AML or MDS.
|
de Lima, Marcos
|
|
|
110 |
11 |
p. 3012
|
artikel
|
| 115 |
A Dose Escalation Study of the Pharmacokinetics, Safety & Efficacy of Deferitrin, an Oral Iron Chelator in Beta Thalassaemia Patients.
|
Galanello, R.
|
|
|
110 |
11 |
p. 2669
|
artikel
|
| 116 |
A Dose Intensified Pediatric-Like Regimen Using Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.
|
Douer, Dan
|
|
|
110 |
11 |
p. 2823
|
artikel
|
| 117 |
Adult Human Stem Cells Exert Therapeutic Effects To Repair Damaged Tissues in Xenograft Systems through Secretion of Trophic Factors Rather Than Direct Incorporation and Expansion.
|
Sondergaard, Claus
|
|
|
110 |
11 |
p. 3693
|
artikel
|
| 118 |
A Dynamic Prognostic Model To Predict Survival in Post-Polycythemia Vera Myelofibrosis.
|
Passamonti, Francesco F.
|
|
|
110 |
11 |
p. 2547
|
artikel
|
| 119 |
A European Phase II Study (BIOV-111) of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia: Final Results.
|
Kearns, Pamela
|
|
|
110 |
11 |
p. 11
|
artikel
|
| 120 |
A First-In-Human Clinical Trial of Adoptive Therapy Using CD19-Specific Chimeric Antigen Receptor Re-Directed T-Cells for Recurrent/Refractory Follicular Lymphoma.
|
Jensen, Michael C.
|
|
|
110 |
11 |
p. 288
|
artikel
|
| 121 |
A Four Protein Plasma Fingerprint of Acute Graft Versus Host Disease (GVHD) Predicts Long Term Survival.
|
Paczesny, Sophie
|
|
|
110 |
11 |
p. 38
|
artikel
|
| 122 |
A FVII Deficiency Induces Cardiac Fibrosis in Mice Resulting in Systolic and Diastolic Dysfunction.
|
Xu, Haifeng
|
|
|
110 |
11 |
p. 1747
|
artikel
|
| 123 |
A GATA-1-Regulated microRNA Cluster That Is Essential for Erythropoiesis.
|
Dore, Louis C.
|
|
|
110 |
11 |
p. 378
|
artikel
|
| 124 |
A GC Box Element Is Critical for Transcriptional Regulation of the K-Cl Cotransporter Isoform KCC3a in Hematopoetic Cells.
|
Crable, Scott
|
|
|
110 |
11 |
p. 1712
|
artikel
|
| 125 |
Age-Associated Difference in Gene Expression of Pediatric Myelo-Monocytic and MLL-Rearranged AML.
|
Jo, Aoi
|
|
|
110 |
11 |
p. 3164
|
artikel
|
| 126 |
A Gene Expression-Based Risk Stratification Model Developed in Newly Diagnosed Multiple Myeloma Treated with High Dose Therapy Is Predictive of Outcome in Relapsed Disease Treated with Single Agent Bortezomib.
|
Zhan, Fenghaung
|
|
|
110 |
11 |
p. 656
|
artikel
|
| 127 |
A Genome-Wide Map of Acquired Uniparental Disomy in Acute Myeloid Leukemia.
|
Gupta, Manu
|
|
|
110 |
11 |
p. 996
|
artikel
|
| 128 |
A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.
|
Friedman, Daphne R.
|
|
|
110 |
11 |
p. 3096
|
artikel
|
| 129 |
“Age” of the Cord Blood (CB) Unit: Impact of Long-Term Cryopreservation and Storage on Transplant Outcome.
|
Scaradavou, Andromachi
|
|
|
110 |
11 |
p. 2033
|
artikel
|
| 130 |
Age-Related Changes in Hemostasis in Children with Acute Lymphoblastic Leukemia; Influences of Peg-Asparaginase Upfront and Native E Coli Asparaginase during Remission Induction Therapy.
|
Appel, Inge M.
|
|
|
110 |
11 |
p. 850
|
artikel
|
| 131 |
Age under 40 Does Not Confer Superior Prognosis in Patients with Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplant Despite High Response Rates.
|
Cheema, Parneet K.
|
|
|
110 |
11 |
p. 5123
|
artikel
|
| 132 |
Aggregation of Serum Free Light Chains (FLC) Causes Overestimation of FLC Nephelometric Results as Compared to Serum Protein Electrophoresis (SPE) While Preserving Clinical Usefulness.
|
Émond, Jean-Pierre
|
|
|
110 |
11 |
p. 4767
|
artikel
|
| 133 |
A GITIL Prospective Randomized Multicenter Phase III Study of High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Transplantation (ASCT) of Peripheral Blood Stem Cells Versus CHOP and Rituximab Delivered Every 14 Days (R-CHOP-14) in High-Risk Patients with Diffuse Large B-Cell Lymphomas (DLBCL): Interim Analysis on Feasibility and Toxicity (Protocol R-HDS 0305).
|
Cortelazzo, Sergio
|
|
|
110 |
11 |
p. 1898
|
artikel
|
| 134 |
A GMCSF/Interleukin-15 Fusokine Leads to the Generation of a Novel Type of CD2/MHCII Immune Regulatory Cell with Potent Immune Suppressive Properties as Demonstrated in the EAE Mouse Model of Multiple Sclerosis.
|
Rafei, Moutih
|
|
|
110 |
11 |
p. 2295
|
artikel
|
| 135 |
A Heat-Inducible Gene Expression System for a Dominant Negative Version of a TGF-β-Receptor Reveals Antitumor Activity in a Rodent Tumor Model
|
Noyan, Fatih
|
|
|
110 |
11 |
p. 3742
|
artikel
|
| 136 |
A Heme Export Protein Is Required for Red Cell Differentiation and Iron Homeostasis.
|
Keel, Sioban B.
|
|
|
110 |
11 |
p. 2658
|
artikel
|
| 137 |
A Heparin-Based Inhibitor of Heparanase Blocks Myeloma Growth In Vivo by Targeting the Tumor Microenvironment.
|
Yang, Yang
|
|
|
110 |
11 |
p. 1502
|
artikel
|
| 138 |
A Higher Ratio of Dose to Actual Weight of Conditioning Chemotherapy Leads to More Toxicity without Improvement in Outcome in Autologous HSC Transplant for DLBCL.
|
Costa, Luciano J.
|
|
|
110 |
11 |
p. 3017
|
artikel
|
| 139 |
A Highly Accurate and Linear Clauss Fibrinogen Assay Provides Increased Clinical Value for Patient Reporting throughout the 30 – 1000 mg/dL Medical Decision-Making Range.
|
Callahan, Janet
|
|
|
110 |
11 |
p. 3935
|
artikel
|
| 140 |
A High Purity Factor VIII/vWF Complex Concentrate Is Effective in the Management of Mild Hemophillia A with Inhibitors: A Case Report.
|
Dukka, Srivasavi
|
|
|
110 |
11 |
p. 3959
|
artikel
|
| 141 |
A High-Throughput Arrayed Lentiviral RNAi Screen To Identify Novel Oncogenes in Multiple Myeloma.
|
Schinzel, Anna C.
|
|
|
110 |
11 |
p. 4770
|
artikel
|
| 142 |
A High Throughput Screen Identified Cyproheptadine That Decreases D-Type Cyclins, Arrests Cells in the G1 Phase, and Induces Apoptosis in Multiple Myeloma and Leukemia Cells.
|
Mao, Xinliang
|
|
|
110 |
11 |
p. 1507
|
artikel
|
| 143 |
AHOD0321: A COG Phase 2 Study of Weekly Gemcitabine and Vinorelbine for Children with Recurrent or Refractory Hodgkin Disease.
|
Cole, Peter D.
|
|
|
110 |
11 |
p. 2318
|
artikel
|
| 144 |
AHSP Knockdown in Human Erythroleukemia Cell Line and Human Hematopoietic Stem Cells Results in Alpha Hemoglobin Chain Precipitation, Decreased Hemoglobin Levels and Increased Cell Death.
|
Pinho, Flavia O.
|
|
|
110 |
11 |
p. 1778
|
artikel
|
| 145 |
A Humanized Cooley's Anemia Mouse Model.
|
Huo, Yongliang
|
|
|
110 |
11 |
p. 1784
|
artikel
|
| 146 |
A Human Lymphoid Progenitor Capable of Circulating and Seeding the Thymus.
|
Six, Emmanuelle M.
|
|
|
110 |
11 |
p. 2216
|
artikel
|
| 147 |
Air Leak Syndrome (ALS) Following Allogeneic Stem Cell Transplantation (SCT): A Report of 22 Patients from Kanto Study Group for Cell Therapy (KSGCT) in Japan.
|
Sakai, Rika
|
|
|
110 |
11 |
p. 5022
|
artikel
|
| 148 |
A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.
|
Nanri, Tomoko
|
|
|
110 |
11 |
p. 3492
|
artikel
|
| 149 |
AKT Dependent and AKT Independent Multiple Myeloma: Heterogeneity in Tumor Cell Signaling.
|
Zöllinger, Angela
|
|
|
110 |
11 |
p. 1511
|
artikel
|
| 150 |
A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.
|
Cermak, Jaroslav
|
|
|
110 |
11 |
p. 2441
|
artikel
|
| 151 |
A Large Cohort Analysis of CMV Viral Load and Ganciclovir-Related Neutropenia in Nonmyeloablative (NM-HCT) and Myeloablative (M-HCT) Allogeneic Hematopoietic Cell Transplant Recipients.
|
Nakamae, Hirohisa
|
|
|
110 |
11 |
p. 2975
|
artikel
|
| 152 |
A Large Proportion of Elderly Patients with Anemia Seen in the Outpatient Setting Have Unexplained Anemia, Which Is Characterized as a Hypoproliferative, Normocytic Anemia.
|
Price, Elizabeth A.
|
|
|
110 |
11 |
p. 3667
|
artikel
|
| 153 |
A Large Ribosomal Subunit Protein Abnormality in Diamond-Blackfan Anemia (DBA).
|
Farrar, Jason
|
|
|
110 |
11 |
p. 422
|
artikel
|
| 154 |
Aldehyde Dehydrogenase-Activity Purifies Multiple Hemangiogenic Lineages That Accelerate Vascularization of Ischemic Tissue through Paracrine Support of Neovessel Formation.
|
Levac, Krysta D.
|
|
|
110 |
11 |
p. 3716
|
artikel
|
| 155 |
Alemtuzumab (ALZ) Is an Effective Treatment for Both Primary and Relapsed Severe Paraneoplastic Pemphigus (PNP) Associated to B-Cell Chronic Lymphocytic Leukemia (CLL).
|
Bech, Rikke
|
|
|
110 |
11 |
p. 4716
|
artikel
|
| 156 |
Alemtuzumab and Rituximab for Initial Treatment of High Risk, Early Stage Chronic Lymphocytic Leukemia (CLL).
|
Zent, Clive S.
|
|
|
110 |
11 |
p. 2050
|
artikel
|
| 157 |
Alemtuzumab as a Single Agent or Combined with Methylprednisolone (MPD) or Fludarabine (FDR) for the Treatment of CLL Patients with p53 and ATM Deletions.
|
Sebrango, A.
|
|
|
110 |
11 |
p. 3121
|
artikel
|
| 158 |
Alemtuzumab Increases Serious Infections in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine-Based Therapy: A Comparative Analysis of 3 Cancer and Leukemia Group B Studies (CALGB 9011, 9712, 19901).
|
Morrison, Vicki A.
|
|
|
110 |
11 |
p. 756
|
artikel
|
| 159 |
Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.
|
Beltran-Garate, Brady
|
|
|
110 |
11 |
p. 3425
|
artikel
|
| 160 |
Alemtuzumab Plus Cyclosporin A for Treatment of Patients with Bone Marrow Failure Syndrome.
|
Kim, Hawk
|
|
|
110 |
11 |
p. 3759
|
artikel
|
| 161 |
Alemtuzumab Reduces Chronic Graft Versus Host Disease (cGVHD) and Treatment Related Mortality (TRM) after Reduced Intensity Conditioning for AML and MDS.
|
van Besien, Koen
|
|
|
110 |
11 |
p. 1076
|
artikel
|
| 162 |
Alemtuzumab Treatment for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS): Preliminary Results.
|
Lee, Je-Hwan
|
|
|
110 |
11 |
p. 1464
|
artikel
|
| 163 |
Allelic Expression Imbalance of JAK2 V617F Mutant Contributes to Phenotypic Variation in BCR-ABL Negative Chronic Myeloproliferative Disorders.
|
Shin, Myung-Geun
|
|
|
110 |
11 |
p. 4651
|
artikel
|
| 164 |
Allogeneic Antibodies Identify GVL Targets CHAF1b and NuSAP1 in AML Patients.
|
Wadia, Persis P.
|
|
|
110 |
11 |
p. 168
|
artikel
|
| 165 |
Allogeneic Committed Hematopoietic Progenitors Are Protective Against Radiation.
|
Chen, Benny J.
|
|
|
110 |
11 |
p. 4871
|
artikel
|
| 166 |
Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: A Retrospective EBMT Analysis.
|
Schetelig, Johannes
|
|
|
110 |
11 |
p. 47
|
artikel
|
| 167 |
Allogeneic Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) after Pretransplant 5-Azacitidine.
|
Field, Teresa
|
|
|
110 |
11 |
p. 5035
|
artikel
|
| 168 |
Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.
|
Kienast, Joachim
|
|
|
110 |
11 |
p. 328
|
artikel
|
| 169 |
Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation Therapy for Adult T Cell Leukemia/Lymphoma Patients: A Single-Center Experience in 35 Patients.
|
Takemoto, Shigeki
|
|
|
110 |
11 |
p. 5037
|
artikel
|
| 170 |
Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Does the Melphalan Dose Matter?.
|
Mehta, Jayesh
|
|
|
110 |
11 |
p. 3035
|
artikel
|
| 171 |
Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia in Second Chronic Phase Attained by Imatinib after Onset of Blast Crisis.
|
Wang, Ying
|
|
|
110 |
11 |
p. 4566
|
artikel
|
| 172 |
Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: Evidence of Graft-Versus-Lymphoma Effect.
|
Hamadani, Mehdi
|
|
|
110 |
11 |
p. 3044
|
artikel
|
| 173 |
Allogeneic Hemopoietic Stem Transplant for Patients with Idiopathic Myelofibrosis Using a Reduced Intensity Thiotepa Based Conditioning Regimen.
|
Bacigalupo, Andrea
|
|
|
110 |
11 |
p. 684
|
artikel
|
| 174 |
Allogeneic HSCT for Hematologic Malignancies in 145 Patients - Identical Biologic Prognostic Factors Affect Outcome Despite Different Conditioning Regimen Intensities.
|
Rondelli, Damiano
|
|
|
110 |
11 |
p. 1087
|
artikel
|
| 175 |
Allogeneic HSC Transplantation for Multiple Myeloma: A Single Institution Experience.
|
Costa, Luciano J.
|
|
|
110 |
11 |
p. 3036
|
artikel
|
| 176 |
Allogeneic Peripheral Blood Stem Cell Transplantation for Hematological Malignancies in Patients with HIV.
|
Polizzotto, Mark N.
|
|
|
110 |
11 |
p. 4941
|
artikel
|
| 177 |
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.
|
Hemmati, Philipp G.
|
|
|
110 |
11 |
p. 3020
|
artikel
|
| 178 |
Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR).
|
Litzow, Mark
|
|
|
110 |
11 |
p. 3057
|
artikel
|
| 179 |
Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom's Macroglobulinemia (WM).
|
Kyriakou, Charalampia
|
|
|
110 |
11 |
p. 619
|
artikel
|
| 180 |
Allogeneic Stem Cell Transplantation as Treatment for Relapsed and High-Risk Peripheral T-Cell Lymphoma.
|
O'Leary, Hilary M.
|
|
|
110 |
11 |
p. 3040
|
artikel
|
| 181 |
Allogeneic Stem Cell Transplantation Can Be an Effective Post-Remission Strategy for Acute Myeloid Leukemia Patients Aged Less Than 60 Years with Core Binding Factor: A Nation-Wide Retrospective Study in Korea.
|
Shin, Ho-Jin
|
|
|
110 |
11 |
p. 1092
|
artikel
|
| 182 |
Allogeneic Stem Cell Transplantation for Relapsed Follicular Non-Hodgkin's Lymphoma: Single Centre Experience.
|
Peyman, Amir
|
|
|
110 |
11 |
p. 5054
|
artikel
|
| 183 |
Allogeneic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndrome (t-MDS) and Acute Myeloid Leukemia. A Report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
|
Kroeger, Nicolaus
|
|
|
110 |
11 |
p. 252
|
artikel
|
| 184 |
Allogeneic Stem Cell Transplantation in Angioimmunoblastic T-Cell Lymphoma (AITL): A Retrospective Survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).
|
Kyriakou, Charalampia
|
|
|
110 |
11 |
p. 3042
|
artikel
|
| 185 |
Allogeneic Stem Cell Transplantation in Multiple Myeloma: One Center Experience of 86 Patients.
|
Volin, Liisa
|
|
|
110 |
11 |
p. 3033
|
artikel
|
| 186 |
Allogeneic Stem Cell Transplantation with Dose-Reduced Conditioning in Relapsed Follicular and Mantle Cell Lymphoma - A Prospective Phase II Trial of the German Low Grade Lymphoma Study Group (GLSG).
|
Dreyling, Martin H.
|
|
|
110 |
11 |
p. 3058
|
artikel
|
| 187 |
Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.
|
Power, Maryse M.
|
|
|
110 |
11 |
p. 3491
|
artikel
|
| 188 |
Allografting for Adult T-Cell Leukemia/Lymphoma: A Nationwide Retrospective Analysis.
|
Hishizawa, Masakatsu
|
|
|
110 |
11 |
p. 3060
|
artikel
|
| 189 |
Allo-HLA Reactive CD8 T-Cells May Recognize Tissue Specific Peptides Explaining Tissue Restricted GVHD after HLA Mismatched SCT.
|
Amir, Avital
|
|
|
110 |
11 |
p. 72
|
artikel
|
| 190 |
All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct to High-Dose Cytarabine-Based Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of AMLSG 05-04 Trial.
|
Schlenk, Richard F.
|
|
|
110 |
11 |
p. 1837
|
artikel
|
| 191 |
All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As2O3) Combination Therapy Induces High Rates of Durable Molecular Remission in Newly Diagnosed Acute Promyelocytic Leukemia (APL).
|
Tsimberidou, Apostolia-Maria
|
|
|
110 |
11 |
p. 1834
|
artikel
|
| 192 |
A Long-Term Study on Indolent Adult T-Cell Leukemia/Lymphoma (ATLL).
|
Takasaki, Yumi
|
|
|
110 |
11 |
p. 3575
|
artikel
|
| 193 |
A Long-Term (5-Year) Sustained Efficacy of Tocilizumab for Multicentric Castleman's Disease and the Effect on Pulmonary Complications.
|
Nishimoto, Norihiro
|
|
|
110 |
11 |
p. 646
|
artikel
|
| 194 |
AlphaVBeta3 (αvβ3) Integrin Drives the Osteoclastogenesis through a Osteoclast-Like Functional Differentiation of Myeloma Cells.
|
Tucci, Marco
|
|
|
110 |
11 |
p. 814
|
artikel
|
| 195 |
Alteration in Melphalan Conditioning Regimen for Multiple Myeloma: Reflection on Therapeutic Benefit and Length of Hospital Stay.
|
Gopaluni, Srivalli
|
|
|
110 |
11 |
p. 4848
|
artikel
|
| 196 |
Altered ADAMTS-13 Expression in Human Umbilical Vein Endothelial Cells.
|
Kling, Stephen J.
|
|
|
110 |
11 |
p. 2709
|
artikel
|
| 197 |
Altered Expression of PP2A Regulatory Subunits in Chronic Myelogenous Leukemia: Identifying Targets for Improved Therapies.
|
Roberts, Kathryn G.
|
|
|
110 |
11 |
p. 2925
|
artikel
|
| 198 |
Alternate Donor HSCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study.
|
MacMillan, Margaret L.
|
|
|
110 |
11 |
p. 5071
|
artikel
|
| 199 |
Alternate Promoters Direct Tissue-Specific Expression of Erythrocyte Ankyrin Transcripts with Novel NH2-Termini.
|
Steiner, Laurie A.
|
|
|
110 |
11 |
p. 1710
|
artikel
|
| 200 |
A Mathematical Model of Stochastic Engraftment by Non-Interacting Single Umbilical Cord Blood (UCB) Grafts Predicts Accelerated Engraftment Using Multiple UCB Grafts.
|
Waller, Anthony F.
|
|
|
110 |
11 |
p. 2034
|
artikel
|
| 201 |
Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma.
|
Davies, Faith E.
|
|
|
110 |
11 |
p. 2505
|
artikel
|
| 202 |
AML1-ETO9a Correlated with C-KIT Overexpression/Mutation and Indicated Poor Disease Outcome in t(8;21) Acute Myeloid Leukemia.
|
Liang, Yang
|
|
|
110 |
11 |
p. 1822
|
artikel
|
| 203 |
AML1/RUNX1, One of the Most Common Targets of Aberration in Acute Myeloid Leukemia as a Transcriptional Regulator of Vascular Endothelial Growth Factor (VEGFA).
|
Elst, Arja ter
|
|
|
110 |
11 |
p. 1618
|
artikel
|
| 204 |
Ammonium Ions Derived from Spontaneous Decomposition of L-Glutamine Inhibit Lymphoid Differentiation from Hematopoietic Stem/Progenitor Cells.
|
Spangrude, Gerald J.
|
|
|
110 |
11 |
p. 2244
|
artikel
|
| 205 |
A Molecular Cytogenetics Profile of Chromosome 9p in CMPD.
|
Vaughan, Beverley R.
|
|
|
110 |
11 |
p. 4659
|
artikel
|
| 206 |
A Molecular Signature of Anergy Detected in a Subset of CLL Patients.
|
Ghia, Paolo
|
|
|
110 |
11 |
p. 742
|
artikel
|
| 207 |
Amonafide L-Malate Bypasses Multidrug Resistance Proteins in Secondary Acute Myeloid Leukemia.
|
O'Loughlin, Kieran L.
|
|
|
110 |
11 |
p. 2380
|
artikel
|
| 208 |
A Mouse Strain Which Responds Poorly to Angiogenic Stimuli Has a Higher Incidence of Irradiation-Induced Hematological Malignancies.
|
Osorio, Catarina
|
|
|
110 |
11 |
p. 4283
|
artikel
|
| 209 |
Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.
|
Lu, Shuqing
|
|
|
110 |
11 |
p. 2373
|
artikel
|
| 210 |
Amplification at 7q22 Targets CDK6 in T-Cell Lymphoma.
|
Nagel, Stefan
|
|
|
110 |
11 |
p. 3563
|
artikel
|
| 211 |
Amplitude of Response, Early Mobilization (M) and Pre-Autologous Transplant (ASCT) Use of Bortezomib (V) and/or Thalidomide (T) Are Predictors of Longer Progression Free (PFS) and/or Overall Survival (OS) in Myeloma.
|
Beksac, Meral
|
|
|
110 |
11 |
p. 5096
|
artikel
|
| 212 |
A Multi-Center Analysis of Renal Impairment as a Potential Prognostic Factor: Analysis in Multiple Myeloma Patients Treated with Standard or High-Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation.
|
Kleber, Martina
|
|
|
110 |
11 |
p. 4830
|
artikel
|
| 213 |
A Multicenter Clinicopathologic Experience of HTLV-1 ATLL: A Retrospective 15 Year Review Reveals Little Progress.
|
Phillips, Adrienne A.
|
|
|
110 |
11 |
p. 3569
|
artikel
|
| 214 |
A Multicenter Comparison of Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation with Tandem Autologous Stem Cell Transplantation in Multiple Myeloma.
|
Min, Chang-Ki
|
|
|
110 |
11 |
p. 940
|
artikel
|
| 215 |
A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV Chronic Lymphocytic Leukemia (CLL).
|
Mena, Raul R.
|
|
|
110 |
11 |
p. 1356
|
artikel
|
| 216 |
A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade B-Cell Non-Hodgkin's Lymphoma (NHL) or Bulky Stage II Lymphoma.
|
Mena, Raul R.
|
|
|
110 |
11 |
p. 1354
|
artikel
|
| 217 |
A Multicenter Phase II Study Using a Dose Intensified Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia.
|
DeAngelo, Daniel J.
|
|
|
110 |
11 |
p. 587
|
artikel
|
| 218 |
A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma.
|
Sym, Sun Jin
|
|
|
110 |
11 |
p. 3446
|
artikel
|
| 219 |
A Multicenter Study of a Gemcitabine-Based Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients.
|
Validire, Patricia
|
|
|
110 |
11 |
p. 4436
|
artikel
|
| 220 |
A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.
|
Epner, Elliot M.
|
|
|
110 |
11 |
p. 387
|
artikel
|
| 221 |
A Multicentre Phase II Trial Testing Gemcitabine in the Treatment of Patients with Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma: SAKK 36/03.
|
Hitz, Felicitas
|
|
|
110 |
11 |
p. 4454
|
artikel
|
| 222 |
A Multiple Myeloma Research Consortium (MMRC) Multicenter Phase I Trial of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM): Updated Results.
|
Jakubowiak, Andrzej
|
|
|
110 |
11 |
p. 1169
|
artikel
|
| 223 |
A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis.
|
Kouides, Peter A.
|
|
|
110 |
11 |
p. 711
|
artikel
|
| 224 |
Amyloidogenic lambda Light Chain Renal Toxicity: Oxidative Stress Implicated.
|
Zeldenrust, Steven R.
|
|
|
110 |
11 |
p. 3531
|
artikel
|
| 225 |
Amyloidosis Presenting with Platelet Dysfunction and Recurrent Retroperitoneal Hemorrhage (RH).
|
Rezazadeh, Arash
|
|
|
110 |
11 |
p. 3944
|
artikel
|
| 226 |
An Activating KRAS Mutation in Imatinib Resistant Chronic Myeloid Leukemia.
|
Agarwal, Anupriya
|
|
|
110 |
11 |
p. 1006
|
artikel
|
| 227 |
An Active Hemovigilance Program Characterizing the Safety Profile of 7,437 Platelet Transfusions Prepared with Photochemical Treatment (INTERCEPT™).
|
Osselaer, J.C.
|
|
|
110 |
11 |
p. 2894
|
artikel
|
| 228 |
Analyses of Heme-Regulated Genes during Erythoid Differentiation.
|
Fujiwara, Tohru
|
|
|
110 |
11 |
p. 2660
|
artikel
|
| 229 |
Analyses of Immune Defense Mechanisms of Human Polymorphonuclear Neutrophils Co-Cultivated with Aspergillus fumigatus Germ Tubes.
|
Loeffler, Juergen
|
|
|
110 |
11 |
p. 3848
|
artikel
|
| 230 |
Analysis of ADAMTS13 and Its IgG-Autoantibodies in 170 Patients with Connective Tissue Disease-Associated Thrombotic Microangiopathy Indicates More Than 2 Types on Its Pathogenesis.
|
Matsuyama, Tomomi
|
|
|
110 |
11 |
p. 1322
|
artikel
|
| 231 |
Analysis of 121 Allograft Recipients for the Treatment of Lymphoma: Progressive Disease by Functional and/or CT Imaging Is a Critical Determinant of Survival.
|
Sauter, Craig S.
|
|
|
110 |
11 |
p. 1658
|
artikel
|
| 232 |
Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).
|
Yavuz, Akif S.
|
|
|
110 |
11 |
p. 4662
|
artikel
|
| 233 |
Analysis of CD4+CD25hi Regulatory T Cells in the Peripheral Blood of Patients with B Cell Chronic Lymphocytic Leukemia (CLL).
|
Pappa, Vassiliki
|
|
|
110 |
11 |
p. 4710
|
artikel
|
| 234 |
Analysis of Class I and II Histone Deacetylase Fails To Identify a Human Leukemia Specific Expression Profile.
|
Garcia-Manero, Guillermo
|
|
|
110 |
11 |
p. 2130
|
artikel
|
| 235 |
Analysis of Factors Influencing Skin Toxicity after Autologous Hematopoeitic Stem Cell Transplant.
|
Mahindra, Anuj
|
|
|
110 |
11 |
p. 2882
|
artikel
|
| 236 |
Analysis of β Globin Mutations in the Indian Population: Presence of Rare and Novel Mutations and Region Wise Heterogeneity.
|
Edison, Eunice S.
|
|
|
110 |
11 |
p. 3822
|
artikel
|
| 237 |
Analysis of Glucose Profiles in Imatinib-Resistant or Intolerant Chronic Myelogenous Leukemia (CML) Patients (pts) Treated with Nilotinib: Lack of Correlation between Glucose Levels and Nilotinib Efficacy.
|
le Coutre, Philipp
|
|
|
110 |
11 |
p. 4588
|
artikel
|
| 238 |
Analysis of HOXA5 and HOXB3 Expression Complements Conventional Cytogenetic Analysis in Acute Myeloid Leukemia.
|
Finnegan, Damian P.J.
|
|
|
110 |
11 |
p. 2388
|
artikel
|
| 239 |
Analysis of Immunogenetic Factors in Myelodysplastic Syndromes (MDS) Reveals Potential Pathogenic Role Cytokine Genotypes Such as TGF-β.
|
Serio, Bianca
|
|
|
110 |
11 |
p. 2446
|
artikel
|
| 240 |
Analysis of Immunological and Clinical Response Kinetics to WT1 Peptide Vaccine in Patients with AML and MDS: Need for Supplementation of IWG Response Criteria?.
|
Keilholz, Ulrich
|
|
|
110 |
11 |
p. 902
|
artikel
|
| 241 |
Analysis of JAK2 V167F Mutation in Myelodysplastic Syndromes.
|
Fermo, Elisa
|
|
|
110 |
11 |
p. 4591
|
artikel
|
| 242 |
Analysis of Minimal Residual Disease (MRD) from the Phase 2 Multicenter Study of Subcutaneous (SC) Alemtuzumab Combined with Fludarabine for Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (CLL).
|
Flowers, Christopher
|
|
|
110 |
11 |
p. 3111
|
artikel
|
| 243 |
Analysis of Mismatched Umbilical Cord Blood Transplants for Adults Patients 45 Years or Older.
|
Lim, Seah H.
|
|
|
110 |
11 |
p. 5067
|
artikel
|
| 244 |
Analysis of Mutant cMPL in Philadelphia Chromosome-Negative Myeloproliferative Disorders (Ph−MPDs) Using a Novel High-Sensitivity Assay.
|
Samuelson, Scott J.
|
|
|
110 |
11 |
p. 2544
|
artikel
|
| 245 |
Analysis of Philadelphia Negative Clones Detected during Treatment with Tyrosine Kinase Inhibitors: A Study on 63 CML Cases.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 4541
|
artikel
|
| 246 |
Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.
|
Parker, Pablo M.
|
|
|
110 |
11 |
p. 1975
|
artikel
|
| 247 |
Analysis of T-Cell Leukemia/Lymphoma (TCL1) Oncoprotein Interacting Proteins by Immunoprecipitation and Tandem Mass Spectrometry.
|
Elenitoba-Johnson, Kojo S.J.
|
|
|
110 |
11 |
p. 3566
|
artikel
|
| 248 |
Analysis of T-Cell Subpopulations in the Lymph Nodes of Patients with Mantle Cell Lymphoma.
|
Sagatys, Elizabeth
|
|
|
110 |
11 |
p. 1580
|
artikel
|
| 249 |
Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.
|
Prasad, Vinod K.
|
|
|
110 |
11 |
p. 336
|
artikel
|
| 250 |
Analysis of the Role of Wnt Signaling for the Interaction between Leukemia Cells and Stroma.
|
Abe, Akihiro
|
|
|
110 |
11 |
p. 4314
|
artikel
|
| 251 |
Analysis of the V617F Mutation of the JAK2- and the W515 Mutation of the MPL Gene in Patients with Chronic Myeloproliferative Disease (CMPD) Treated in an Outpatient Practice.
|
Bojko, Peter
|
|
|
110 |
11 |
p. 4631
|
artikel
|
| 252 |
Analysis of ZAP-70 Expression in Chronic Lymphocytic Leukemia (CLL) Using Kolmogorov-Smirnov (KS) Statistics.
|
Gibbs, Graham
|
|
|
110 |
11 |
p. 4671
|
artikel
|
| 253 |
An Analysis of Occurrence and Prognosis Related Factors of Renal Dysfunction in Patients with Multiple Myeloma.
|
Fu, Rong
|
|
|
110 |
11 |
p. 4732
|
artikel
|
| 254 |
An Analysis of Treatment Choices for Acute Myeloid Leukemia in Patients 60 Years and Older from the University of Duesseldorf AML/MDS Database.
|
Klaerner, Viola
|
|
|
110 |
11 |
p. 4378
|
artikel
|
| 255 |
An Animal Model That Predicts Unit Engraftment in Double Unit Cord Blood Transplant Recipients.
|
Chaudhury, S.
|
|
|
110 |
11 |
p. 176
|
artikel
|
| 256 |
An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.
|
Campbell, Richard A.
|
|
|
110 |
11 |
p. 4802
|
artikel
|
| 257 |
An Approach to Virtual Karyotyping for Unbalanced Rearrangements Based on Gene Expression Data.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 885
|
artikel
|
| 258 |
An Association Study of Candidate Modifier Genes in a Large Pedigree with Von Willebrand Disease.
|
Di Paola, Jorge
|
|
|
110 |
11 |
p. 2135
|
artikel
|
| 259 |
An Atlas of the MicroRNA Genome in Human DLBCL.
|
Karanti, Shailaja
|
|
|
110 |
11 |
p. 563
|
artikel
|
| 260 |
Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.
|
Lapierre, Valerie
|
|
|
110 |
11 |
p. 3281
|
artikel
|
| 261 |
A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study.
|
Bates, Shannon
|
|
|
110 |
11 |
p. 698
|
artikel
|
| 262 |
Anemia and Iron Deficiency in Strenuously Trained Adolescents.
|
Merkel, Drorit
|
|
|
110 |
11 |
p. 961
|
artikel
|
| 263 |
Anemia an Old Player or a Cut-Throat in Patients with Coronary Artery Disease or Chronic Heart Failure.
|
Corinaldesi, Giorgio
|
|
|
110 |
11 |
p. 3762
|
artikel
|
| 264 |
Anemia as a Complication of Bariatric Surgery: Frequency and Evidence for Progressive Negative Iron Balance.
|
von Drygalski, Annette
|
|
|
110 |
11 |
p. 1721
|
artikel
|
| 265 |
Anemia in Congestive Heart Failure: The Anemia Is Common and Is Associated with More Severe CHF - Results of a National Survey.
|
Oster, Howard S.
|
|
|
110 |
11 |
p. 3685
|
artikel
|
| 266 |
An Enriched Multigen Low-Density Array To Predict Outcome in Advanced Hodgkin Lymphoma Paraffin-Embedded Samples.
|
Sanchez-Espiridion, Beatriz
|
|
|
110 |
11 |
p. 383
|
artikel
|
| 267 |
An Essential Role for ras in LPS Mediated Amplification of TREM-1 Induced Neutrophil Activation.
|
Radsak, Markus P.
|
|
|
110 |
11 |
p. 3311
|
artikel
|
| 268 |
A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.
|
Toulon, Pierre A.
|
|
|
110 |
11 |
p. 1626
|
artikel
|
| 269 |
A New Class of Dimeric α-Interferons (IFN-α) Made by the Dock and Lock (DNL) Method for Improved Cancer Therapy.
|
Rossi, Edmund A.
|
|
|
110 |
11 |
p. 1396
|
artikel
|
| 270 |
A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.
|
Lang, Peter J.
|
|
|
110 |
11 |
p. 3019
|
artikel
|
| 271 |
A New Enzyme Immuno-Assay That Only Detects IgG Antibodies to Heparin-PF4 Complexes (Zymutest HIA IgG®) Improves the Specificity of the Diagnosis of HIT without Loss of Sensitivity.
|
Pouplard, Claire
|
|
|
110 |
11 |
p. 2096
|
artikel
|
| 272 |
A New Fusion Gene NUP98-IQCG Identified in an Acute T/Myeloid Leukemia with t(3;11)(q29q13;p15) Translocation.
|
Pan, Qin
|
|
|
110 |
11 |
p. 1828
|
artikel
|
| 273 |
A New Generation XIAP Inhibitor Induces Apoptosis of Human Myeloma Cells and Synergises with Conventional and Novel Anti-Myeloma Therapeutics.
|
Khong, Tiffany
|
|
|
110 |
11 |
p. 4787
|
artikel
|
| 274 |
A New Mechanism of Platelet Activation and Oxidative Death Induced by ADAMTS-18 and Regulating Bleeding Time.
|
Li, Zongdong
|
|
|
110 |
11 |
p. 133
|
artikel
|
| 275 |
A New Mice Model of Graft Versus Host Disease Based on Chemotherapy Conditioning.
|
Sadeghi, Behnam
|
|
|
110 |
11 |
p. 4880
|
artikel
|
| 276 |
A New Model of Hereditary Spherocytosis Demonstrates Profound Homeostatic Compensation in Severely Anemic Mice.
|
Hughes, Michael R.
|
|
|
110 |
11 |
p. 1713
|
artikel
|
| 277 |
A New Mouse Model of Multiple Myeloma: Engraftment of Primary Human Multiple Myeloma in SCID/Beige Mice.
|
Arditti, Fabian D.
|
|
|
110 |
11 |
p. 3532
|
artikel
|
| 278 |
A New Multiparametric Flow Cytometry Technique Based on Combined Side Population (SP) and Aldehyde Deshydrogenase (ALDH) Functionalities Identifies a Hierarchy within the Human Hematopoietic Stem/Progenitor Compartment.
|
Pierre-Louis, Olivier
|
|
|
110 |
11 |
p. 2226
|
artikel
|
| 279 |
A New Murine Model of Immune Thrombocytopenia: Evidence of Both Antibody- and CD8+ T Cell-Mediated Platelet Destruction.
|
Chow, Leola
|
|
|
110 |
11 |
p. 99
|
artikel
|
| 280 |
A New Plate Based Plasma von Willebrand Factor (VWF): Ristocetin Cofactor Activity Assay.
|
Chen, Dong
|
|
|
110 |
11 |
p. 2143
|
artikel
|
| 281 |
A New Subtype of T-Cell Acute Leukemia in Very Young Children Is Defined by a Translocation Targeting the C-MYB Oncogene, and a Specific Gene Expression Signature.
|
Clappier, Emmanuelle
|
|
|
110 |
11 |
p. 982
|
artikel
|
| 282 |
An Exercise Training Programme Produces Significant Improvements in Quality of Life (QoL), Muscle Strength and Cardiorespiratory Function in Patients with Myeloma.
|
Groeneveldt, Lara J.
|
|
|
110 |
11 |
p. 3323
|
artikel
|
| 283 |
An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.
|
Sharathkumar, Anjali A.
|
|
|
110 |
11 |
p. 3196
|
artikel
|
| 284 |
An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.
|
Ramackers, Wolf
|
|
|
110 |
11 |
p. 3190
|
artikel
|
| 285 |
Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.
|
Clear, Andrew J.
|
|
|
110 |
11 |
p. 2609
|
artikel
|
| 286 |
Angiogenic Signature of Multiple Myeloma Determined by Gene Expression Profiling.
|
Hose, Dirk
|
|
|
110 |
11 |
p. 2484
|
artikel
|
| 287 |
Animal Model of Mitochondrial Dysfunction Generating Macrocytic Anemia and Myelodysplastic Bone Marrow Failure.
|
Chen, Michael
|
|
|
110 |
11 |
p. 402
|
artikel
|
| 288 |
An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.
|
Arnold, Donald M.
|
|
|
110 |
11 |
p. 3926
|
artikel
|
| 289 |
An Intact Spleen Is Required for Alloimmunization to Transfused Red Blood Cells Due to Intrasplenic Activation of CD4+ T Cells.
|
Hendrickson, Jeanne E.
|
|
|
110 |
11 |
p. 453
|
artikel
|
| 290 |
An Integrated Pharmacogenomic Strategy for the Definition of Thalidomide Response Signatures in Presenting Cases of Multiple Myeloma.
|
Morgan, Gareth J.
|
|
|
110 |
11 |
p. 2493
|
artikel
|
| 291 |
An Interim Analysis of Phase II, Open Randomized Comparative Trial: Alternate or Multiple-Day Dosing of Palonosetron (PALO) Is Effective and Safe in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients (pts) with Leukemia Receiving High Dose Ara-C (HDAC).
|
Mattiuzzi, Gloria
|
|
|
110 |
11 |
p. 2840
|
artikel
|
| 292 |
An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.
|
Haferlach, Torsten
|
|
|
110 |
11 |
p. 3169
|
artikel
|
| 293 |
An International Multi-Institutional Study of Double Cord Blood Transplantation in a Racially Diverse Population.
|
Ballen, Karen
|
|
|
110 |
11 |
p. 2017
|
artikel
|
| 294 |
An Intron-Derived Insertion/Truncation Mutation in the BCR-ABL Kinase Domain in Three CML Patients Undergoing Kinase Inhibitor Therapy.
|
Laudadio, Jennifer
|
|
|
110 |
11 |
p. 1953
|
artikel
|
| 295 |
An In Vitro and In Vivo Evidence That Interleukin-8 Is a Pivotal Hypoxia-Regulated Pro-Angiopoietic Factor Secreted by Human Rhabdomyosarcomas (RMS) - Therapeutic Implications.
|
Wysoczynski, Marcin
|
|
|
110 |
11 |
p. 3720
|
artikel
|
| 296 |
An In Vitro Study To Compare Argatroban with Bivalirudin, Lepirudin and Danaparoid Concerning the Effects on Fibrin Gel Permeability, APTT and INR.
|
He, Shu
|
|
|
110 |
11 |
p. 1886
|
artikel
|
| 297 |
An In Vivo Evidence That Murine Very Small Embryonic Like (VSEL) Stem Cells Are Mobilized into Peripheral Blood after Acute Myocardial Infarction (AMI) and Contribute to Myocardiac Regeneration.
|
Zuba-Surma, Ewa K.
|
|
|
110 |
11 |
p. 3694
|
artikel
|
| 298 |
An In Vivo Evidence That the CD45negative Adult Marrow-Derived CXCR4+ SSEA-1+ OCT-4+ Very Small Embryonic-Like (VSEL) Stem Cells May Differentiate into CD45positive Long Term Repopulating Hematopoietic Stem Cells.
|
Wysoczynski, Marcin
|
|
|
110 |
11 |
p. 505
|
artikel
|
| 299 |
An MMR Control RNA for Reliable Monitoring of BCR-ABL Transcripts in Treated CML Patients.
|
Toplin, Julie
|
|
|
110 |
11 |
p. 2939
|
artikel
|
| 300 |
Annexin 2 Mediates Plasminogen-Related Recruitment of Neovascular Mural Cells in Lymphoma Angiogenesis.
|
Hajjar, Katherine A.
|
|
|
110 |
11 |
p. 3708
|
artikel
|
| 301 |
An Observational Post Authorization Study on the Use of Bortezomib in Multiple Myeloma Patients in The Netherlands: Results of an Interim Analysis.
|
Biesma, Douwe H.
|
|
|
110 |
11 |
p. 4808
|
artikel
|
| 302 |
A Noncatalytic, Ras-Independent Function of SHP-2 Is Essential in Hematopoietic Progenitors.
|
Braun, Benjamin S.
|
|
|
110 |
11 |
p. 85
|
artikel
|
| 303 |
A Non-Myeloablative Regimen of Fludarabine and Melphalan Is Safe and Well Tolerated for Allogeneic Transplantation in Multiple Myeloma.
|
Qazilbash, Muzaffar H.
|
|
|
110 |
11 |
p. 3032
|
artikel
|
| 304 |
An Open Label, Dose Escalation Study of AVE9633 Administered as a Single Agent by Intravenous (IV) Infusion Weekly for 2 Weeks in 4-Week Cycle to Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia (AML).
|
Legrand, Ollivier
|
|
|
110 |
11 |
p. 1850
|
artikel
|
| 305 |
An Open-Label, Phase 2 Trial of Denosumab in the Treatment of Relapsed (R) or Plateau-Phase (PP) Multiple Myeloma (MM).
|
Vij, Ravi
|
|
|
110 |
11 |
p. 3604
|
artikel
|
| 306 |
An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.
|
Shen, Yang
|
|
|
110 |
11 |
p. 4816
|
artikel
|
| 307 |
An Open, Phase I Study of Cediranib in Patients with Acute Myeloid Leukemia (AML).
|
Fiedler, Walter
|
|
|
110 |
11 |
p. 895
|
artikel
|
| 308 |
A NOTCH1-Independant Pathway of c-Myc Oncogenesis in TAL1+ Human T-ALL.
|
Montpellier, B.
|
|
|
110 |
11 |
p. 4162
|
artikel
|
| 309 |
A Novel Antibody-Based Minimal Intensity Conditioning Regimen for Children with Severe Organ Toxicity or DNA Repair Disorders.
|
Straathof, K.C.
|
|
|
110 |
11 |
p. 3253
|
artikel
|
| 310 |
A Novel Approach for Analyzing Gene Expression Profiles Defines Two Distinct Subgroups of t(4;11) Positive Infant Acute Lymphoblastic Leukemia Patients.
|
Stam, Ronald W.
|
|
|
110 |
11 |
p. 4282
|
artikel
|
| 311 |
A Novel Approach for Minimal Residual Disease Detection in Childhood T-Cell Lymphoblastic Lymphoma (T-LL): A Children's Oncology Group Report.
|
Coustan-Smith, Elaine
|
|
|
110 |
11 |
p. 3564
|
artikel
|
| 312 |
A Novel Assay for Development of Chromosomal Lesions in Human CD34+ Cells Following Exposure to Ionizing Radiation Reveals Increased Susceptibility To Acquire Unstable Chromosomal Lesions in CML CD34+ Cells.
|
Chakraborty, Sujata
|
|
|
110 |
11 |
p. 997
|
artikel
|
| 313 |
A Novel Assay for Juvenile Myelomonocytic Leukemia Based on Aberrant Signaling Networks Measured Via Phospho-Specific Flow Cytometry Reduces Diagnosis Time from Weeks to Days.
|
Kotecha, Nikesh
|
|
|
110 |
11 |
p. 546
|
artikel
|
| 314 |
A Novel Chemo Sensitivity Index for Melphalan Based on Gene Expression Profiling (GEP).
|
Dahlgaard, Jesper O.
|
|
|
110 |
11 |
p. 4191
|
artikel
|
| 315 |
A Novel Class of Activating Mutations in NOTCH1 in T-ALL.
|
Sulis, Maria Luisa
|
|
|
110 |
11 |
p. 694
|
artikel
|
| 316 |
A Novel Cytotoxic Mechanism by Leukemia-Specific Antibody in Immunotherapy with Leukemia Cell-Derived Heat Shock Protein 70.
|
Sato, Kazuya
|
|
|
110 |
11 |
p. 2302
|
artikel
|
| 317 |
A Novel HIFalpha Mutation Associated with Familial Erythrocytosis Supports This Isoform Being the Major Regulator of Erythropoietin in Humans.
|
Percy, Melanie J.
|
|
|
110 |
11 |
p. LB5
|
artikel
|
| 318 |
A Novel Histone Deacetylase Inhibitor MCT-3 Augments Inhibition of Leukemia Cell Growth and Suppresses Induction of MMP-9 Expression by Azacitidine in HL-60 Cells.
|
Liu, Hongbin
|
|
|
110 |
11 |
p. 4151
|
artikel
|
| 319 |
A Novel In-Frame Deletion in Domain C1 of Factor V Gene Results in Profound Decrease in Factor V Activity.
|
Song, Jaewoo
|
|
|
110 |
11 |
p. 2151
|
artikel
|
| 320 |
A Novel Marker for Blood Platelet Storage Lesion: Newly Synthesized Rap1 in Integrin Signaling.
|
Schubert, Peter
|
|
|
110 |
11 |
p. 4020
|
artikel
|
| 321 |
A Novel Measurement of the Rate of Spontaneous Mutations in Human Myeloid Cells.
|
Araten, David J.
|
|
|
110 |
11 |
p. 1823
|
artikel
|
| 322 |
A Novel Mechanism for CTL Mediated Veto Activity: CTLs Respond to Recognition by Alloreactive T Cell with Activation and Cytotoxic Granule Secretion.
|
Milstein, Oren
|
|
|
110 |
11 |
p. 2303
|
artikel
|
| 323 |
A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.
|
Shi, Jumei
|
|
|
110 |
11 |
p. 1525
|
artikel
|
| 324 |
A Novel Mechanism of Ig and Myc Translocations in AID-Deficient Mice.
|
Kovalchuk, Alexander L.
|
|
|
110 |
11 |
p. 990
|
artikel
|
| 325 |
A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.
|
Shou, Beiming
|
|
|
110 |
11 |
p. 4140
|
artikel
|
| 326 |
A Novel Mutation of the α Spectrin Gene in a Family of Northern European Descent Is Associated with Three Different Phenotypes.
|
Agarwal#, Neeraj
|
|
|
110 |
11 |
p. 1717
|
artikel
|
| 327 |
A Novel Non-Invasive Method of Detecting Galactomannan in Suspected Pulmonary Aspergillosis.
|
Doffman, Sarah R.
|
|
|
110 |
11 |
p. 3862
|
artikel
|
| 328 |
A Novel Notch Pathway Inhibitor Blocks Osteoclast Activity and Synergistically Induces Apoptosis with the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cells.
|
Jundt, Franziska
|
|
|
110 |
11 |
p. 1522
|
artikel
|
| 329 |
A Novel Pan-PI3K/Akt Inhibitor, SF1126, Inhibits In Vitro Growth of Multiple Myeloma Cells.
|
Silberman, Jeannine
|
|
|
110 |
11 |
p. 4806
|
artikel
|
| 330 |
A Novel PF4-Heparin Microbead Assay and Plasma Protein Biomarker Profiling for Improved Diagnosis of Heparin Induced Thrombocytopenia.
|
Ravindran, Resmi
|
|
|
110 |
11 |
p. 3216
|
artikel
|
| 331 |
A Novel Plant Mannose-Binding Lectin, NTL, Preserves Cord Blood Hematopoietic Stem/Progenitor Cells in Long-Term Culture and Enhances Their Ex Vivo Expansion.
|
Li, Karen Kwai Har
|
|
|
110 |
11 |
p. 1197
|
artikel
|
| 332 |
A Novel Putative Mechanism of Anti-Myeloma Activity Targeted Against Heat Shock Protein 27 by Derivative of Artemisinin, Artesunate.
|
Chizuka, Aki
|
|
|
110 |
11 |
p. 1521
|
artikel
|
| 333 |
A Novel Role for Bcl-xL in the Context of p210 BCR/ABL B Cell Acute Lymphoblastic Leukemia (B-ALL).
|
Harb, Jason G.
|
|
|
110 |
11 |
p. 156
|
artikel
|
| 334 |
A Novel Role for CpG Oligonucleotides in Tumor Immunotherapy: CpG-ODN Induce Targeted Chemokine-Induced Lymphocyte Migration to the Peripheral Tissues in Humans.
|
Haining, W. Nicholas
|
|
|
110 |
11 |
p. 1791
|
artikel
|
| 335 |
A Novel Role of Histone Deacetylase 11 (HDAC11) in the Regulation of IL-10 Production and Immune Tolerance Mediated by Antigen-Presenting Cells.
|
Wang, Hongwei
|
|
|
110 |
11 |
p. 1330
|
artikel
|
| 336 |
A Novel Selectin Antagonist, GMI-1070, Prevents Vaso-Occlusion in Sickle Cell Mice by Inhibiting Leukocyte Adhesion and Activation.
|
Chang, Jungshan
|
|
|
110 |
11 |
p. 2245
|
artikel
|
| 337 |
A Novel Small-Molecule Approach To Inhibit Jak2 Tyrosine Kinase Signaling.
|
Kapuria, Vaibhav
|
|
|
110 |
11 |
p. 1556
|
artikel
|
| 338 |
A Novel, Small Non-Peptidyl Butyzamide Activates Human Thrombopoietin Receptor and Promotes Megakaryopoiesis.
|
Nogami, Wataru
|
|
|
110 |
11 |
p. 2201
|
artikel
|
| 339 |
A Novel Splicing Factor RBM25 in Erythroid Differentiation.
|
Zhou, Anyu
|
|
|
110 |
11 |
p. 1711
|
artikel
|
| 340 |
A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.
|
Takami, Akiyoshi
|
|
|
110 |
11 |
p. 5001
|
artikel
|
| 341 |
A Novel Target of Histone Deacetylase Inhibitor, Involves in Mitochondria Membrane Protein Ubiquitination and Regulates Apoptosis.
|
Wu, Peng
|
|
|
110 |
11 |
p. 4187
|
artikel
|
| 342 |
A Novel Therapy of Clofarabine in Combination with Etoposide and Cyclophosphamide Shows Activity in Pediatric Patients with Refractory or Relapsed Acute Leukemia.
|
Hijiya, Nobuko
|
|
|
110 |
11 |
p. 883
|
artikel
|
| 343 |
A Novel Whole Blood Real-Time Microparticles Detection Assay Using Lactadherin-Coupled Dynabeads.
|
Shah, Mona D.
|
|
|
110 |
11 |
p. 702
|
artikel
|
| 344 |
An 86-Probe Gene Expression Signature Can Predict Survival in AML with Normal Karyotype Independently of FLT3 ITD and NPM1 Mutation Status - A Collaborative Study from the AMLCG and CALGB Study Groups.
|
Metzeler, Klaus H.
|
|
|
110 |
11 |
p. 596
|
artikel
|
| 345 |
Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.
|
Chaib, Hassiba
|
|
|
110 |
11 |
p. 889
|
artikel
|
| 346 |
Anti-Angiogenic Effects of Sorafenib in Relapsed Chronic Lymphocytic Leukemia: Correlative Studies of a Phase 2 Clinical Trial.
|
Reganti, Sowjanya
|
|
|
110 |
11 |
p. 4726
|
artikel
|
| 347 |
Anti-Apoptotic Effect of Soluble IL-6 Receptor on Megakaryocytic Lineage in Physiologic Conditions and Essential Thrombocythemia.
|
Chazarreta, Carlos D.
|
|
|
110 |
11 |
p. 4087
|
artikel
|
| 348 |
Anti-Apoptotic Proteins, HSP90 and Activated STAT3 Contribute to Busulfan Resistance of Myeloid Leukemia Cells.
|
Andersson, Borje S.
|
|
|
110 |
11 |
p. 3472
|
artikel
|
| 349 |
Antibiotic Prophylaxis Before Dental Procedures Can Reduce ONJ Incidence.
|
Montefusco, Vittorio
|
|
|
110 |
11 |
p. 3613
|
artikel
|
| 350 |
Antibodies Targeting Subunit 1 of the N-Methyl-D-Aspartate Receptor May Contribute to Immune Mediated Thrombocytopenia.
|
Kalev-Zylinska, Maggie L.
|
|
|
110 |
11 |
p. 2110
|
artikel
|
| 351 |
Antibody-Based Depletion of Hematopoietic Stem Cells Empties Niches for Efficient Transplantation.
|
Czechowicz, Agnieszka
|
|
|
110 |
11 |
p. LB2
|
artikel
|
| 352 |
Antibody-Drug Conjugates with Uncleavable Linkers for the Treatment of Non-Hodgkin Lymphoma.
|
Polson, Andrew G.
|
|
|
110 |
11 |
p. 526
|
artikel
|
| 353 |
Antibody-Targeted FISH Analysis Improves Detection of Residual Disease in “High Risk” B-Cell Acute Lymphoblastic Leukemia.
|
Slovak, Marilyn L.
|
|
|
110 |
11 |
p. 3500
|
artikel
|
| 354 |
Anti-Cancer Effects of Rapamycin on U937 Cell Line.
|
Jin, Lina
|
|
|
110 |
11 |
p. 4518
|
artikel
|
| 355 |
Anti-CD3 Activated T Cells from Cord Blood Can Be Expanded Ex Vivo and Armed with Bispecific Antibodies To Lyse Her2/Neu + and CD20+ Targets: A Strategy for Providing Anti-Tumor/Lymphoma Effects after Cord Blood Transplant.
|
Sorenson, Carly B.
|
|
|
110 |
11 |
p. 2751
|
artikel
|
| 356 |
Anti-CD45 Pretargeted Radioimmunotherapy in a Nonhuman Primate Model.
|
Green, Damian J.
|
|
|
110 |
11 |
p. 2336
|
artikel
|
| 357 |
Anti-Chronic Graft Versus Host Disease Activity Though a Regulatory T Cell Dependent Mechanism after Photodynamic Therapy.
|
Bastien, Jean-Philippe
|
|
|
110 |
11 |
p. 3280
|
artikel
|
| 358 |
Anti-DKK1 mAb (BHQ880) as a Potential Therapeutic for Multiple Myeloma.
|
Fulciniti, Mariateresa
|
|
|
110 |
11 |
p. 551
|
artikel
|
| 359 |
Anti-Erythroblast Autoimmunity in Pediatric Myelodysplatic Syndromes.
|
Caruso, Roberta
|
|
|
110 |
11 |
p. 4596
|
artikel
|
| 360 |
Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation: Results of a Retrospective Cohort Study.
|
Wolschke, Christine
|
|
|
110 |
11 |
p. 5004
|
artikel
|
| 361 |
Antigen Activation and Impaired Fas-Induced Death-Inducing Signaling Complex (DISC) Formation in Large Granular Lymphocyte Leukemaia.
|
Yang, Jun
|
|
|
110 |
11 |
p. 4701
|
artikel
|
| 362 |
Anti-Glycophorin C Induces a Loss of Mitochondrial Membrane Potential but Fails To Activate Apoptotic Caspases.
|
Denomme, Gregory A.
|
|
|
110 |
11 |
p. 4097
|
artikel
|
| 363 |
Anti-Idiotype Antibody Response after Vaccination Correlates with Better Overall Survival in Follicular Lymphoma.
|
Ai, Wei Z.
|
|
|
110 |
11 |
p. 647
|
artikel
|
| 364 |
Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo.
|
Wagtmann, Nicolai
|
|
|
110 |
11 |
p. 582
|
artikel
|
| 365 |
Anti-β2-Microglobulin Monoclonal Antibodies Recruit MHC Class I to and Exclude Growth and Survival Cytokine Receptors from Lipid Rafts and Induce Apoptosis in Myeloma Cells.
|
Yang, Jing
|
|
|
110 |
11 |
p. 1523
|
artikel
|
| 366 |
Anti-Moesin Antibodies Derived from Patients with Aplastic Anemia Stimulate Monocytes To Secrete TNF-α through an ERK1/2-Dependent Pathway.
|
Espinoza, Luis J.
|
|
|
110 |
11 |
p. 1690
|
artikel
|
| 367 |
Anti-Murine Thymocyte Globulin Prevents Acute Graft-Versus-Host Disease and Induces Foxp3+ T Cells in Target Organs.
|
Ruzek, Melanie C.
|
|
|
110 |
11 |
p. 3251
|
artikel
|
| 368 |
Anti-Myeloma Activity of Selective PI-3K/PDK/mTOR Inhibitor BEZ235.
|
McMillin, Douglas W.
|
|
|
110 |
11 |
p. 1185
|
artikel
|
| 369 |
Anti-Myeloma Activity of the Dual Akt/p70S6K Inhibitor EXEL-6075.
|
McMillin, Douglas W.
|
|
|
110 |
11 |
p. 649
|
artikel
|
| 370 |
Antimyeloma Efficacy of Plitidepsin (Aplidin®): From Bench to the Bedside.
|
Ocio, Enrique M.
|
|
|
110 |
11 |
p. 1178
|
artikel
|
| 371 |
Anti-Oxidant Treatment with α-Lipoic Acid and Acetyl L-Carnitine in Hemoglobinopathies.
|
Lal, Ashutosh
|
|
|
110 |
11 |
p. 3799
|
artikel
|
| 372 |
Antiphospholipid Antibodies with LAC Activity That Bind beta2-Glycoprotein I Cause Increased Resistance Against Activated Protein C.
|
de Laat, Bas
|
|
|
110 |
11 |
p. 3622
|
artikel
|
| 373 |
Antiphospholipid Antibody Syndrome: The Flow Cytometric Annexin A5 Competition Assay as a Diagnostic Tool.
|
Tomer, Aaron
|
|
|
110 |
11 |
p. 3981
|
artikel
|
| 374 |
Anti-Proliferative Effect of Rapamycin on Human T Cell Leukemia Cell Line Jurkat by Cell Cycle Arrest and Telomerase Inhibition.
|
Zhao, Yanmin
|
|
|
110 |
11 |
p. 4285
|
artikel
|
| 375 |
Antisense Strategies to Specifically Deplete Levels of Factors II, VII and IX in Mice To Assess Their Potential as Targets for Anticoagulation.
|
Zhang, Hong
|
|
|
110 |
11 |
p. 922
|
artikel
|
| 376 |
Antithrombin Deficiency in Pregnancy.
|
Andrew, Retter J.
|
|
|
110 |
11 |
p. 1879
|
artikel
|
| 377 |
Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects.
|
Zhao, Yongqiang
|
|
|
110 |
11 |
p. 3982
|
artikel
|
| 378 |
Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.
|
Ayuk, Francis
|
|
|
110 |
11 |
p. 2980
|
artikel
|
| 379 |
Antitumor Activity of Bortezomib Alone and in Combination with TRAIL in Human Acute Myeloid Leukemia.
|
Conticello, Concetta
|
|
|
110 |
11 |
p. 4307
|
artikel
|
| 380 |
Anti-Tumor Activity of Immunoproteasome Selective Inhibitors.
|
Parlati, Francesco
|
|
|
110 |
11 |
p. 1599
|
artikel
|
| 381 |
Anti-Tumor Cytotoxicity of γδ T Cells Expanded from Blood Cells of Myeloma and Leukemia Patients Against Self Tumor Cells — Enhancement of the Anti-Tumor Cytotoxicity by Type I IFN, Dendritic Cells, and Activated αβ T Cells.
|
Saito, Anri
|
|
|
110 |
11 |
p. 4762
|
artikel
|
| 382 |
Anti-Tumor Effect of INNO-406, a Novel Bcr-Abl Inhibitor in Combination with Cyclosporin A Against the Murine Central Nervous System and Systemic Leukemia Model.
|
Yokota, Asumi
|
|
|
110 |
11 |
p. 1598
|
artikel
|
| 383 |
Antitumour Activity of Bortezomib-Pegylated Liposomal Doxorubicine Association as Salvage Therapy in Multiple Myeloma Patients.
|
Braccalenti, Giulia
|
|
|
110 |
11 |
p. 4832
|
artikel
|
| 384 |
An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma.
|
Bruno, B.
|
|
|
110 |
11 |
p. 482
|
artikel
|
| 385 |
A NUP98-HOXD13 Fusion Gene Impairs Differentiation of T and B Lymphocytes.
|
Choi, Chul Won
|
|
|
110 |
11 |
p. 2650
|
artikel
|
| 386 |
A NUP98-HOXD13 Fusion Gene Induces a Transplantable Myelodysplastic Syndrome in Mice.
|
Chung, Yang Jo
|
|
|
110 |
11 |
p. 401
|
artikel
|
| 387 |
A Panel of Artificial Antigen-Presenting Cells (AAPC) Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Subdominant and Dominant Viral Epitopes for Adoptive Therapy.
|
Hasan, Aisha
|
|
|
110 |
11 |
p. 2589
|
artikel
|
| 388 |
A 3,239 -Patient Combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) Analysis of the Effect of CR vs. Responses < CR on Long-Term Survival in Newly-Diagnosed AML Treated with Ara-C-Containing Regimens: Implications for Targeted Drug Development.
|
Estey, Elihu
|
|
|
110 |
11 |
p. 298
|
artikel
|
| 389 |
A Pharmacokinetic Study of the Plasma-Derived Factor IX AlphaNine® and Its Comparison with the Recombinant Factor IX BeneFIX®, in Previously Treated Patients with Severe Hereditary Hemophilia B.
|
Cortina, Vicente R.
|
|
|
110 |
11 |
p. 3955
|
artikel
|
| 390 |
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.
|
Wilson, Wyndham H.
|
|
|
110 |
11 |
p. 1371
|
artikel
|
| 391 |
A Phase I Dose Escalation Study of KW-2449, an Oral Multi-Kinase Inhibitor Against FLT3, Abl, FGFR1 and Aurora in Patients with Relapsed/Refractory AML, Treatment Resistant/Intolerant CML, ALL and MDS.
|
Cortes, Jorge
|
|
|
110 |
11 |
p. 909
|
artikel
|
| 392 |
A Phase I/II Dose Escalation Trial of ONCOHIST® (Recombinant Human Histone H1.3) in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
|
Zeppezauer, Michael
|
|
|
110 |
11 |
p. 918
|
artikel
|
| 393 |
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. G-CSF+Placebo for Mobilization in Multiple Myeloma (MM) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.
|
DiPersio, John
|
|
|
110 |
11 |
p. 445
|
artikel
|
| 394 |
A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. Placebo+G-CSF in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.
|
DiPersio, John F.
|
|
|
110 |
11 |
p. 601
|
artikel
|
| 395 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).
|
Gerds, Aaron
|
|
|
110 |
11 |
p. 479
|
artikel
|
| 396 |
A Phase I–II Study To Determine the Maximum Tolerated Infusion-Rate of Rituximab, with a Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function.
|
Siano, Marco
|
|
|
110 |
11 |
p. 3411
|
artikel
|
| 397 |
A Phase I-II Study To Determine the Safety, Pharmacokinetics and Potential Efficacy of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 on Days 1 and 15 of a 28 Day Schedule in Patients with Non-Hodgkin's or Hodgkin's Lymphoma.
|
O'Connor, Owen A.
|
|
|
110 |
11 |
p. 2556
|
artikel
|
| 398 |
A Phase I/II Trial of Radioimmunotherapy (RIT) with 90Yttrium-Ibritumomab Tiuxetan (Zevalin®; 90Y-Zevalin) Combined with the Redox-Active Agent Motexafin Gadolinium (MGd): Prompt and High Remission Rates in Patients with Rituximab-Refractory Non-Hodgkin's Lymphoma (NHL).
|
Evens, Andrew M.
|
|
|
110 |
11 |
p. 2558
|
artikel
|
| 399 |
A Phase I/II Trial on Melphalan, Prednisone, Thalidomide and Defribotide Combination in Relapsed/Refractory Multiple Myeloma Patients.
|
Palumbo, Antonio
|
|
|
110 |
11 |
p. 2715
|
artikel
|
| 400 |
A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results.
|
Galli, Monica
|
|
|
110 |
11 |
p. 1175
|
artikel
|
| 401 |
A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.
|
Mahlangu, Johnny
|
|
|
110 |
11 |
p. 783
|
artikel
|
| 402 |
A Phase II, Open Label Study of AT-101 in Combination with Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Evaluation of Two Dose Regimens.
|
Castro, Januario E.
|
|
|
110 |
11 |
p. 3119
|
artikel
|
| 403 |
A Phase II Study of Bortezomib (Velcade®), Cylophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma.
|
Jagannath, Sundar
|
|
|
110 |
11 |
p. 188
|
artikel
|
| 404 |
A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).
|
Amrein, Philip C.
|
|
|
110 |
11 |
p. 3126
|
artikel
|
| 405 |
A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.
|
Walgren, Richard
|
|
|
110 |
11 |
p. 1451
|
artikel
|
| 406 |
A Phase II Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL).
|
Chen, Christine I.
|
|
|
110 |
11 |
p. 2042
|
artikel
|
| 407 |
A Phase II Study To Assess the Safety, Efficacy and Tolerability of Rituximab in Combination with Plasma Exchange in Patients with Acute Idiopathic Thrombotic Thrombocytopenic Purpura.
|
Scully, Marie
|
|
|
110 |
11 |
p. 1303
|
artikel
|
| 408 |
A Phase II Study with Cyclophosphamide, Vincristine, Liposomal Doxorubicin (Myocet™), and Prednisone Plus Rituximab, Administered in a Two Weeks Regimen (R-COMP-14) as Primary Treatment for NHL: Efficacy and Safety Interim Analysis.
|
Herrero, J.
|
|
|
110 |
11 |
p. 1368
|
artikel
|
| 409 |
A Phase II Trial of Alemtizimab and Rituximab in Patients with Previously Untreated CLL.
|
Frankfurt, Olga
|
|
|
110 |
11 |
p. 2056
|
artikel
|
| 410 |
A Phase II Trial of Autologous Stem Cell Transplant (AHSCT) Followed by Mini-Allogeneic Stem Cell Transplant (AlloTx) for the Treatment of Multiple Myeloma: Analysis of ECOG E4A98.
|
Vesole, David H.
|
|
|
110 |
11 |
p. 3027
|
artikel
|
| 411 |
A Phase II Trial of Combination Therapy with Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients with Overlap Myelodysplastic/Myeloproliferative Diseases (MDS/MPD) or Chronic Idiopathic Myelofibrosis (CIMF).
|
Sekeres, Mikkael A.
|
|
|
110 |
11 |
p. 1457
|
artikel
|
| 412 |
A Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls.
|
Reeder, Craig B.
|
|
|
110 |
11 |
p. 3601
|
artikel
|
| 413 |
A Phase II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Relapsed Aggressive Non-Hodgkin Lymphoma (NHL).
|
Reeder, Craig B.
|
|
|
110 |
11 |
p. 121
|
artikel
|
| 414 |
A Phase II Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by a 24-h Continuous Infusion Every 2 Weeks to Patients with Chronic Idiopathic Myelofibrosis (CIMF).
|
Verstovsek, Srdan
|
|
|
110 |
11 |
p. 3553
|
artikel
|
| 415 |
A Phase I Study of a Novel Human Monoclonal Antibody (mAb216) with Chemotherapy for the Treatment of Patients with Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia.
|
Liedtke, Michaela
|
|
|
110 |
11 |
p. 2831
|
artikel
|
| 416 |
A Phase I Study of CHR-2797, an Orally Active Aminopeptidase Inhibitor in Elderly and/or Treatment Refractory Patients with Acute Myeloid Leukemia or Multiple Myeloma.
|
Davies, Faith
|
|
|
110 |
11 |
p. 443
|
artikel
|
| 417 |
A Phase I Study of Immune Gene Therapy for Patients with CLL Using a Membrane-Stable, Humanized CD154.
|
Wierda, William G.
|
|
|
110 |
11 |
p. 2040
|
artikel
|
| 418 |
A Phase I Study of INNO-406 in Patients with Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Imatinib and Second Generation Tyrosine Kinase Inhibitors.
|
Kantarjian, Hagop M.
|
|
|
110 |
11 |
p. 469
|
artikel
|
| 419 |
A Phase I Study of the Combination of the Histone Deacetylase Inhibitor Vorinostat with Idarubicin in Advanced Acute Leukemia.
|
Kadia, Tapan M.
|
|
|
110 |
11 |
p. 1842
|
artikel
|
| 420 |
A Phase I Study of the Farnesyltransferase Inhibitor Tipifarnib in a Week-On Week-Off Dose Schedule in Acute Myelogenous Leukemia.
|
Kirschbaum, Mark H.
|
|
|
110 |
11 |
p. 891
|
artikel
|
| 421 |
A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.
|
Barosi, Giovanni
|
|
|
110 |
11 |
p. 3540
|
artikel
|
| 422 |
A Phase I Study of Tipifarnib Combined with Conventional Induction and Consolidation Therapy for Previously Untreated Patients with Acute Myeloid Leukemia Age 60 and Over.
|
Brandwein, Joseph M.
|
|
|
110 |
11 |
p. 899
|
artikel
|
| 423 |
A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.
|
Verstovsek, Srdan
|
|
|
110 |
11 |
p. 553
|
artikel
|
| 424 |
A Phase I Study with CP-4055 In Patients with Hematologic Malignancies.
|
Giles, Francis
|
|
|
110 |
11 |
p. 901
|
artikel
|
| 425 |
A Phase I Trial of AT9283, a Multitargeted Kinase Inhibitor, in Patients with Refractory Hematological Malignancies.
|
Ravandi, Farhad
|
|
|
110 |
11 |
p. 904
|
artikel
|
| 426 |
A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.
|
Jang, Geundoo
|
|
|
110 |
11 |
p. 4446
|
artikel
|
| 427 |
A Phase I Trial of CpG-7909, Rituximab Immunotherapy, and Y90 Zevalin Radioimmunotherapy for Patients (Pts) with Previously Treated CD20+ Non-Hodgkin Lymphoma (NHL).
|
Witzig, Thomas E.
|
|
|
110 |
11 |
p. 124
|
artikel
|
| 428 |
A Phase I Trial of Sirolimus (Rapamycin) in Pediatric Patients with Relapsed/Refractory Leukemia.
|
Rheingold, Susan R.
|
|
|
110 |
11 |
p. 2834
|
artikel
|
| 429 |
A Phase I Trial of Subcutaneous (SQ) Dose-Escalated Alemtuzumab in Patients with T-Cell Lymphoproliferative Disorders (T-LPD).
|
Porcu, Pierluigi
|
|
|
110 |
11 |
p. 3417
|
artikel
|
| 430 |
A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by Continuous Infusion for up to Four Days to Patients with Hematological Malignancies.
|
Schimmer, Aaron D.
|
|
|
110 |
11 |
p. 892
|
artikel
|
| 431 |
A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML).
|
Yee, Karen W.L.
|
|
|
110 |
11 |
p. 908
|
artikel
|
| 432 |
A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).
|
Shirasugi, Yukari
|
|
|
110 |
11 |
p. 1308
|
artikel
|
| 433 |
A Phase 3 Pilot Study of Continuous Imatinib Versus Pulsed Imatinib with or without G-CSF in Patients with Chronic Phase CML Who Have Achieved a Complete Cytogenetic Response to Imatinib.
|
Heaney, Nicholas
|
|
|
110 |
11 |
p. 1033
|
artikel
|
| 434 |
A Phase 3 Randomized, Historically-Controlled Clinical Trial Investigating the Use of Defibrotide in the Treatment of Severe Veno-Occlusive Disease Post-SCT: A Novel Approach to the Validation of a Promising New Drug for the Treatment of a Life Threatening Disease.
|
Richardson, Paul
|
|
|
110 |
11 |
p. 614
|
artikel
|
| 435 |
A Phase 2 Study of Fludarabine and Rituximab for the Treatment of Marginal Zone Lymphomas.
|
Brown, Jennifer R.
|
|
|
110 |
11 |
p. 1358
|
artikel
|
| 436 |
A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non Hodgkin Lymphoma. A California Cancer Consortium Study.
|
Kirschbaum, Mark H.
|
|
|
110 |
11 |
p. 2568
|
artikel
|
| 437 |
A Phase 1 Trial of Daily Oral Green Tea Extract in Asymptomatic, Rai Stage 0–II Patients with Chronic Lymphocytic Leukemia.
|
Shanafelt, T.D.
|
|
|
110 |
11 |
p. 2047
|
artikel
|
| 438 |
A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).
|
Advani, Anjali S.
|
|
|
110 |
11 |
p. 906
|
artikel
|
| 439 |
A Phase 1 Trial of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) in Combination with Bortezomib in Patients with Relapsed/Refractory Mantle Cell Lymphoma.
|
Goy, Andre
|
|
|
110 |
11 |
p. 2569
|
artikel
|
| 440 |
A Pilot Study Evaluating the CD34+ Cell Mobilizing Activity and Adverse Events Associated with Escalating Doses of AMD3100 in Healthy Volunteers.
|
Lemery, Steven J.
|
|
|
110 |
11 |
p. 3278
|
artikel
|
| 441 |
A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.
|
Luo, Chengwei
|
|
|
110 |
11 |
p. 4969
|
artikel
|
| 442 |
A Pilot Study of the Accuracy of Diagnostic Coding for Venous Thromboembolism within an Administrative Dataset of Emergency Department Visits.
|
Pai, Menaka
|
|
|
110 |
11 |
p. 969
|
artikel
|
| 443 |
A Pilot Study of Treatment with Mesterlone, Prednisone and Low-Dose Thalidomide for Patients with Myelodysplastic Syndromes.
|
Aguayo, Alvaro
|
|
|
110 |
11 |
p. 4598
|
artikel
|
| 444 |
A Pilot Trial of Valproic Acid in Patients with Kaposi's Sarcoma: A Multi-Center Trial of the AIDS Malignancy Consortium.
|
Lechowicz, Mary Jo
|
|
|
110 |
11 |
p. 2279
|
artikel
|
| 445 |
A Pilot Trial To Assess College Student's Willingness To Donate Blood.
|
Demmons, Derrick G.
|
|
|
110 |
11 |
p. 4029
|
artikel
|
| 446 |
A Point Mutation in the Juxtamembrane Wedge of CD45 Impacts Myeloid Development and Generates a Novel Model for Hemophagocytic Disorders in the Context of a MHC I-Restricted Transgene.
|
Hermiston, Michelle L.
|
|
|
110 |
11 |
p. 317
|
artikel
|
| 447 |
Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia.
|
Weinberg, J. Brice
|
|
|
110 |
11 |
p. 3081
|
artikel
|
| 448 |
Apoptosis Induced by Extracts of Helleborus Niger in Different Lymphoma and Leukemia Cell Lines and Primary Lymphoblasts of Children with ALL Is Independent of Smac-Overexpression and Executed Via the Mitochondrial Pathway.
|
Jesse, Patrick
|
|
|
110 |
11 |
p. 4215
|
artikel
|
| 449 |
Apoptosis Inducing Factor Acts as a Survival Factor in Acute Myelogenous Leukemia through Mitochondrial Complex 1.
|
Wang, Rui-yu
|
|
|
110 |
11 |
p. 1812
|
artikel
|
| 450 |
Apoptosis in Response to Inhibition of Dipeptidyl Peptidase 2 (DPP2) Defines Low Risk Chronic Lymphocytic Leukemia (CLL).
|
Danilov, Alexey V.
|
|
|
110 |
11 |
p. 3094
|
artikel
|
| 451 |
Apoptosis Stimulating Protein of p53 (ASPP2) Haploinsufficiency Promotes Irradiation-Induced High Grade Lymphomas in a Mouse Model.
|
Kampa, Kerstin M.
|
|
|
110 |
11 |
p. 2639
|
artikel
|
| 452 |
Apoptosis Taqman Low-Density Array: Analysis of Programmed Cell Death Patway in CLL.
|
Cortelezzi, Agostino
|
|
|
110 |
11 |
p. 3369
|
artikel
|
| 453 |
A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients with Hematologic Malignancies.
|
Mould, Diane R.
|
|
|
110 |
11 |
p. 1370
|
artikel
|
| 454 |
Apotransferrin Injection Leads to More Effective Erythropoiesis in β-Thalassemic Mice.
|
Ginzburg, Yelena Z.
|
|
|
110 |
11 |
p. 276
|
artikel
|
| 455 |
Application of Homoharringtonine in the Treatment of Acute Promyelocytic Leukemia.
|
Wang, Jianxiang
|
|
|
110 |
11 |
p. 1841
|
artikel
|
| 456 |
Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population.
|
Hyatt, Sarah A.
|
|
|
110 |
11 |
p. 2138
|
artikel
|
| 457 |
Applying the Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Myeloablative MUD Transplants Predicts NRM and OS Using a Modified 2-Tier Scoring System.
|
Kovacsovics, Tibor
|
|
|
110 |
11 |
p. 1988
|
artikel
|
| 458 |
A Predictive Statistical Model To Identify Thalassemic Phenotype (β0 vs β+) in Heterozygous β-Thalassemia.
|
Calvo-Villas, Jose Manuel
|
|
|
110 |
11 |
p. 3823
|
artikel
|
| 459 |
APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21.
|
Gupta, Mamta
|
|
|
110 |
11 |
p. 3585
|
artikel
|
| 460 |
A Profile of 44 Long Term Survivors (>10yrs) with AL Amyloidosis.
|
Wechalekar, Ashutosh D.
|
|
|
110 |
11 |
p. 4765
|
artikel
|
| 461 |
A Profile of 648 Signaling Network Events Identifies Cell Subsets with Diverse, Abnormal Responses to Lymphocyte Stimuli within Follicular Lymphoma Tumors.
|
Irish, Jonathan M.
|
|
|
110 |
11 |
p. 356
|
artikel
|
| 462 |
A Prognostic Model for Predicting the Impact of Comorbidities on Survival of Patients with Myelodysplastic Syndromes.
|
Porta, Matteo G. Della
|
|
|
110 |
11 |
p. 2453
|
artikel
|
| 463 |
A Prospective Clinical Trial of a Novel Epstein-Barr Virus (EBV) PCR Panel in Patients with EBV Associated Malignancies.
|
Xavier, Marin F.
|
|
|
110 |
11 |
p. 2628
|
artikel
|
| 464 |
A Prospective Gene Expression Profiling Study for Prediction of Cytogenetic Response in Early and Late Chronic Phase CML.
|
Wolf, Dominik
|
|
|
110 |
11 |
p. 2916
|
artikel
|
| 465 |
A Prospective Multivariate Analysis of Risk Factors Associated with Occurrence of Febrile Neutropenia in Any Cycle in NHL Patients Receiving Chemotherapy.
|
Pettengell, Ruth
|
|
|
110 |
11 |
p. 4447
|
artikel
|
| 466 |
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.
|
Bruno, B.
|
|
|
110 |
11 |
p. 3026
|
artikel
|
| 467 |
A Prospective Randomised Trial of Intravenous Iron Therapy Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Australian Women
|
Khalafallah, Alhossain A.
|
|
|
110 |
11 |
p. 3750
|
artikel
|
| 468 |
A Prospective, Randomized, Phase III Study of Enoxaparin Versus Aspirin Versus Low-Fixed-Dose of Warfarin in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Containing Regimens.
|
Palumbo, Antonio
|
|
|
110 |
11 |
p. 310
|
artikel
|
| 469 |
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients.
|
Palumbo, Antonio
|
|
|
110 |
11 |
p. 727
|
artikel
|
| 470 |
A Prospective Randomized Study of Rituximab and Dexamethasone vs Dexamethasone Alone in ITP.
|
Zaja, Francesco
|
|
|
110 |
11 |
p. 567
|
artikel
|
| 471 |
A Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine Plus Mitoxantrone Followed by Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) and Maintenance Rituximab as Front Line Therapy for Patients with Intermediate or High Risk Follicular Non-Hodgkin's Lymphoma.
|
Gregory, Stephanie A.
|
|
|
110 |
11 |
p. 1360
|
artikel
|
| 472 |
A Prospective Study of Imatinib 400 mg vs 800 mg Frontline in High Risk Ph+ Chronic Myeloid Leukemia (CML) Patients.
|
Baccarani, Michele
|
|
|
110 |
11 |
p. 26
|
artikel
|
| 473 |
A Prospective Study of the Prognostic Impact of 18[F]-FDG-PET and Molecular Response in Patients with Relapsed Indolent Non-Hodgkin Lymphoma (NHL) Following Iodine-131-Rituximab Radio-Immunotherapy (RIT).
|
Bishton, Mark J.
|
|
|
110 |
11 |
p. 3421
|
artikel
|
| 474 |
A Prospective Study of t(4;14) Multiple Myeloma.
|
Karlin, Lionel
|
|
|
110 |
11 |
p. 414
|
artikel
|
| 475 |
A Randomized Comparison of Total-Marrow Irradiation, Busulfan and Cyclophosphamide with Tandem High-Dose Melphalan in Patients with Multiple Myeloma.
|
Knop, Stefan
|
|
|
110 |
11 |
p. 728
|
artikel
|
| 476 |
A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.
|
Lonial, Sagar
|
|
|
110 |
11 |
p. 949
|
artikel
|
| 477 |
A Randomized Phase 3 Study of Tipifarnib Compared to Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients 70 Years or Older.
|
Harousseau, Jean-Luc
|
|
|
110 |
11 |
p. 439
|
artikel
|
| 478 |
A Randomized, Placebo-Controlled, Dose-Escalation, Phase 1 Study of the Safety and Pharmacokinetics of Amphotericin B Inhalation Powder in Healthy Subjects.
|
Marcantonio, Annette
|
|
|
110 |
11 |
p. 4988
|
artikel
|
| 479 |
A Randomized Placebo Controlled Phase II Trial of Prevention of Severe Oral Mucositis Using Single Dose Velafermin in Patients Receiving Myeloablative Therapy and Autologous Hematopoietic Stem Cell Transplant (AHSCT).
|
Schuster, Michael W.
|
|
|
110 |
11 |
p. 615
|
artikel
|
| 480 |
A Randomized Study of Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine in Patients with Hairy Cell Leukemia.
|
Zenhausern, Reinhard
|
|
|
110 |
11 |
p. 1352
|
artikel
|
| 481 |
A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.
|
Rajkumar, S. Vincent
|
|
|
110 |
11 |
p. 74
|
artikel
|
| 482 |
A Rapid and Sensitive Method for Large-Scale Screening of CEBPA Mutations in AML Patients with Normal Karyotype.
|
Benthaus, Tobias
|
|
|
110 |
11 |
p. 3483
|
artikel
|
| 483 |
A Rapid Assay of Cytosine Arabinoside Uptake and Metabolism by Acute Myeloid Leukaemic Cells Using a Bioluminescent Bacterial Biosensor.
|
Smith, Graham
|
|
|
110 |
11 |
p. 4308
|
artikel
|
| 484 |
A Rapid Automated Method for the Sequential Isolation of CD19, CD3 and Myeloid Cells from One Tube of Whole Blood.
|
McQueen, Karina L.
|
|
|
110 |
11 |
p. 4867
|
artikel
|
| 485 |
A Rare Case of JAK2 V617F Positive Polycythemia Vera in a Child with Neurofibromatosis Type I.
|
Berman, Jason N.
|
|
|
110 |
11 |
p. 4661
|
artikel
|
| 486 |
Are Back-Up Bone Marrow Harvests of Value in Unrelated Donor Allogeneic Transplants?.
|
Stotler, Christy
|
|
|
110 |
11 |
p. 5023
|
artikel
|
| 487 |
A Repertoire of Genes Modifying the Risk of Death in Sickle Cell Anemia.
|
Sebastiani, Paola
|
|
|
110 |
11 |
p. 150
|
artikel
|
| 488 |
A Retrospective Analysis of Response to High Dose Rituximab Monotherapy in CLL/NHL Patients Who Received Prior Standard Dose Rituximab Therapy.
|
Moffa, Casey A.
|
|
|
110 |
11 |
p. 4722
|
artikel
|
| 489 |
A Retrospective Chart Review of the Hematologic Consequences of Roux-en-y Gastric Bypass Surgery.
|
Costantino, Christina L.
|
|
|
110 |
11 |
p. 3772
|
artikel
|
| 490 |
Argatroban Associated Bleeding Complications.
|
Berz, David
|
|
|
110 |
11 |
p. 1867
|
artikel
|
| 491 |
Arginine Diet for Sickle Transgenic Mice Reduces Endothelin-1-Stimulated Gardos Channel Activity.
|
Romero, Jose R.
|
|
|
110 |
11 |
p. 3399
|
artikel
|
| 492 |
Arginine Therapy Does Not Benefit Children with Sickle Cell Anemia — Results of the CSCC Clinical Trial Consortium Multi-Institutional Study.
|
Styles, Lori
|
|
|
110 |
11 |
p. 2252
|
artikel
|
| 493 |
A Rho-GTPase Effector, Rhotekin-2 (RTKN2) Is Associated with BMP8b and IL-16 Cytokine Expression and Increased Sensitivity to Apoptosis in Lymphocytes.
|
Collier, Fiona M.
|
|
|
110 |
11 |
p. 2293
|
artikel
|
| 494 |
A Role for Regulatory Cells in Tolerance Induction in Recipients of Haploidentical Combined Non-Myeloablative Bone Marrow and Kidney Transplantation?.
|
Andreola, Giovanna
|
|
|
110 |
11 |
p. 3255
|
artikel
|
| 495 |
A Role for Survivin in Enucleation of Erythroid Progenitors.
|
Keerthivasan, Ganesan
|
|
|
110 |
11 |
p. 1704
|
artikel
|
| 496 |
A Role of Autotaxin in Non-Mutational Resistance in Imatinib-Resistant Acute Lymphoblastic Leukemia (ALL) Cell Line SupB15RT.
|
Schmidt-Tanguy, Aline
|
|
|
110 |
11 |
p. 2804
|
artikel
|
| 497 |
Array CGH Analysis at 60kb Resolution of CML Samples at Advanced Stage of Disease.
|
Grace, Colin
|
|
|
110 |
11 |
p. 2927
|
artikel
|
| 498 |
Array CGH Analysis for PTCL-U Revealed a Distinct Subgroup with Pathological and Clinical Relevance.
|
Nakagawa, Masao
|
|
|
110 |
11 |
p. 4412
|
artikel
|
| 499 |
Array CGH Analysis of Nodal T-Cell Lymphomas: Identification of Genomic Alterations Specific to Angioimmunoblastic and Unspecified Subtypes, and Correlation with Transcriptomic Data.
|
de Leval, Laurence
|
|
|
110 |
11 |
p. 3567
|
artikel
|
| 500 |
Arsenic Trioxide (As2O3) Mediated Cell Death in Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL): Investigation of Reactive Oxygen Species (ROS), Caspase, and MAP Kinase Signaling Pathways.
|
Bhalla, Savita
|
|
|
110 |
11 |
p. 2576
|
artikel
|
| 501 |
Arsenic Trioxide Induce the Upregulation of β1-Subunit of Proteasome in NB4 Cell.
|
Wang, Huaiyu
|
|
|
110 |
11 |
p. 4361
|
artikel
|
| 502 |
Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan Is Safe and Effective for Autotransplantation for Multiple Myeloma.
|
Qazilbash, Muzaffar H.
|
|
|
110 |
11 |
p. 942
|
artikel
|
| 503 |
Artificial Hematopoietic Stem Cell Niche Sustains Growth and Differentiation of Human ES-Derived Early Hematopoietic Progenitors.
|
Esmaeli-Azad, Babak
|
|
|
110 |
11 |
p. 1415
|
artikel
|
| 504 |
ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.
|
Ashraf, Khaleel K.
|
|
|
110 |
11 |
p. 5006
|
artikel
|
| 505 |
A SCID-hu In Vivo Mouse Model of Human Primary Mantle Cell Lymphoma.
|
Wang, Michael
|
|
|
110 |
11 |
p. 2337
|
artikel
|
| 506 |
A Search of Public Gene Expression Microarray Data Identifies Novel Agents That Selectively Eradicate AML Stem Cells.
|
Hassane, Duane C.
|
|
|
110 |
11 |
p. 776
|
artikel
|
| 507 |
A Selective and Potent Oral Inhibitor of the JAK2 Tyrosine Kinase Reverses Polycythemia and Leukocytosis Induced by JAK2 V617F in a Mouse Model.
|
Zaleskas, Virginia M.
|
|
|
110 |
11 |
p. 557
|
artikel
|
| 508 |
A Sense Oligonucleotide Specifically Reverses the Prothrombin Depletion and Anticoagulation Caused by ISIS 401025, an Antisense Oligonucleotide Targeting Prothrombin RNA in Mice.
|
Zhao, Chenguang
|
|
|
110 |
11 |
p. 926
|
artikel
|
| 509 |
A Shift in the Intestinal Microflora towards Pro-Inflammatory Bacteria and Signaling Via Toll-Like-Receptor 2 Triggers Early Onset of Graft-Versus-Host Disease.
|
Nogai, Axel
|
|
|
110 |
11 |
p. 2171
|
artikel
|
| 510 |
A Simple and Reliable Method To Verify the Authenticity and Purity of Human Myeloma Cell Lines.
|
Keats, Jonathan J.
|
|
|
110 |
11 |
p. 2485
|
artikel
|
| 511 |
A Single-Center Study To Evaluate the Safety and Efficacy of Intravenous/Oral Fludarabine in Untreated Gastric MALT Lymphoma. Impact of t(11;18)(q21;q21) in Molecular Response Rates.
|
Salar, Antonio
|
|
|
110 |
11 |
p. 4439
|
artikel
|
| 512 |
A Single-Centre Experience of Clinico-Pathological Features, Risk Factors and Treatment Outcome of Posttransplant Lymphoproliferative Disorders (PTLD) after Renal Transplantation.
|
Sondergaard, Esben
|
|
|
110 |
11 |
p. 4421
|
artikel
|
| 513 |
A Single Nucleotide Polymorphism in CD19 Defines a Novel Target for Immunotherapy of B Cell Malignancies with CD4+ Cytotoxic T Cells.
|
Spaapen, Robbert M.
|
|
|
110 |
11 |
p. 1798
|
artikel
|
| 514 |
A Small Animal In Vivo Imaging Model of Expanded vs. Unexpanded UCB Stem Cells Reveals Differential Patterns of Engraftment.
|
Steiner, David
|
|
|
110 |
11 |
p. 1191
|
artikel
|
| 515 |
A Small Fragment of ADAMTS13 Enhances Cleavage of von Willebrand Factor by the Intact Enzyme.
|
Majerus, Elaine M.
|
|
|
110 |
11 |
p. 1742
|
artikel
|
| 516 |
A Soft-Drug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.
|
Bradner, James
|
|
|
110 |
11 |
p. 800
|
artikel
|
| 517 |
Asparagine Depletion, Safety and Antibody Production after E Coli Asparaginase Treatment in Children with Newly Diagnosed Acute Lymphoblastic Leukaemia Treated with EORTC 58951 Protocol: A Single Center Report.
|
Bertrand, Yves
|
|
|
110 |
11 |
p. 4337
|
artikel
|
| 518 |
Assesment of the Prevalence and Impact of Anemia on Women Hospitalized for Gynecologic Conditions Associated with Heavy Uterine Bleeding.
|
Morrison, John
|
|
|
110 |
11 |
p. 5167
|
artikel
|
| 519 |
Assessment of Epoetin Alfa in Patients with Myelodysplastic Syndrome Utilizing an Electronic Medical Record Database.
|
Feinberg, Bruce
|
|
|
110 |
11 |
p. 5180
|
artikel
|
| 520 |
Assessment of Individual Characteristics on the Pharmacokinetics of Oral Busulfan in Adults Patients Undergoing Hematopoietic Stem-Cell Transplantation.
|
Bouchard, Philippe
|
|
|
110 |
11 |
p. 1993
|
artikel
|
| 521 |
Assessment of Multidrug Resistance and FLT3 Internal Tandem Duplication in Patients with Plasmacytoid Dendritic Cell Leukemia.
|
Sandes, Alex F.
|
|
|
110 |
11 |
p. 4251
|
artikel
|
| 522 |
Assessment of Psychological Distress in Patients Suffering from Hematological Disorders.
|
Cole, Craig E.
|
|
|
110 |
11 |
p. 636
|
artikel
|
| 523 |
Assessment of Renal Function in Transfused b-Thalassemia Patients Based on Cystatin C Measurements and Equations.
|
Kattamis, Antonios
|
|
|
110 |
11 |
p. 2769
|
artikel
|
| 524 |
Assessment of Thrombotic Risk in Cancer Patients: Proposal of a Scoring System. A Monocentric Study.
|
Giordano, Giulio
|
|
|
110 |
11 |
p. 3991
|
artikel
|
| 525 |
Assessment of Two Doses of Infliximab in Patients with Low/Intermediate Risk IPSS Myelodysplastic Syndrome (MDS): An EORTC Leukemia Group (LG) Randomized Phase II Trial (06023).
|
Baila, Liliana
|
|
|
110 |
11 |
p. 1456
|
artikel
|
| 526 |
Association between Acute Graft Versus Host Disease and Early Lung Injury after Allogenic Hematopoietic Stem Cell Transplantation.
|
Liu, Qifa
|
|
|
110 |
11 |
p. 4966
|
artikel
|
| 527 |
Association between Genetic Polymorphisms of β-Cell Differentiation Genes and Insulin Resistance (β-Cell Dysfunction) in Childhood Acute Lymphoblastic Leukemia (ALL) Survivors.
|
Surapolchai, Pacharapan
|
|
|
110 |
11 |
p. 4281
|
artikel
|
| 528 |
Association between Polymorphic Variation at the IL5RA Locus and the Severity of FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia
|
Burgstaller, Sonja
|
|
|
110 |
11 |
p. 1544
|
artikel
|
| 529 |
Association between the Polycomb Group (PcG) BMI-1 Gene Expression and Outcome in Chronic Myeloid Leukemia (CML) Patients Receiving Allogeneic Stem Cell Transplantation (allo-SCT).
|
Mohty, Mohamad
|
|
|
110 |
11 |
p. 464
|
artikel
|
| 530 |
Association of Fc Receptor-Like Protein Family with Chronic Graft-Versus-Host Disease.
|
Onizuka, Makoto
|
|
|
110 |
11 |
p. 2970
|
artikel
|
| 531 |
Association of γ' Fibrinogen with Risk Factors and Prevalent Cardiovascular Disease in the Framingham Heart Study.
|
Lovely, Rehana S.
|
|
|
110 |
11 |
p. 131
|
artikel
|
| 532 |
Association of Genetic Polymorphisms in the TGF-β Pathway with the Acute Chest Syndrome of Sickle Cell Anemia.
|
Martinez-Castaldi, Carolina
|
|
|
110 |
11 |
p. 2247
|
artikel
|
| 533 |
Association of MicroRNA Expression Profiles with Karyotype in Acute Myeloid Leukaemias Revealed by Real-Time PCR and In Situ Hybridisation.
|
Dixon-McIver, Amanda
|
|
|
110 |
11 |
p. 105
|
artikel
|
| 534 |
Association of Neurodevelopmental Abnormalities Is a Common Clinical Character in Japanese Patients with Severe Congenital Neutropenia Due to HAX1 Deficiency.
|
Okada, Satoshi
|
|
|
110 |
11 |
p. 665
|
artikel
|
| 535 |
Association of Wind Speed and the Occurrence of Sickle Cell Acute Painful Episodes: Results of a Case-Crossover Study.
|
Nolan, Vikki G.
|
|
|
110 |
11 |
p. 3402
|
artikel
|
| 536 |
Asthma Is Associated with Acute Chest Syndrome, but Not an Increase Rate of Hospitalization for Pain among Children with Sickle Cell Anemia: A Retrospective Cohort Study.
|
Bernaudin, Francoise
|
|
|
110 |
11 |
p. 3406
|
artikel
|
| 537 |
A Study of Bedside Visual Art To Decrease Anxiety and Improve Pain and Mood in Cancer Patients: The Mayo Clinic Experience.
|
Wolanskyj, Alexandra P.
|
|
|
110 |
11 |
p. 975
|
artikel
|
| 538 |
A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines In Vitro.
|
Uyuklu, Tolga
|
|
|
110 |
11 |
p. 4183
|
artikel
|
| 539 |
A Study of the Protein Phosphatase 2A Involved in the Induction of NB4 and MR2 Cell Differentiation by ATRA.
|
Ouyang, Jian
|
|
|
110 |
11 |
p. 4309
|
artikel
|
| 540 |
A Study on t(9;22)(q34;q11) in Endothelial Cells in Chronic Myeloid Leukemia.
|
Huang, Liang
|
|
|
110 |
11 |
p. 4125
|
artikel
|
| 541 |
A Successful Re-Induction Regimen for Relapsed Pediatric Acute Lymphoblastic Leukemia.
|
Ackerman, Jason
|
|
|
110 |
11 |
p. 863
|
artikel
|
| 542 |
A “Survival of the Fittest” Mechanism for Weeding Out Potentially Lymphomagenic B-Cells during Germinal Center B-Cell Differentiation.
|
Ci, Weimin
|
|
|
110 |
11 |
p. 559
|
artikel
|
| 543 |
A Tamoxifen-Dependent Conditional Model of MYC-Induced T Cell Acute Lymphoblastic Leukemia in the Zebrafish.
|
Gutierrez, Alejandro
|
|
|
110 |
11 |
p. 2808
|
artikel
|
| 544 |
AT7519, a Potent CDK Inhibitor, Is Active in Leukemia Models and Primary CLL Patient Samples.
|
Squires, Matthew S.
|
|
|
110 |
11 |
p. 3127
|
artikel
|
| 545 |
AT9283, a Potent Inhibitor of JAK2, Is Active in JAK2 V617F Myeloproliferative Disease Models.
|
Squires, Matthew S.
|
|
|
110 |
11 |
p. 3537
|
artikel
|
| 546 |
Ataxia Telangiectasia Mutated (ATM) Gene Expression Is Reversibly Up-Regulated in FANCA-Mutant Patient Fibroblasts by an Indirect Mechanism.
|
Liu, Johnson M.
|
|
|
110 |
11 |
p. 1679
|
artikel
|
| 547 |
A Tiered Management Program To Conserve Replacement Therapy Resources for a Rural Population of Women with Type 2M von Willebrand Disease during Labor and Delivery.
|
Salter, John T.
|
|
|
110 |
11 |
p. 3961
|
artikel
|
| 548 |
Atiprimod Inhibits the JAK-STAT Pathway and Induces Apoptosis in Human Cells Carrying the JAK2V617F or JAK3 Mutation.
|
Manshouri, Taghi
|
|
|
110 |
11 |
p. 3556
|
artikel
|
| 549 |
A Tissue Microarray Classification in Multiple Myeloma (MM) Predicts Survival Post Autologous Stem Cell Transplant (ASCT).
|
Bahlis, Nizar
|
|
|
110 |
11 |
p. 449
|
artikel
|
| 550 |
A Transcriptomal Profile for Predicting Complete Cytogenetic Response (CCR) in Chronic Phase CML Patients Treated with Imatinib.
|
McWeeney, Shannon K.
|
|
|
110 |
11 |
p. 1007
|
artikel
|
| 551 |
A Transgenic Mouse Model for Adult Acute Chest Syndrome.
|
Fabry, Mary E.
|
|
|
110 |
11 |
p. 2259
|
artikel
|
| 552 |
A Transgenic Mouse Model of Multiple Myeloma Shows Heterogeneity in Drug Response with Alterations Due to Selective Gene Modifications.
|
Gosse, Mary A.
|
|
|
110 |
11 |
p. 552
|
artikel
|
| 553 |
ATR Dependent Phosphorylation of FANCM Is Required for the Fanconi Anemia Pathway.
|
Singh, Thiyam R.
|
|
|
110 |
11 |
p. 837
|
artikel
|
| 554 |
Attitudes toward Participation in Research, New Treatments, and Medication Side Effects among Multiple Myeloma and Myelodysplastic Syndrome Patients - The Patient Registries at Slone: Myeloma & MDS.
|
Van Bennekom, Carla M.
|
|
|
110 |
11 |
p. 3325
|
artikel
|
| 555 |
A Two-Gene Classifier for Predicting Response to the Farnesyltransferase Inhibitor Tipifarnib in Acute Myeloid Leukemia.
|
Raponi, Mitch
|
|
|
110 |
11 |
p. 1445
|
artikel
|
| 556 |
A Two Step Approach to Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Patients with Hematologic Disorders.
|
Flomenberg, Neal
|
|
|
110 |
11 |
p. 5072
|
artikel
|
| 557 |
Atypical Serum Immunofixation Pattern (ASIP) Development during Induction Therapy with BiRD for Newly Diagnosed Multiple Myeloma Correlates with a High Rate of Complete Remission.
|
Mark, Tomer
|
|
|
110 |
11 |
p. 2737
|
artikel
|
| 558 |
Augmentation of Vasculogenesis by Injected Human Hematopoietic Stem Cells in Response to Ischemia Follows Early Activation of Innate Immune Response.
|
Finney, Marcie R.
|
|
|
110 |
11 |
p. 4051
|
artikel
|
| 559 |
Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.
|
Rosenthal, Joseph
|
|
|
110 |
11 |
p. 3021
|
artikel
|
| 560 |
A Unified Mechanism of Tyrosine Kinase Regulation by the Gatekeeper Residue.
|
Azam, Mohammad
|
|
|
110 |
11 |
p. 223
|
artikel
|
| 561 |
A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.
|
Kujawski, Michelle R.
|
|
|
110 |
11 |
p. 3205
|
artikel
|
| 562 |
A Unique Pre-Clinical Model Providing Access to a Drug Resistant Population within the Multiple Myeloma Stem Cell Niche in a Novel 3-D Culture System for Bone Marrow.
|
Kirshner, Julia
|
|
|
110 |
11 |
p. 547
|
artikel
|
| 563 |
Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.
|
Ochi, Toshiki
|
|
|
110 |
11 |
p. 1796
|
artikel
|
| 564 |
Autoantibodies Against p53 Are Associated with p17 Deletions in CLL.
|
Messmer, Bradley T.
|
|
|
110 |
11 |
p. 2066
|
artikel
|
| 565 |
Autoantibodies in Patients with Sickle Cell Anemia Receiving Extended Antigen Matched Packed Red Cell Transfusions.
|
Ambruso, Daniel R.
|
|
|
110 |
11 |
p. 2889
|
artikel
|
| 566 |
Autoimmune or Chronic Infectious Disease in B-CLL at Diagnosis: Association with Unmutated VH Gene Status and Unfavorable Cytogenetics.
|
Vanura, Katrina
|
|
|
110 |
11 |
p. 3092
|
artikel
|
| 567 |
Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.
|
Jimenez, Antonio
|
|
|
110 |
11 |
p. 5044
|
artikel
|
| 568 |
Autologous Bone Marrow-Derived Stem Cell Therapy in Patients with Severe Peripheral Arterial Disorders: A Pilot Study.
|
Boda, Zoltan
|
|
|
110 |
11 |
p. 2877
|
artikel
|
| 569 |
Autologous Bone Marrow Mononuclear Cell (ABMMC) Transplantation in Type 1 and Type 2 Insulin Dependent Diabetes Mellitus (IDM).
|
Carrasco-Yalán, Antonio A.
|
|
|
110 |
11 |
p. 3690
|
artikel
|
| 570 |
Autologous Bone-Marrow Stem Cell Support in Acute Anterior Myocardial Infarction.
|
Vallisa, Daniele
|
|
|
110 |
11 |
p. 3692
|
artikel
|
| 571 |
Autologous Bone Marrow Transplantation as an Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myeloid Leukemia.
|
Jung, Andre S.
|
|
|
110 |
11 |
p. 5121
|
artikel
|
| 572 |
Autologous Bone Marrow Transplant for Human Diabetes Mellitus.
|
Novoa, Jose E.
|
|
|
110 |
11 |
p. 4060
|
artikel
|
| 573 |
Autologous Cytokine-Induced Killer Cells as Post-Transplant Cellular Immunotherapy.
|
Arai, Sally
|
|
|
110 |
11 |
p. 580
|
artikel
|
| 574 |
Autologous Hematopoietic Stem Cell Transplantation in Severe Multiple Sclerosis. The Brazilian Experience with Two Conditioning Regimes: BEAM and High-Dose Cyclophosphamide.
|
Voltarelli, Julio C
|
|
|
110 |
11 |
p. 2881
|
artikel
|
| 575 |
Autologous Human Cord Blood CD4+CD25+ T Cells Stimulate CD8+ T Cell Killing Activity, and Their Expression of NKG2D and Granzyme B.
|
Ruffin, Pamela L.
|
|
|
110 |
11 |
p. 2297
|
artikel
|
| 576 |
Autologous Implantation of Bone Marrow for Non-Unions and Avascular Necrosis of the Bone.
|
Nedelcu, Elena
|
|
|
110 |
11 |
p. 1220
|
artikel
|
| 577 |
Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) Combined with Haploidentical Lymphocytes Infusion Increases the Long Term Survival of Adult Acute Myeloid Leukemia with Standard Risk.
|
Wu, Bingyi
|
|
|
110 |
11 |
p. 2879
|
artikel
|
| 578 |
Autologous Stem Cell Transplantation (ASCT) for Elderly Patients (≥ 60 Years) with Non-Hodgkin's Lymphoma (NHL): An Analysis Based on EBMT Registry.
|
Jantunen, Esa
|
|
|
110 |
11 |
p. 1888
|
artikel
|
| 579 |
Autologous Stem Cell Transplantation (ASCT) in HIV Associated Lymphoma (HIV-Ly) Patients: An Updated Analysis of the EBMT Lymphoma Working Party (EBMT-LWP) Experience.
|
Balsalobre, Pascual
|
|
|
110 |
11 |
p. 1887
|
artikel
|
| 580 |
Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients over Age 70.
|
Borgono, Carla
|
|
|
110 |
11 |
p. 4952
|
artikel
|
| 581 |
Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.
|
Chodirker, Lisa
|
|
|
110 |
11 |
p. 954
|
artikel
|
| 582 |
Autologous Stem Cell Transplantation (auto-SCT) in Elderly Patients with Multiple Myeloma (MM): Age per se Does Not Affect Outcome.
|
El-Cheikh, Jean
|
|
|
110 |
11 |
p. 947
|
artikel
|
| 583 |
Autologous Stem Cell Transplantation (SCT) Following Sequential Chemotherapy and Imatinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) — CALGB Study 10001.
|
Wetzler, Meir
|
|
|
110 |
11 |
p. 2869
|
artikel
|
| 584 |
Automated Sorting of Monocytes from Whole Blood for Reproducible Gene Expression Profiling.
|
Poggel, Carsten
|
|
|
110 |
11 |
p. 3840
|
artikel
|
| 585 |
Autophagy as a Target Pathway in Multiple Myeloma: A Forward Chemical Genetic Approach.
|
Shen, John P.
|
|
|
110 |
11 |
p. 2510
|
artikel
|
| 586 |
Autophagy Induction of Acute Myeloid Leukemia (AML) Cells after Treatment with Low Dose-Cytarabine (Ara-C) and Enhanced Cytocidal Effect on AML Cells by Combined Treatment with Ara-C Plus Lenograstim.
|
Miyazawa, Keisuke
|
|
|
110 |
11 |
p. 4185
|
artikel
|
| 587 |
Autotransplantation in Patients with Multiple Myeloma and Concurrent Renal Failure Is Safe and Feasible and Associated with Recovery of Renal Function in > 30% of Patients.
|
Parikh, Gaurav C.
|
|
|
110 |
11 |
p. 5126
|
artikel
|
| 588 |
A Variant Allele of the Gene Growth Factor Independence 1 (GFI1) Is Associated with Acute Myeloid Leukemia.
|
Khandanpour, Cyrus
|
|
|
110 |
11 |
p. 13
|
artikel
|
| 589 |
AVE5026, a New Anticoagulant for the Prevention of Venous Thromboembolism in Total Knee Replacement Surgery - TREK: A Dose Ranging Study.
|
Lassen, Michael R.
|
|
|
110 |
11 |
p. 311
|
artikel
|
| 590 |
AVE5026: A Novel, Extractive Heparinoid with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity.
|
Hoppensteadt, Debra
|
|
|
110 |
11 |
p. 1881
|
artikel
|
| 591 |
A Vector Expressing PML-RARα Fused to GM-CSF Is an Effective DNA Vaccine for Inducing Specific Immune Response to APL Cells.
|
Li, Yangqiu
|
|
|
110 |
11 |
p. 4882
|
artikel
|
| 592 |
AV513 Enhances Tissue Factor Activity by Inhibiting TFPI in Hemophilia A Plasma: Potential TFPI Target Sites and Potentiation of Factor VIII Activity.
|
Knappe, Sabine
|
|
|
110 |
11 |
p. 497
|
artikel
|
| 593 |
AVIDA: A Longitudinal Registry of Clinical and Quality of Life Outcomes in Patients with Hematologic Disorders Receiving Azacitidine.
|
Grinblatt, David
|
|
|
110 |
11 |
p. 4605
|
artikel
|
| 594 |
Avoidance of Post-Thaw Wash Prior to Transplantation of Plasma Depleted Cord Blood (PD CB) Is Associated with Improved Engraftment & Decreased Severity of Chronic GvHD (cGvHD) without Increased Relapse.
|
Chow, Robert
|
|
|
110 |
11 |
p. 1657
|
artikel
|
| 595 |
A Worldwide Meta-Analysis on the Use of Zidovudine and Interferon-alpha for the Treatment of Adult T–Cell Leukemia/Lymphoma.
|
Bazarbachi, Ali
|
|
|
110 |
11 |
p. 2049
|
artikel
|
| 596 |
A 21-Year-Old Woman with Thrombotic Thrombocytopenic Purpura as Initial Symptom of Systemic Lupus Erythematosus and a Literature Review.
|
Zhou, Rongfu
|
|
|
110 |
11 |
p. 3963
|
artikel
|
| 597 |
A 3-Year Prospective Surveillance Study of Microbiological Isolates among Hematologic Inpatients Shows a High Frequency of Both Community-Acquired and Nosocomial Methicillin-Resistant (MR) and Fluoroquinolone-Resistant (FqR) Strains and the Recent Increase of Enterococci, Viridans Streptococci and Pseudomonaceae with Frequent Antibiotic Multiresistance.
|
Cattaneo, Chiara
|
|
|
110 |
11 |
p. 2286
|
artikel
|
| 598 |
Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.
|
Fenaux, Pierre
|
|
|
110 |
11 |
p. 817
|
artikel
|
| 599 |
5-Azacytidine Augments the Cytotoxicity of Mylotarg toward AML Blasts In Vitro and In Vivo.
|
Balaian, Larisa
|
|
|
110 |
11 |
p. 1835
|
artikel
|
| 600 |
BACOPP-D - An Etoposide-Free Dose-Escalated Polychemotherapy Regimen in Advanced Hodgkin Lymphoma.
|
Naumann, Ralph
|
|
|
110 |
11 |
p. 2317
|
artikel
|
| 601 |
Bacterial Omptins Proteolytically Inactivate Tissue Factor Pathway Inhibitor (TFPI).
|
Yun, Thomas H.
|
|
|
110 |
11 |
p. 1739
|
artikel
|
| 602 |
Bacterial, Viral and Fungal Infections in Patients after Allogeneic Stem Cell or Bone Marrow Transplantation - A Comparison between Patients with Related and Patients with HLA-Matched Non-Related Stem Cell Donors.
|
Rieger, Christina T.
|
|
|
110 |
11 |
p. 4978
|
artikel
|
| 603 |
BAFF Accelerates Development of Chronic Lymphocytic Leukemia in TCL1 Transgenic Mice.
|
Enzler, Thomas
|
|
|
110 |
11 |
p. 1117
|
artikel
|
| 604 |
Balancing Acute Graft Versus Host Disease (aGVHD) and Survival after Peripheral Allogeneic Stem Cell Transplantation (SCT) in Hematological Malignancies: A Potential for Graft Engineering.
|
Saad, Ayman
|
|
|
110 |
11 |
p. 3285
|
artikel
|
| 605 |
B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.
|
Yamashita, Taishi
|
|
|
110 |
11 |
p. 3524
|
artikel
|
| 606 |
Bartonella Henselae Survives after the Storage Period of the Red Blood Cell Units.
|
Magalhaes, Renata Ferreira
|
|
|
110 |
11 |
p. 2906
|
artikel
|
| 607 |
Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy.
|
Else, Monica
|
|
|
110 |
11 |
p. 2062
|
artikel
|
| 608 |
Baseline Characteristics of 65 Subjects in the Correction of Anemia with Darbepoetin alfa (DA) in the Community-Dwelling Frail Elderly (CAFÉ) Study.
|
Artz, Andrew S.
|
|
|
110 |
11 |
p. 3779
|
artikel
|
| 609 |
Baseline Thrombophilic Alterations and Risk of Venous Thromboembolism in 266 Multiple Myeloma Patients Primarily Treated with Thalidomide and High-Dose Dexamethasone.
|
Zamagni, Elena
|
|
|
110 |
11 |
p. 3997
|
artikel
|
| 610 |
Basophilic Blast Phase (B-BP) of Chronic Myelogenous Leukemia (CML).
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 4562
|
artikel
|
| 611 |
Bax Degradation Activity Is a Novel Poor Prognosis Marker of Chronic Lymphocytic Leukemia.
|
Agrawal, Samir G.
|
|
|
110 |
11 |
p. 3087
|
artikel
|
| 612 |
B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.
|
Lim, Seah H.
|
|
|
110 |
11 |
p. 4480
|
artikel
|
| 613 |
B Cell Lineage-Specific Deletion of Icsbp/IRF8 Reveals Roles for IRF8 in the Regulation of Marginal Zone and Follicular B Cell Development.
|
Wang, Hongsheng
|
|
|
110 |
11 |
p. 1334
|
artikel
|
| 614 |
B Cell Lymphomas Escape Bone Morphogenetic Protein (BMP) Induced Growth Inhibition: Downregulation of BMP Receptors and Upregulation of Inhibitory Smads.
|
Huse, Kanutte
|
|
|
110 |
11 |
p. 2605
|
artikel
|
| 615 |
B-Cell Lymphoproliferative Disorders with t(11;14)(q13;q32) or t(14;18)(q32;q21) Can Be Subdivided into 4 Distinct Categories Based on Their Pattern of Additional Cytogenetic Aberrations and Antigen Expression.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 2625
|
artikel
|
| 616 |
Bcl11a Causes p21Cip1 Down-Regulation and Transplantable Leukemia in Nf1-Deficient Mice.
|
Yin, Bin
|
|
|
110 |
11 |
p. 2657
|
artikel
|
| 617 |
BCL2A1 Is A Survival and Immortalization Factor for Primitive Myeloid Hematopoietic Cells.
|
Metais, Jean-Yves
|
|
|
110 |
11 |
p. 3365
|
artikel
|
| 618 |
BCL-2/IgH PCR Values at the End of Induction Treatment Are Not Predictive for Progression Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized Phase III Intergroup Trial.
|
van der Reijden, Bert A.
|
|
|
110 |
11 |
p. 791
|
artikel
|
| 619 |
BCL2 Induces Suppressor of Cytokine Signaling-3 (SOCS3) Expression in Murine B Cells Via Pathways Involving an HSP70/90 Complex and Activation of p44/42 Map Kinase.
|
Parnes, Aric
|
|
|
110 |
11 |
p. 2199
|
artikel
|
| 620 |
B-CLL Antibodies Encoded by Stereotypic V
H
1-69, D3-16, and J
H
3 Rearrangements Immunoprecipitate Non-Muscle Myosin Heavy Chain IIA.
|
Chu, Charles C.
|
|
|
110 |
11 |
p. 739
|
artikel
|
| 621 |
Bcl-6 May Be a Survival Factor in Pre-B Cell Ph+ Blast Crisis Cell Lines.
|
Batlle, Ana
|
|
|
110 |
11 |
p. 4536
|
artikel
|
| 622 |
BCL-2 Phosphorylation Modulates Sensitivity to the BH3-Mimetic GX15-070 (Obatoclax) and Reduces Its Synergistic Interaction with Bortezomib in Chronic Lymphocytic Leukemia Cells.
|
Galan, Patricia Perez
|
|
|
110 |
11 |
p. 3464
|
artikel
|
| 623 |
BCL6 Transcriptionally Reprograms the DLBCL Genome by Forming Distinct Biochemically Active Complexes on Genes Corresponding to Different Pathways.
|
Polo, Jose M.
|
|
|
110 |
11 |
p. 2646
|
artikel
|
| 624 |
bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.
|
Ailawadhi, Sikander
|
|
|
110 |
11 |
p. 1498
|
artikel
|
| 625 |
Bcl-xS Is an Important Pro-Apoptotic Bcl-2 Family Member in Chronic Lymphocytic Leukaemia and Its Expression Is Regulated by SAM68, hnRNP-F and hnRNP-H.
|
Willimott, Shaun
|
|
|
110 |
11 |
p. 2083
|
artikel
|
| 626 |
BCR/ABL and Other Oncogenic Fusion Tyrosine Kinases (FTKs) Stimulate Single Strand Annealing (SSA), the Rare and Extremely Unfaithful DNA Double-Strand Break Repair Pathway To Facilitate Genomic Instability in Hematologic Malignancies.
|
Cramer, Kimberly
|
|
|
110 |
11 |
p. 998
|
artikel
|
| 627 |
BCR-ABL1 Disrupts SDF-1-Dependent Hematopoietic Cell Migration and Adhesion through the LFA-1 Integrin-Mediated Mechanism.
|
Chen, Ying-Yu
|
|
|
110 |
11 |
p. 1011
|
artikel
|
| 628 |
BCR-ABL Induces Autocrine IGF-1 Signaling.
|
Kumarylakshmikuttyamma, Asha
|
|
|
110 |
11 |
p. 4545
|
artikel
|
| 629 |
BCR-ABL Induces Error-Prone Single Strand Annealing in Transformed Cells.
|
Rodrigues, Margret S.
|
|
|
110 |
11 |
p. 2937
|
artikel
|
| 630 |
BCR-ABL Kinase Domain Mutations and Their Kinetics on Second Line Dasatinib or Nilotinib Therapy in CML Patients after Imatinib Failure: A Cooperative Evaluation of Four Different Detection Methods.
|
Ernst, Thomas
|
|
|
110 |
11 |
p. 321
|
artikel
|
| 631 |
BCR-ABL Kinase Domain Mutations in the P-Loop and at Imatinib Contact Sites in CML Patients with Imatinib Resistance Are Associated with Higher Maximum Imatinib Doses.
|
Pelz-Ackermann, Oliver
|
|
|
110 |
11 |
p. 2918
|
artikel
|
| 632 |
BCR-ABL Kinase Domain Mutations & SNPs in Imatinib Resistant or Intolerant Chronic Myeloid Leukaemia Patients.
|
O'Connor, Lisa M.
|
|
|
110 |
11 |
p. 2369
|
artikel
|
| 633 |
BCR/ABL Kinase Elevates ROS-Mediated Oxidative DNA Damage in CML Stem/Progenitor Cells and Affects the Efficiency and Fidelity of DNA Repair To Induce Genetic Instability.
|
Nieborowska-Skorska, Margaret
|
|
|
110 |
11 |
p. 34
|
artikel
|
| 634 |
BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.
|
Stoklosa, Tomasz
|
|
|
110 |
11 |
p. 32
|
artikel
|
| 635 |
BCR/ABL Stimulates WRN Helicase Activity To Facilitate DNA Double-Strand Breaks Repair.
|
Slupianek, Artur
|
|
|
110 |
11 |
p. 1024
|
artikel
|
| 636 |
BCR-ABL Transcript Levels at Time of Complete Cytogenetic Remission Achieved after Salvage with Dasatinib or Nilotinib.
|
Mauro, Michael J.
|
|
|
110 |
11 |
p. 1945
|
artikel
|
| 637 |
BCRs of Mutated and Unmutated CLL Bind Peptides with Distinct Sequence Features: Evidence from Phage Display Libraries.
|
Woelfle, Manuela
|
|
|
110 |
11 |
p. 1118
|
artikel
|
| 638 |
B-Diffuse Large Cell Lymphoma and Nonrandon Karyotipic Abnormalities in Ph Negative Cells of Patients with Ph-Positive Chronic Myeloid Leukemia Imatinib Treated.
|
Luño, E.
|
|
|
110 |
11 |
p. 4579
|
artikel
|
| 639 |
BEAM as a Frontline High Dose Chemotherapy Supported by Autologous PBSCT in Elderly Patients (≥60 Years) with Diffuse Large B-Cell Lymphoma (DLBCL): Comparison with Younger Cohort of Patients.
|
Ivanov, V.
|
|
|
110 |
11 |
p. 1910
|
artikel
|
| 640 |
Belinostat (PXD101) in Patients with Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma: Results of a Phase II Study.
|
Advani, Ranjana
|
|
|
110 |
11 |
p. 3453
|
artikel
|
| 641 |
Bendamustine in Combination with Rituximab (BR) for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase II Trial of the German CLL Study Group (GCLLSG).
|
Fischer, Kirsten
|
|
|
110 |
11 |
p. 3106
|
artikel
|
| 642 |
Bendamustine Is Safe and Effective in Patients with Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma.
|
Kahl, Brad
|
|
|
110 |
11 |
p. 1351
|
artikel
|
| 643 |
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line Treatment of Patients with Indolent and Mantle Cell Lymphomas - First Interim Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).
|
Rummel, Mathias J.
|
|
|
110 |
11 |
p. 385
|
artikel
|
| 644 |
Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study.
|
Knauf, Wolfgang Ulrich
|
|
|
110 |
11 |
p. 2043
|
artikel
|
| 645 |
Benefit of Anti-Infectious Prophylaxis in Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Receiving Frontline “Targeted Therapy”.
|
Jain, Nitin
|
|
|
110 |
11 |
p. 2858
|
artikel
|
| 646 |
Benzodiazepine-423, an Inhibitor of Mitochondrial Respiration, Causes Selective Apoptosis of Activated Lymphocytes and Reverses Experimental GVHD While Preserving GVL Effects.
|
Gatza, Erin
|
|
|
110 |
11 |
p. 68
|
artikel
|
| 647 |
Berkeley Sickle Cell Disease Mice Exhibit Multifaceted Immune Hyper-Activation, and Avidly Reject Allogeneic Bone Marrow Transplantation.
|
Kean, Leslie S.
|
|
|
110 |
11 |
p. 2251
|
artikel
|
| 648 |
Beta2-Glycoprotein I: Implications for a Regulatory Role in Thrombotic Thrombocytopenic Purpura.
|
de Laat, Bas
|
|
|
110 |
11 |
p. 278
|
artikel
|
| 649 |
Better Molecular Response to Imatinib for Patients (pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Carrying the b3a2 Transcript Compared to b2a2.
|
Vega-Ruiz, Arturo
|
|
|
110 |
11 |
p. 1939
|
artikel
|
| 650 |
Biclonal Multiple Myeloma with Monoclonal Free IgG3 Heavy Chain and kappa Free Light Chains.
|
Richter, Alex G.
|
|
|
110 |
11 |
p. 4768
|
artikel
|
| 651 |
Bifunctional siRNA Design Targeting Non-Hodgkin's Lymphoma.
|
Höhn, Britta
|
|
|
110 |
11 |
p. 2357
|
artikel
|
| 652 |
Bimodal Degradation of MLL Protein by the Cell Cycle SCFSkp2 and APCCdc20 E3 Lilgases Assures Cell Cycle Execution: A Critical Regulatory Circuit Lost in Leukemogenic MLL-Fusions.
|
Liu, Han
|
|
|
110 |
11 |
p. 828
|
artikel
|
| 653 |
Binding of CLL B-Cell Receptors to Viable and Apoptotic Human Cells Offers Insight into the Role of Autoantigens in Leukemic Transformation.
|
Catera, Rosa
|
|
|
110 |
11 |
p. 741
|
artikel
|
| 654 |
Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.
|
Moreaux, Jerome
|
|
|
110 |
11 |
p. 3522
|
artikel
|
| 655 |
Bio-Cell Chip Method for Stable DNA Storage and Simple Extraction.
|
Kim, Miyoung
|
|
|
110 |
11 |
p. 4135
|
artikel
|
| 656 |
Biochemical Comparison of VWF/FVIII Concentrates - Are There Differences in Product Characteristics and Purity?.
|
Schwartz, B.A.
|
|
|
110 |
11 |
p. 3936
|
artikel
|
| 657 |
Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.
|
Leleu, Xavier
|
|
|
110 |
11 |
p. 3526
|
artikel
|
| 658 |
Biological Significance of Erythropoietin and Erythropoietin Receptor Expression by Human Ovarian Cancer Cells.
|
Jeong, Jee-Yeong
|
|
|
110 |
11 |
p. 2214
|
artikel
|
| 659 |
Biologic Assignment Clinical Trials in Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma: Baseline Characteristics by Treatment Allocation from BMT CTN 0102 According to Availability of an HLA-Matched Sibling Donor.
|
Pasquini, Marcelo C.
|
|
|
110 |
11 |
p. 3028
|
artikel
|
| 660 |
Biologic Features and Treatment Outcome of Secondary Acute Lymphoblastic Leukemia - Review of 101 Cases.
|
Shivakumar, Ranga
|
|
|
110 |
11 |
p. 4345
|
artikel
|
| 661 |
Biologic Sequelae of CDC2 Inhibition in MM.
|
Fulciniti, Mariateresa
|
|
|
110 |
11 |
p. 4797
|
artikel
|
| 662 |
Biology of Childhood Acute Hybrid Leukemias in a Population-Based Study (Czech Pediatric Hematology Working Group).
|
Mejstrikova, Ester
|
|
|
110 |
11 |
p. 4247
|
artikel
|
| 663 |
Biomarkers and Pulmonary Hypertension in Sickle Cell Disease.
|
Ataga, Kenneth I.
|
|
|
110 |
11 |
p. 3401
|
artikel
|
| 664 |
Biomarkers of Vorinostat Resistance in Cutaneous T-Cell Lymphoma.
|
Zhang, Chunlei
|
|
|
110 |
11 |
p. 1381
|
artikel
|
| 665 |
Biomarkers To Predict Outcome after Allogeneic Hematopoietic Cell Transplant (HCT).
|
Dinner, Shira N.
|
|
|
110 |
11 |
p. 1100
|
artikel
|
| 666 |
BiovaxID Vaccine Therapy of Follicular Lymphoma in First Remission: Phase III Blinded Safety Update.
|
Stergiou, Angelos M.
|
|
|
110 |
11 |
p. 4500
|
artikel
|
| 667 |
Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.
|
Copelan, Edward
|
|
|
110 |
11 |
p. 5003
|
artikel
|
| 668 |
Biscoclaurine Alkaloid Cepharanthine Inhibits the Growth of Primary Effusion Lymphoma In Vitro and In Vivo and Induce Apoptosis Via Suppressing the NK-κB Pathway.
|
Okada, Seiji
|
|
|
110 |
11 |
p. 4520
|
artikel
|
| 669 |
Blast Transformation in a Patient with Primary Myelofibrosis Initiated from JAK2 V617F Progenitor.
|
Swierczek, Sabina I.
|
|
|
110 |
11 |
p. 4665
|
artikel
|
| 670 |
Bleeding and Thromboembolic Events after Termination of Therapy with Idraparinux for Prevention of Recurrent Venous Thromboembolism-Observation after the van Gogh Trials.
|
Harenberg, Job
|
|
|
110 |
11 |
p. 1877
|
artikel
|
| 671 |
Bleeding Complications and Pregnancies in an Established Plasminogen Activator Inhibitor, Type-1 (PAI-1) Deficient Population.
|
Mehta, Rakesh P.
|
|
|
110 |
11 |
p. 2147
|
artikel
|
| 672 |
Bleeding Diathesis in Patients (pts) with Chronic Myelogenous Leukemia Receiving Dasatinib Therapy.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 2958
|
artikel
|
| 673 |
Bleeding Events and Factor IX Levels in Female Carriers from a Large Kindred of Hemophilia B.
|
Salter, John T.
|
|
|
110 |
11 |
p. 1150
|
artikel
|
| 674 |
Bleeding Risk in Patients with Essential Thrombocythemia and a Platelet Count of More Than 1.5 Million/μl: A Challenge of the Dogma of Mandatory Initiation of Cytoreductive Therapy.
|
Petrides, Petro E.
|
|
|
110 |
11 |
p. 4660
|
artikel
|
| 675 |
Bleeding Symptoms and Laboratory Correlation in 150 Patients with Severe von Willebrand Disease.
|
Metjian, Ara D.
|
|
|
110 |
11 |
p. 2134
|
artikel
|
| 676 |
Blockade of Chemotherapy-Induced Thrombocytopenia by Bax Inhibiting Peptides (BIPs) in Mouse Model.
|
Gomez, Jose A.
|
|
|
110 |
11 |
p. 281
|
artikel
|
| 677 |
Blockage of TRAF6 Signaling Inhibits Osteoclast Formation and Tumor Cell through Blocking the NF-kB and JNK Pathways in Multiple Myeloma.
|
Chen, Haiming
|
|
|
110 |
11 |
p. 2511
|
artikel
|
| 678 |
Blocking Adhesion of Sickle Erythrocytes to Endothelial P-Selectin Using an RNA Aptamer.
|
Nishimura, Jun-ichi
|
|
|
110 |
11 |
p. 147
|
artikel
|
| 679 |
Blood Donors with a Positive Direct Antiglobulin Test Are at Increased Risk for Hematologic Malignancies and Cancer in General.
|
Rottenberg, Yakir
|
|
|
110 |
11 |
p. 2903
|
artikel
|
| 680 |
Blood Group O and ABO Non-Identical Platelet Transfusions Are Associated with Increased Red Cell Utilization in Non-Trauma Surgical Patients.
|
Blumberg, Neil
|
|
|
110 |
11 |
p. 4012
|
artikel
|
| 681 |
Blood Induced Cartilage Changes in a Hemophilia A Murine Model.
|
Dunn, Amy L.
|
|
|
110 |
11 |
p. 1152
|
artikel
|
| 682 |
Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.
|
Takagi, Shinsuke
|
|
|
110 |
11 |
p. 4981
|
artikel
|
| 683 |
BMP and Wnt Induce Embryonic Blood Fate by Activation of the Cdx-Hox Pathway.
|
Lengerke, Claudia
|
|
|
110 |
11 |
p. 199
|
artikel
|
| 684 |
Bone Marrow Adipocytes: A Novel Negative Regulator of the Hematopoietic Microenvironment.
|
Naveiras, Olaia
|
|
|
110 |
11 |
p. 1405
|
artikel
|
| 685 |
Bone Marrow Biopsy for the Staging of Diffuse Large B-Cell Lymphoma: Is It Necessary Bilateral Trephine Biopsy?.
|
Bellesso, Marcelo
|
|
|
110 |
11 |
p. 4427
|
artikel
|
| 686 |
Bone Marrow Cells from Patients with Shwachman-Diamond Syndrome Abnormally Express Ribosomal Protein and Ribosomal Biogenesis-Related Genes.
|
Rujkijyanont, Piya
|
|
|
110 |
11 |
p. 3303
|
artikel
|
| 687 |
Bone Marrow Derived CD34+CXCR4+ Cells Maintain Viability, Mobility and Sterility up to 72 Hours and Are Compatible with Balloon Dilatation Catheters Used for Intra Coronary Artery Infusion; Pre-Clinical Development of a Pharmaceutical Grade Cell Therapy for Acute Myocardial Infarction (AMR-001).
|
Pecora, Andrew L.
|
|
|
110 |
11 |
p. 1214
|
artikel
|
| 688 |
Bone Marrow Reaction in Patients with Chronic GvHD - An Immunohistochemical Analysis of Microvessels and Lymphocytes.
|
Hill, Wolfgang
|
|
|
110 |
11 |
p. 1963
|
artikel
|
| 689 |
Bone Marrow Sinusoidal Endothelium Undergoes DNA Damage and Repair Following Lethal Irradiation.
|
Li, Xiao-Miao
|
|
|
110 |
11 |
p. 4866
|
artikel
|
| 690 |
Bone Marrow Small Molecule Radioprotectors.
|
Epperly, Michael W.
|
|
|
110 |
11 |
p. 4096
|
artikel
|
| 691 |
Bone Marrow Stem Cell Transplantation Restores Heme Oxygenase and Antioxidants Genes and Pancreatic Function in Type 1 Diabetes.
|
Wang, Jishi
|
|
|
110 |
11 |
p. 4856
|
artikel
|
| 692 |
Bone Marrow T Cell Subpopulations in Patients with Newly Diagnosed B-Cell Precursor Acute Lymphoblastic Leukemia (ALL).
|
Brinkrolf, Peter
|
|
|
110 |
11 |
p. 4278
|
artikel
|
| 693 |
Bone Marrow Transplant Activity - A Country Report from Pakistan.
|
Ullah, Khalil
|
|
|
110 |
11 |
p. 5038
|
artikel
|
| 694 |
Bone Marrow Transplantation for β Thalassemia Major: Long Term Experience from a Single Centre in India.
|
Chandy, Mammen
|
|
|
110 |
11 |
p. 1106
|
artikel
|
| 695 |
Bone Marrow Transplant (BMT) for Acute Myeloid Leukemia (AML) Patients with Translocation (6; 9).
|
Haddad, Abdo S.
|
|
|
110 |
11 |
p. 5051
|
artikel
|
| 696 |
Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.
|
Giona, Fiorina
|
|
|
110 |
11 |
p. 2942
|
artikel
|
| 697 |
Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.
|
Grosse, Regine
|
|
|
110 |
11 |
p. 2772
|
artikel
|
| 698 |
Bone Remodeling in Patients with Relapsed/Refractory Multiple Myeloma Who Receive Lenalidomide-Based Regimens.
|
Terpos, Evangelos
|
|
|
110 |
11 |
p. 4745
|
artikel
|
| 699 |
Bortezomib Alone or in Combinination with Doxil Is Active in Adult Refractory Multi-System Langerhans Cell Histiocytosis (LCH).
|
Haddad, Philip A.
|
|
|
110 |
11 |
p. 3835
|
artikel
|
| 700 |
Bortezomib and Gemcitabine in Relapsed Hodgkin Lymphoma (HL).
|
Friedberg, Jonathan W.
|
|
|
110 |
11 |
p. 2325
|
artikel
|
| 701 |
Bortezomib, Ascorbic Acid and Melphalan (BAM) Therapy for Patients (pts) with Newly Diagnosed Multiple Myeloma (MM): An Effective and Well-Tolerated Frontline Regimen.
|
Berenson, James R.
|
|
|
110 |
11 |
p. 3602
|
artikel
|
| 702 |
Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.
|
Ozdemir, Evren
|
|
|
110 |
11 |
p. 4810
|
artikel
|
| 703 |
Bortezomib, Doxorubicin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide and Dexamethasone (TD) as a Salvage Treatment for Relapsed Multiple Myeloma (MM): Preliminary Analysis of Efficacy and Safety.
|
Lee, Sung Sook
|
|
|
110 |
11 |
p. 2731
|
artikel
|
| 704 |
Bortezomib Enhances the Antitumor Activity of Adoptively Infused Natural Killer Cells In Vivo: A Novel Approach To Override KIR-Mediated Inhibition of NK Cell Cytotoxicity.
|
Lundqvist, Andreas
|
|
|
110 |
11 |
p. 1786
|
artikel
|
| 705 |
Bortezomib Has Anti-Proliferative and Apoptotic Effects Against CML Stem Cells, Including the Quiescent Population.
|
Heaney, Nicholas
|
|
|
110 |
11 |
p. 2943
|
artikel
|
| 706 |
Bortezomib in Combination with Bendamustine and Prednisone in the Treatment of Patients with Refractory/Relapsed Multiple Myeloma.
|
Poenisch, Wolfram
|
|
|
110 |
11 |
p. 2723
|
artikel
|
| 707 |
Bortezomib in Combination with Dexamethasone and Subsequent Thalidomide for Newly-Diagnosed Multiple Myeloma in Chinese Patients.
|
Cai, Zhen
|
|
|
110 |
11 |
p. 4827
|
artikel
|
| 708 |
Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma.
|
Chanan-Khan, Asher A.
|
|
|
110 |
11 |
p. 3614
|
artikel
|
| 709 |
Bortezomib Inhibits mTOR Pathway in Multiple Myeloma Cell Lines Via Induced Expression of REDD1.
|
Decaux, Olivier
|
|
|
110 |
11 |
p. 242
|
artikel
|
| 710 |
Bortezomib in Multiple Myeloma: Treatment and Retreatment. A Single Center Experience.
|
Bilalis, Antonios G.
|
|
|
110 |
11 |
p. 4819
|
artikel
|
| 711 |
Bortezomib Is Synergistic with Rituximab and Cyclophosphamide in Inducing Apoptosis of Mantle Cell Lymphoma Cells In Vitro and In Vivo.
|
Zhang, Liang
|
|
|
110 |
11 |
p. 4514
|
artikel
|
| 712 |
Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM.
|
Natarajan, Shanti
|
|
|
110 |
11 |
p. 1453
|
artikel
|
| 713 |
Bortezomib, Low Dose Intravenous Melphalan and Dexamethasone for Patients with Relapsed Multiple Myeloma: Final Results of a Phase I/II Clinical Trial.
|
Popat, Rakesh
|
|
|
110 |
11 |
p. 2713
|
artikel
|
| 714 |
Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m2 in Elderly Newly Diagnosed Patients: An Interim Analysis.
|
Palumbo, Antonio
|
|
|
110 |
11 |
p. 448
|
artikel
|
| 715 |
Bortezomib Plus Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity: Results of a Multicenter Study.
|
Chen, Shilun
|
|
|
110 |
11 |
p. 3600
|
artikel
|
| 716 |
Bortezomib Protects Osteoblasts from Glucocorticoid-Induced Damage, and Enhances Glucocorticoid-Induced Toxicity Against Osteoclasts and Myeloma Cells.
|
Soe, Kent
|
|
|
110 |
11 |
p. 3523
|
artikel
|
| 717 |
Bortezomib Resistant Constitutive NF-κB Activation in Mantle Cell Lymphoma.
|
Yang, David T.
|
|
|
110 |
11 |
p. 3465
|
artikel
|
| 718 |
Bortezomib Retreatment in Relapsed Multiple Mycelia - A Retrospective Multicenter Survey.
|
Hrusovsky, Irena
|
|
|
110 |
11 |
p. 2720
|
artikel
|
| 719 |
Bortezomib, Rituximab, and Dexamethason (BORID) as Salvage Treatment in Relapsed/Refractory Mantle Cell Lymphoma: Sustained Disease Control in Patients Achieving a Complete Remission.
|
Drach, Johannes
|
|
|
110 |
11 |
p. 2578
|
artikel
|
| 720 |
Bortezomib, Thalidomide, and Dexamethasone as Induction Therapy for Patients with Symptomatic Multiple Myeloma.
|
Kaufman, Jonathan L.
|
|
|
110 |
11 |
p. 3605
|
artikel
|
| 721 |
Bortezomib (Velcade™) Observational Study in China - Efficacy and Safety of Bortezomib Based Regimen in 223 Relapsed or Refractory Multiple Myeloma Patients.
|
Shen, Zhi-xiang
|
|
|
110 |
11 |
p. 4833
|
artikel
|
| 722 |
Bortezomib [VELCADE™], Pegylated Liposomal Doxorubicin [DOXIL/CAELYX®] and Dexamethasone in the Treatment of Previously Untreated Multiple Myeloma Patients: Impact on Quality-of-Life.
|
Belch, Andrew
|
|
|
110 |
11 |
p. 3618
|
artikel
|
| 723 |
Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) in Preparation for Autologous Stem-Cell (SC) Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM).
|
Cavo, Michele
|
|
|
110 |
11 |
p. 73
|
artikel
|
| 724 |
Bortezomib with HIG-Dose Dexamethasone as First Line Therapy in Patients with Multiple Myeloma Candidates to High-Dose Therapy.
|
Corso, Alessandro
|
|
|
110 |
11 |
p. 3595
|
artikel
|
| 725 |
Bosutinib (SKI-606) Demonstrates Clinical Activity and Is Well Tolerated among Patients with AP and BP CML and Ph+ ALL.
|
Gambacorti-Passerini, C.
|
|
|
110 |
11 |
p. 473
|
artikel
|
| 726 |
Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.
|
Sehn, Laurie H.
|
|
|
110 |
11 |
p. 1559
|
artikel
|
| 727 |
BRAF Mutations in Juvenile Myelomonocytic Leukemia.
|
de Vries, Andrica C.H.
|
|
|
110 |
11 |
p. 4602
|
artikel
|
| 728 |
Brain MRI Findings in Lebanese Sickle Cell Disease Patients.
|
Inati, Adlette
|
|
|
110 |
11 |
p. 3794
|
artikel
|
| 729 |
Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.
|
Tiribelli, Mario
|
|
|
110 |
11 |
p. 2948
|
artikel
|
| 730 |
Brain Sparing Conditioning Regimen and Umbilical Cord Blood Transplantation for Inherited High Risk Neurologic Metabolic Diseases.
|
Tolar, Jakub
|
|
|
110 |
11 |
p. 3009
|
artikel
|
| 731 |
Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).
|
Duarte, Bruno K.L.
|
|
|
110 |
11 |
p. 5102
|
artikel
|
| 732 |
Breast-Feeding Mediates Feto-Maternal Tolerance and Improves Outcome of Allogeneic Bone Marrow Transplantation.
|
Aoyama, Kazutoshi
|
|
|
110 |
11 |
p. 2165
|
artikel
|
| 733 |
Breast Nodules: First Manifestation of LLA.
|
Avila, Estela Est.
|
|
|
110 |
11 |
p. 4235
|
artikel
|
| 734 |
Bruton's Tyrosine Kinase (BTK) Is Not Required for BCR-ABL-Mediated Transformation of Hematopoietic Cells.
|
MacPartlin, Mary
|
|
|
110 |
11 |
p. 1015
|
artikel
|
| 735 |
B-Type Natriuretic Peptide (BNP) and Mitral Velocity E/A Ratio (MV E/A) Are Two Important Noninvasive Functional Indices of Cardiac AL Amyloidosis.
|
Kabos, Peter
|
|
|
110 |
11 |
p. 4773
|
artikel
|
| 736 |
Building and Clinical Use of Activated Plasma Clotting Time Test and the Value of APCT on Predicting the Bleeding Due to Leukemia Chemotherapy-Induced Thrombocytopenia.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 3915
|
artikel
|
| 737 |
Burden of Illness in Chronic Graft vs. Host Disease - A Prospective Cohort Study.
|
Pusic, Iskra
|
|
|
110 |
11 |
p. 1667
|
artikel
|
| 738 |
Burdern of Long-Term Morbidity after Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor Study (BMTSS).
|
Sun, Can-Lan
|
|
|
110 |
11 |
p. 832
|
artikel
|
| 739 |
Burkitt Transformation of Mantle Cell Lymphoma.
|
Reddy, Kavita S.
|
|
|
110 |
11 |
p. 4129
|
artikel
|
| 740 |
Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.
|
Dessureault, Sophie
|
|
|
110 |
11 |
p. 4483
|
artikel
|
| 741 |
c-Abl Kinase Inhibitors Overcome CD40-Mediated Drug Resistance in CLL.
|
Hallaert, Delfine Y.
|
|
|
110 |
11 |
p. 3078
|
artikel
|
| 742 |
CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin αIIbβ3 in Platelets.
|
Bergmeier, Wolfgang
|
|
|
110 |
11 |
p. 3646
|
artikel
|
| 743 |
Can Bortezomib Treatment Overcome Glucocorticoid Resistance of Childhood Acute Lymphoblastic Leukemia Cells?.
|
Junk, Stefanie V.
|
|
|
110 |
11 |
p. 2801
|
artikel
|
| 744 |
Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer.
|
Siragusa, Sergio
|
|
|
110 |
11 |
p. 699
|
artikel
|
| 745 |
Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.
|
Kutlar, Abdullah
|
|
|
110 |
11 |
p. 429
|
artikel
|
| 746 |
Can Genomic Copy Number Variants Be a Part of Complex Genetic Traits Predisposing to Marrow Failure?.
|
O'Keefe, Christine
|
|
|
110 |
11 |
p. 106
|
artikel
|
| 747 |
Can NK Cells Play a Role in Anti-CD20 Immunotherapy for CLL Patients?.
|
Le Garff-Tavernier, Magali
|
|
|
110 |
11 |
p. 3103
|
artikel
|
| 748 |
Canonical Correlation Analysis (CCA) of Imatinib Treatment (ImRx) Nonadherence (NA) with Associated Patient Variables (APVs) in Chronic Myeloid Leukemia (CML) - Results from the ADAGIO Study.
|
van Lierde, Marie-Anne
|
|
|
110 |
11 |
p. 5164
|
artikel
|
| 749 |
Can Rituximab Replace Splenectomy in Immune Thrombocytopenic Purpura (ITP)?.
|
Dabak, Vrushali
|
|
|
110 |
11 |
p. 1306
|
artikel
|
| 750 |
Capture and Enrichment of CD34-Positive Haematopoietic Stem and Progenitor Cells from Blood Circulation Using P-Selectin in an Implantable Device.
|
Narasipura, Srinivasa D.
|
|
|
110 |
11 |
p. 4918
|
artikel
|
| 751 |
Carbonyl-Substituted Titanocenes as New Cytostatic Agents Against Lymphoma and Leukemia in Childhood.
|
Selig, Anja
|
|
|
110 |
11 |
p. 4208
|
artikel
|
| 752 |
CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.
|
Lenz, Georg
|
|
|
110 |
11 |
p. 692
|
artikel
|
| 753 |
Cardiac T2* Magnetic Resonance Imaging (MRI) in Iron Overload and Ventricular Diastolic Function.
|
Hankins, Jane
|
|
|
110 |
11 |
p. 2676
|
artikel
|
| 754 |
Cardiac Toxicity and Non-Relapse Mortality in Patients with Low Left Ventricular Ejection Fraction Undergoing Stem Cell Transplantation.
|
Chu, Diem T.
|
|
|
110 |
11 |
p. 3002
|
artikel
|
| 755 |
Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.
|
Dey, Bimalangshu R.
|
|
|
110 |
11 |
p. 732
|
artikel
|
| 756 |
Cardiotoxicity and Treatment Efficacy of Not Pegilated Liposomal Doxorubicin in Haematological Malignancies: Our Experience.
|
Gagliardi, Alfredo
|
|
|
110 |
11 |
p. 4836
|
artikel
|
| 757 |
Cardiotoxicity in Patients with Multiple Myeloma Treated with Tandem Autologous Hematopoetic Stem Cell Transplantation.
|
Zver, Samo
|
|
|
110 |
11 |
p. 4923
|
artikel
|
| 758 |
Cardiotoxicity of Imatinib Mesylate - A Prospective Cross-Sectional Study.
|
Bittencourt, Henrique
|
|
|
110 |
11 |
p. 4571
|
artikel
|
| 759 |
Cardiovascular Involvement in Thalassemia Major Patients: WEB-THAL® Data Analysis (A Web-Based Multicentric Database).
|
Derchi, Giorgio
|
|
|
110 |
11 |
p. 3824
|
artikel
|
| 760 |
Case-Control Study Using Array-Based Genotyping Produced a Panel of Genes Associated with Risk to Acute Myelogenous Leukemia (AML).
|
Lee, Il-Kwon
|
|
|
110 |
11 |
p. 2384
|
artikel
|
| 761 |
Case Report: A Patient with Haemorrhagic Bleeding, an Acquired Factor VIII Inhibitor and Massive Pulmonary Embolism.
|
Hildebrandt, Martin
|
|
|
110 |
11 |
p. 3940
|
artikel
|
| 762 |
Case Report: Coexistence of Factor VIII Inhibitor and Lupus Anticoagulant.
|
Agostini, Vanessa
|
|
|
110 |
11 |
p. 3948
|
artikel
|
| 763 |
Caspase-3 Activation Is Involved in the Early Megakaryocyte Differentiation, but Not in Platelet Production.
|
Kozuma, Yukinori
|
|
|
110 |
11 |
p. 3364
|
artikel
|
| 764 |
Castleman's Disease: Four Extraordinary Presantations and Review of Literature.
|
Kupesiz, Gokben Yildirim
|
|
|
110 |
11 |
p. 4416
|
artikel
|
| 765 |
β-Catenin Expression in Bone Marrow Stromal Cells Is Required for Normal Proliferation and Differentiation of Primitive Hematopoietic Cells.
|
Nemeth, Michael
|
|
|
110 |
11 |
p. 608
|
artikel
|
| 766 |
ß-Catenin siRNA Successfully Suppressed the Progression of Multiple Myeloma in In Vivo Mouse Model.
|
Kawata, Eri
|
|
|
110 |
11 |
p. 2506
|
artikel
|
| 767 |
Cathepsin G, a Potent Platelet Aggregation Activator, Is Upregulated in Multiple Myeloma Patients during Treatment with Lenalidomide (Revlimid).
|
Pal, Rekha
|
|
|
110 |
11 |
p. 2504
|
artikel
|
| 768 |
Cause-Specific Mortality and Second Cancer Incidence after Non-Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study.
|
Bluhm, Elizabeth C.
|
|
|
110 |
11 |
p. 3579
|
artikel
|
| 769 |
CBFA2/RUNX1 Regulates Human Platelet 12-Lipoxygenase: Studies in Runx1 Haplodeficiency.
|
Kaur, Gurpreet
|
|
|
110 |
11 |
p. 3648
|
artikel
|
| 770 |
CBFB-Independent Activities of the Inv(16) Fusion Gene CBFB-MYH11.
|
Hyde, R. Katherine
|
|
|
110 |
11 |
p. 3376
|
artikel
|
| 771 |
Cbl-b Deficiency Enhances Motility and Impairs Leukemogenesis by Bcr-Abl.
|
Badger-Brown, Karla M.
|
|
|
110 |
11 |
p. 1019
|
artikel
|
| 772 |
Cbl Mutants Interact with c-Kit and Lead to Factor Independent Growth and Transformation of a Myeloid Cell Line 32D.
|
Sargin, Bülent
|
|
|
110 |
11 |
p. 2198
|
artikel
|
| 773 |
CD56+ AML Is Strongly Associated with AML1/ETO Rearrangement and CNS Involvement in Childhood AML.
|
Lee, Hye Ryun
|
|
|
110 |
11 |
p. 4272
|
artikel
|
| 774 |
CD38 and ZAP-70 Mark Chronic Lymphocytic Leukemia (CLL) Cells with High Migratory Potential and Regulate Chemotaxis.
|
Deaglio, Silvia
|
|
|
110 |
11 |
p. 4684
|
artikel
|
| 775 |
CD38 as a Prognostic Factor in Chinese Patients with Chronic Lymphocytic Leukaemia.
|
Jianyong, LI
|
|
|
110 |
11 |
p. 4691
|
artikel
|
| 776 |
CD11b-Donor Dendritic Cells Elevate Donor T-Cell Production of Interferon-Gamma and Graft-Versus-Leukemia Activity in Allogeneic Bone Marrow Transplantation.
|
Li, Jian-Ming
|
|
|
110 |
11 |
p. 2181
|
artikel
|
| 777 |
CD11b Is a Therapy-Induced Marker for Monitoring Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
|
Rhein, Peter
|
|
|
110 |
11 |
p. 1424
|
artikel
|
| 778 |
CD154 Blockade Prevents Allosensitization through Inhibiting Both T- and B-Cell Activation and Decreasing Expression of IFN-γ and IL-10 in T-Cells.
|
Xu, Hong
|
|
|
110 |
11 |
p. 1346
|
artikel
|
| 779 |
CDC4 and NOTCH1 Mutations in Childhood T-Cell Acute Lymphoblastic Leukemia and T Cell Non-Hodgkin's Lymphoma; a Japan Association of Childhood Leukemia Study Group.
|
Park, Myoung-ja
|
|
|
110 |
11 |
p. 2648
|
artikel
|
| 780 |
CD3+/CD56+ Cells, but Not Natural Killer T Cells, Are Increased in Peripheral Blood of Untreated Patients with Leukemia.
|
Le Dieu, Rifca
|
|
|
110 |
11 |
p. 1815
|
artikel
|
| 781 |
CD154:CD40 Co-Stimulatory Blockade: A Specific Approach To Prevent Sensitization to Donor Alloantigens.
|
Xu, Hong
|
|
|
110 |
11 |
p. 2246
|
artikel
|
| 782 |
CD4+CD25+Foxp3+ Regulatory T Cell Function Outside the Immune System: Differential Regulation of Hematopoietic Progenitor Cell Populations.
|
Urbieta, Maite
|
|
|
110 |
11 |
p. 64
|
artikel
|
| 783 |
CD55−CD59− Granulocytes in Patients with Aplastic Anemia Are Clonal Populations Derived from Single PIG-A Mutant Stem Cells without Any Proliferative Advantage.
|
Mochizuki, Kanako
|
|
|
110 |
11 |
p. 1702
|
artikel
|
| 784 |
CD4+CD25high Foxp3+ Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).
|
Kordasti, Shahram Y.
|
|
|
110 |
11 |
p. 2445
|
artikel
|
| 785 |
CD4+ CD25high Regulatory T Cells in Newly Diagnosed Patients with Acute Myeloid Leukemia.
|
Szczepanski, Miroslaw J.
|
|
|
110 |
11 |
p. 2835
|
artikel
|
| 786 |
CD8+CD28− in Peripheral Blood of Patients with Cutaneus T-Cell Lymphoma (CTLC) in Different Clinical Stages.
|
Urbaniak-Kujda, Donata M.
|
|
|
110 |
11 |
p. 4395
|
artikel
|
| 787 |
CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.
|
Tonino, Sanne H.
|
|
|
110 |
11 |
p. 1139
|
artikel
|
| 788 |
CD16+CD56− NK Cells in the Peripheral Blood of Cord Blood Transplant Recipients: A Unique Subset of Immature NK Cells Possibly Associated with Graft-Versus-Leukemia Effect.
|
Lu, Xuzhang
|
|
|
110 |
11 |
p. 1074
|
artikel
|
| 789 |
CD4+CD25+ Regulatory T Cells in Patients with Acute Lymphocytic Leukemia.
|
Cao, Xiangshan
|
|
|
110 |
11 |
p. 3881
|
artikel
|
| 790 |
CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.
|
Ma, Yue
|
|
|
110 |
11 |
p. 384
|
artikel
|
| 791 |
CD34+CXCR4+ Cell Therapy (AMR-001) for Myocardial Infarction: Preliminary Processing and Product Results of a Phase I Dose Escalation Study.
|
Waller, Ned
|
|
|
110 |
11 |
p. 773
|
artikel
|
| 792 |
CD6-Depletion in the Dog Model: New Insights into Chimerism and Tolerance.
|
Zorn, Julia
|
|
|
110 |
11 |
p. 2173
|
artikel
|
| 793 |
CD26 (Dipedtidyl Peptidase IV) Expression in B-CLL.
|
Galligan, Leeona
|
|
|
110 |
11 |
p. 4699
|
artikel
|
| 794 |
CD127 Expression Confers Enhanced Survival on Human B-Lineage Cells; Implications for the Role of IL-7 Signaling in Human B Lymphopoiesis.
|
Johnson, Sonja E.
|
|
|
110 |
11 |
p. 1329
|
artikel
|
| 795 |
CD26 Expression in Mature B-Cell Neoplasia: Its Possible Role as a New Prognostic Marker in B-CLL.
|
Cro, Lilla
|
|
|
110 |
11 |
p. 4670
|
artikel
|
| 796 |
CD5 Expression Is a Predictive Factor for Poor Prognosis among Biomarkers in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy.
|
Ennishi, Daisuke
|
|
|
110 |
11 |
p. 3447
|
artikel
|
| 797 |
CD200 Expression May Help in Differential Diagnosis between Mantle Cell Lymphoma (MCL) and B-Cell Chronic Lymphocytic Leukemia (B-CLL).
|
Palumbo, Giuseppe A.
|
|
|
110 |
11 |
p. 4672
|
artikel
|
| 798 |
CD117 Expression May Signify Enduring Proliferative Capacity of Amniotic Fluid-Derived Mesenchymal Stem Cells (MSC).
|
Decker, William K.
|
|
|
110 |
11 |
p. 3699
|
artikel
|
| 799 |
CD26 Expression on Neutrophils Is Critical for G-CSF Mediated Mobilization of Hematopoietic Stem and Progenitor Cells.
|
Singh, Pratibha
|
|
|
110 |
11 |
p. 1267
|
artikel
|
| 800 |
CD26 Expression on T-Cell Lines Is Associated with SDF-1α-Mediated Invasion and Phosphorylation of Signaling Molecules.
|
Havre, Pamela A.
|
|
|
110 |
11 |
p. 3572
|
artikel
|
| 801 |
CD38 Gene Polymorphisms Contribute to Genetic Predisposition to B-Cell Chronic Lymphocytic Leukemia.
|
Jamroziak, Krzysztof
|
|
|
110 |
11 |
p. 491
|
artikel
|
| 802 |
CD34+ Hematopoietic Progenitor Cells Express CD 184 Antigen and to a Minor Extend MMP9.
|
Abendroth, Jens
|
|
|
110 |
11 |
p. 4032
|
artikel
|
| 803 |
CD123 (IL-3 Receptor α Chain) Neutralization by a Monoclonal Antibody Selectively Eliminates Human Acute Myeloid Leukemic Stem Cells.
|
Lock, Richard B.
|
|
|
110 |
11 |
p. 161
|
artikel
|
| 804 |
CD133 Immunomagnetic Separation: How Effective Is the Method for CD133+ Cell Isolation from Umbilical Cord Blood?.
|
Pelagiadis, Iordanis
|
|
|
110 |
11 |
p. 4917
|
artikel
|
| 805 |
CD26 Inhibition on CD34+ or Lineage− Human Umbilical Cord Blood Donor HSC/HPC Improves Long-Term Engraftment into NOD/SCID/Beta2null Immunodeficient Mice.
|
Christopherson, Kent W.
|
|
|
110 |
11 |
p. 4853
|
artikel
|
| 806 |
CD52 Is Expressed in Childhood Acute Myeloid Leukemia and May Be a Target for Alemtuzumab.
|
Wegmann, Matthew K.
|
|
|
110 |
11 |
p. 4316
|
artikel
|
| 807 |
Cdk2 Kinase Activity Is Not Abrogated after DNA Damage in Mouse Embryonic Stem Cells.
|
Koledova, Zuzana
|
|
|
110 |
11 |
p. 3371
|
artikel
|
| 808 |
CD62L Is Not Critical for T Regulatory Cell-Mediated Protection from Lethal Acute GVHD.
|
Carlson, Michael J.
|
|
|
110 |
11 |
p. 2178
|
artikel
|
| 809 |
CD62L (L-Selectin), CXCR4, CD49d, and CD38 Contribute to Migration of Chronic Lymphocytic B Cells Beneath Marrow Stromal Cells.
|
Quiroga, Maite
|
|
|
110 |
11 |
p. 1119
|
artikel
|
| 810 |
CD20 Mutations at the Rituximab Binding Site Are Rare and Are Not a Significant Cause of R-CHOP Resistance in Patients with De Novo Diffuse Large B-Cell Lymphoma.
|
Johnson, Nathalie A.
|
|
|
110 |
11 |
p. 686
|
artikel
|
| 811 |
CD133+ Purified Hematopoietic Stem Cells in Co-Culture with Mesenchymal Stromal Cells - The Cell to Cell Contact Matters.
|
Alakel, Nael
|
|
|
110 |
11 |
p. 1421
|
artikel
|
| 812 |
CD19-Specific T Cells for Treatment of Pediatric Acute Lymphocytic Leukemia Using Sleeping Beauty Transposition.
|
Singh, Harjeet
|
|
|
110 |
11 |
p. 2820
|
artikel
|
| 813 |
CD4+ T Cell Lines Reactive with Acute Myeloid Leukemia (AML) Cells Generated by Competitive Limiting Dilution Culture of AML Mononulear Cells (MNC) Eliminate Autologous AML by Apoptosis Induction.
|
Zhong, Rui-kun
|
|
|
110 |
11 |
p. 4890
|
artikel
|
| 814 |
CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation.
|
Scaradavou, Andromachi
|
|
|
110 |
11 |
p. 2015
|
artikel
|
| 815 |
CEACAM-1 Is Involved in Graft-Versus-Host-Disease in Murine Allogeneic Bone Marrow Transplantation Models.
|
Lu, Sydney X.
|
|
|
110 |
11 |
p. 67
|
artikel
|
| 816 |
CEBPA Germline Mutation Screening in Cytogenetically Normal Acute Myeloid Leukemia with Somatically Acquired CEBPA Mutations.
|
Corbacioglu, Andrea
|
|
|
110 |
11 |
p. 363
|
artikel
|
| 817 |
CEBPA Methylation and Notch1 Mutations Are Common in Immature T-ALLs but Not M0 AML and Cosegregate with TCRG Rearrangement and the TCRgd Lineage.
|
Terriou, L.
|
|
|
110 |
11 |
p. 2788
|
artikel
|
| 818 |
C/EBPα:AP-1 Leucine Zipper Heterodimers Bind Novel DNA Elements, Activate the PU.1 Promoter, and Direct Monocyte Lineage Commitment More Potently Than C/EBPα Homodimers or AP-1.
|
Friedman, Alan D.
|
|
|
110 |
11 |
p. 1232
|
artikel
|
| 819 |
C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway.
|
Anastasov, Natasa
|
|
|
110 |
11 |
p. 3570
|
artikel
|
| 820 |
C/EBPβ Is a Critical Factor for Proliferation and Apoptosis in MM Cells by Controlling Transcription Factors Like IRF-4, PAX5 and Blimp1.
|
Pal, Rekha
|
|
|
110 |
11 |
p. 1506
|
artikel
|
| 821 |
Cell Cycle Features and Quantitative Alteration of Target Molecules of Malignant B Cells Treated with Inotuzumab Ozogamicin (CMC544) Alone or in Combination with Rituximab.
|
Yamakage, Nozomi
|
|
|
110 |
11 |
p. 2362
|
artikel
|
| 822 |
Cell-Derived Microparticle (C-MP) Profiles in Lymphoproliferative Disorders: Association of Elevated Red Cell Microparticles (RMP) with Thrombosis.
|
Fontana, Vincenzo
|
|
|
110 |
11 |
p. 3988
|
artikel
|
| 823 |
Cell-Derived Microparticles in ITP Patients with vs. without Bleeding Tendency.
|
Fontana, Vincenzo
|
|
|
110 |
11 |
p. 2092
|
artikel
|
| 824 |
Cell Membrane Sulfatide Promotes Sickle Cell Adhesion to Endothelium.
|
Guchhait, Prasenjit
|
|
|
110 |
11 |
p. 1722
|
artikel
|
| 825 |
Cells Lacking the PolQ Polymerase Are Moderately Sensitive to Ionizing Radiation and the Oxidant Induced Toxicity of Paraquat and Bleomycin.
|
Goff, Julie P.
|
|
|
110 |
11 |
p. 4037
|
artikel
|
| 826 |
Cell Therapy in a Mouse Model of Immune-Mediated Bone Marrow Failure.
|
Chen, Jichun
|
|
|
110 |
11 |
p. 1689
|
artikel
|
| 827 |
Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.
|
Jenkins, Christopher
|
|
|
110 |
11 |
p. 1608
|
artikel
|
| 828 |
Central Nervous System Abnormalities in Dyskeratosis Congenita and Fanconi Anemia: Correlation with Clinical Phenotype and Aplastic Anemia.
|
Giri, Neelam
|
|
|
110 |
11 |
p. 1682
|
artikel
|
| 829 |
Central Nervous System (CNS) Relapse in Agressive Non-Hodgkin's Lymphoma; Does CNS Prophylaxis Work?.
|
Bernstein, Steven H.
|
|
|
110 |
11 |
p. 520
|
artikel
|
| 830 |
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia (ALL) at Diagnosis and/or at First Relapse: Results from the GET-LALA Group.
|
Reman, Oumedaly
|
|
|
110 |
11 |
p. 4326
|
artikel
|
| 831 |
Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Reinforced Anthracycline Monochemotherapy.
|
Montesinos, Pau
|
|
|
110 |
11 |
p. 592
|
artikel
|
| 832 |
Cerebrospinal Fluid Immunophenotyping in B-Cell Lymphomas: A Single Centre Experience on 99 Samples.
|
Plonquet, Anne
|
|
|
110 |
11 |
p. 2629
|
artikel
|
| 833 |
C1GALT1C1 (COSMC) Mutations in Four Individuals with Tn+ Phenotype.
|
Crew, Vanja Karamatic
|
|
|
110 |
11 |
p. 1727
|
artikel
|
| 834 |
Change in Expressional Profile of KCl Cotransporter Genes during Human Erythroid Differentiation.
|
Pan, Dao
|
|
|
110 |
11 |
p. 1709
|
artikel
|
| 835 |
Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival.
|
Flowers, Mary E.D.
|
|
|
110 |
11 |
p. 833
|
artikel
|
| 836 |
Changes in Gene Expression Profiles during Treatment with Erythropoetic Growth Factors in Myelodysplastic Syndromes.
|
Oliva, Esther N.
|
|
|
110 |
11 |
p. 4609
|
artikel
|
| 837 |
Changes in L-Selectin Expression by T Lymphocytes after Extracorporeal Photochemotherapy.
|
Ramirez, Manuel
|
|
|
110 |
11 |
p. 1961
|
artikel
|
| 838 |
Changes of Clonality of Paroxysmal Nocturnal Hemoglobinuria (PNH) Clones during Clinical Courses in Patients with PNH.
|
Noji, Hideyoshi
|
|
|
110 |
11 |
p. 3677
|
artikel
|
| 839 |
Changing Gene Expression Patterns during Early Treatment of B-Precursor Acute Lymphoblastic Leukemia May Be Predictive of Relapse.
|
de Haas, Valerie
|
|
|
110 |
11 |
p. 232
|
artikel
|
| 840 |
Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells.
|
Davies, Andrea
|
|
|
110 |
11 |
p. 2364
|
artikel
|
| 841 |
Characteristics and Outcome of Patients with Chronic Myeloid Leukemia (CML) and T315I Mutation Following Failure of Imatinib Mesylate Therapy.
|
Jabbour, Elias
|
|
|
110 |
11 |
p. 1943
|
artikel
|
| 842 |
Characteristics of Patients Experiencing Thromboembolic Events during Treatment for Multiple Myeloma: Aspirin May Not Be Adequate Thromboprophylaxis in Patients with Multiple Risk Factors.
|
Wright, Jennifer A.
|
|
|
110 |
11 |
p. 1882
|
artikel
|
| 843 |
Characteristics of Patients with Myelodysplastic Syndromes (MDS) in the United States from 4528 Physician Surveys.
|
Sekeres, Mikkael A.
|
|
|
110 |
11 |
p. 2462
|
artikel
|
| 844 |
Characteristics of Patients with Stage I Follicular Lymphoma (FL) Selected for Watchful Waiting (WW) in the US: Report from the National LymphoCare Study (NLCS).
|
Friedberg, Jonathan W.
|
|
|
110 |
11 |
p. 3315
|
artikel
|
| 845 |
Characterization of Acute Myeloid Leukemia with PTPN11 Mutation - The Mutation Is Closely Associated with NPM1 Mutation but Inversely Related to FLT3/ITD.
|
Hou, Hsin-An
|
|
|
110 |
11 |
p. 3490
|
artikel
|
| 846 |
Characterization of a Disulfide-Crosslinked αIIbβ3 Cytoplasmic Domain Heterodimer by NMR.
|
Metcalf, Douglas G.
|
|
|
110 |
11 |
p. 415
|
artikel
|
| 847 |
Characterization of a Juxtamembrane Lysine as a Determinant in Lysosomal Routing and Signal Downregulation of the Activated G-CSF Receptor (G-CSFR).
|
Irandoust, Mahban
|
|
|
110 |
11 |
p. 2190
|
artikel
|
| 848 |
Characterization of BCR-ABL Deletion Mutants from Patients with Chronic Myeloid Leukemia.
|
Sherbenou, Daniel W.
|
|
|
110 |
11 |
p. 2936
|
artikel
|
| 849 |
Characterization of BioSafe SEPAX Manufactured Stem Cell Intended for Cardiac Cell Therapy.
|
O'Connor, Sean L.
|
|
|
110 |
11 |
p. 4064
|
artikel
|
| 850 |
Characterization of Cancer Stem Cells in Human B-Cell Lymphoid Hematologic Malignancies.
|
Nishida, Hiroko
|
|
|
110 |
11 |
p. 3384
|
artikel
|
| 851 |
Characterization of CD4+ T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients.
|
Bocchia, Monica
|
|
|
110 |
11 |
p. 1808
|
artikel
|
| 852 |
Characterization of del20q in Peripheral Blood of MPD Patients Using Copy Number Analysis and High Resolution Oligonucleotide CGH Array
|
Schaub, Franz
|
|
|
110 |
11 |
p. 1530
|
artikel
|
| 853 |
Characterization of Ex Vivo Expanded Cord Blood Graft Treated with Chromatin Modifying Agents for Potential Clinical Use.
|
Yoshinaga, Kazumi
|
|
|
110 |
11 |
p. 4921
|
artikel
|
| 854 |
Characterization of Hematopoietic and Non-Hematopoietic Stem/Progenitor Cells in Freshly Isolated Adult Human Bone Marrow Using an 8-Color Flow Cytometric Assay.
|
Tekinturhan, Ferda
|
|
|
110 |
11 |
p. 4045
|
artikel
|
| 855 |
Characterization of Immune Reconstitution Following High Dose Chemotherapy in Acute Myeloid Leukemia.
|
Meyer, Christian F.
|
|
|
110 |
11 |
p. 3888
|
artikel
|
| 856 |
Characterization of Microvesicles in B-Cell Chronic Lymphocytic Leukemia (CLL): A Potential Mediator in CLL B Cell Disease Progression?.
|
Ghosh, Asish K.
|
|
|
110 |
11 |
p. 747
|
artikel
|
| 857 |
Characterization of Pain, Vasculature and Innervation in Sickle Cell Disease.
|
Gupta, Kalpna
|
|
|
110 |
11 |
p. 2248
|
artikel
|
| 858 |
Characterization of Regulatory Elements in the Slc4a1 (Band 3) Locus To Create Safe and Effective Vectors for Globin Gene Therapy
|
Harrow, Faith
|
|
|
110 |
11 |
p. 3740
|
artikel
|
| 859 |
Characterizing Factor VIII Inhibitor Resistance of Platelet-Delivered Factor VIII in the Treatment of Hemophilia A.
|
Gewirtz, Jamie E.
|
|
|
110 |
11 |
p. 781
|
artikel
|
| 860 |
Chemokine RANTES (Regulated upon Activation, Normal T Cell Expressed and Secreted) in Multiple Myeloma and MGUS (Monoclonal Gammopathy of Undetermined Significance).
|
Hayashi, Kunio
|
|
|
110 |
11 |
p. 4756
|
artikel
|
| 861 |
Chemokine Receptor Expression Profile in the Model of Parotid MALT Lymphomagenesis: De Novo Expression of CXCR6.
|
Deutsch, Alexander J.A.
|
|
|
110 |
11 |
p. 2622
|
artikel
|
| 862 |
Chemokine Receptor Gene Polymorphisms and Severity of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Sibling Donors.
|
Pullarkat, Vinod
|
|
|
110 |
11 |
p. 4989
|
artikel
|
| 863 |
Chemotherapy Alone Versus Chemotherapy Plus Radiotherapy for Early Stage Hodgkin Lymphoma.
|
Rehan, Fareed A.
|
|
|
110 |
11 |
p. 2320
|
artikel
|
| 864 |
Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.
|
Cillessen, Saskia A.G.M.
|
|
|
110 |
11 |
p. 2346
|
artikel
|
| 865 |
Chemotherapy with Granulocyte Colony Stimulating Factor (G-CSF) Alone Versus Granulocyte Colony Stimulating Factor (G-CSF) Plus Granulocyte-Macrophage Stimulating Factor (GM-CSF) for Hematopoietic Progenitor Cell Mobilization in Patients with Relapsed Non-Hodgkin's Lymphomas (NHLs).
|
Hosing, Chitra
|
|
|
110 |
11 |
p. 1900
|
artikel
|
| 866 |
Childhood Mixed Lineage Leukemia: The St. Jude Experience.
|
Onciu, Mihaela
|
|
|
110 |
11 |
p. 1844
|
artikel
|
| 867 |
Children with t(12;21)/TEL-AML1-Positive Acute Lymphoblastic Leukemia Exhibit a Distinct Germline Genomic Signature.
|
Trevino, Lisa R.
|
|
|
110 |
11 |
p. 760
|
artikel
|
| 868 |
Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.
|
Schmitt, Timo
|
|
|
110 |
11 |
p. 3249
|
artikel
|
| 869 |
Chimerism May Prolong Islet Allograft Acceptance through the Preservation of CD4+CD25+FoxP3+ Treg in Diabetic NOD Mice.
|
Bozulic, Larry D.
|
|
|
110 |
11 |
p. 3257
|
artikel
|
| 870 |
Chimerism Status as a Possible Marker of Incipient Disease Relapse in Patients with AML.
|
Horky, Ondrej
|
|
|
110 |
11 |
p. 5028
|
artikel
|
| 871 |
2-Chlorodeoxyadenosine (2-CDA) and Dexamethasone Induce Apoptosis in Multiple Myeloma (MM) Via Different Mechanisms.
|
Liu, Bolin
|
|
|
110 |
11 |
p. 4792
|
artikel
|
| 872 |
Choosing Donors Wisely. Reducing the Risk of Transfusion-Transmissible Viral Infection through Blood Donor Selection: The Australian Experience 2000–2006.
|
Polizzotto, Mark N.
|
|
|
110 |
11 |
p. 2910
|
artikel
|
| 873 |
Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.
|
Tefferi, Ayalew
|
|
|
110 |
11 |
p. 3546
|
artikel
|
| 874 |
CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis.
|
Herbrecht, Raoul
|
|
|
110 |
11 |
p. 3445
|
artikel
|
| 875 |
Chromatin Structure and Transcription of the Human alpha Globin Locus in Erythroid and Non-Erythroid Environments.
|
Mahajan, Milind C.
|
|
|
110 |
11 |
p. 1774
|
artikel
|
| 876 |
Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG).
|
Ruchlemer, Rosa
|
|
|
110 |
11 |
p. 4705
|
artikel
|
| 877 |
Chromosomal Abnormalities in the Early Stem Cell Population of CML Patients in Complete Cytogenetic Remission.
|
Bumm, Thomas G.P.
|
|
|
110 |
11 |
p. 36
|
artikel
|
| 878 |
Chromosome 21-Encoded miR-125b and Its Role in the Development of Myeloid Leukemia in Children with Down's Syndrome.
|
Klusmann, Jan-Henning
|
|
|
110 |
11 |
p. 716
|
artikel
|
| 879 |
Chromosome 1p21 Deletion Defines a Subgroup of Multiple Myeloma with Poor Clinical Outcomes Independent of del (13q), del(p53), t(4;14) or 1q21 Amplification.
|
Chang, Hong
|
|
|
110 |
11 |
p. 2475
|
artikel
|
| 880 |
Chronic B-Cell Dyscrasias Are an Important Clinical Feature of LGL Leukemia.
|
Viny, Aaron D.
|
|
|
110 |
11 |
p. 4675
|
artikel
|
| 881 |
Chronic Graft-Versus-Host Disease after Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplantation. A Pediatric Blood and Marrow Transplant Consortium Study..
|
Atlas, Mark P.
|
|
|
110 |
11 |
p. 4984
|
artikel
|
| 882 |
Chronic Graft Versus Host Disease and Pretransplant Disease Status Predict Outcomes in Patients with Hematologic Malignancies Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation.
|
Shah, Megha A.
|
|
|
110 |
11 |
p. 5090
|
artikel
|
| 883 |
Chronic Graft vs. Host Disease (cGVHD) Hinders Long-Term Functional Recovery after Hematopoietic Cell Transplantation.
|
Wong, F. Lennie
|
|
|
110 |
11 |
p. 634
|
artikel
|
| 884 |
Chronic GVHD Is Associated with a BAFF Driven BCR-Activated B Cell Repertoire.
|
Sarantopoulos, Stefanie
|
|
|
110 |
11 |
p. 166
|
artikel
|
| 885 |
Chronic Lymphocytic Leukemia Cells Produce a Soluble Factor(s) That Can Induce CD14+ Blood Mononuclear Cells To Assume Properties of Nurselike Cells In Vitro.
|
Messmer, Davorka
|
|
|
110 |
11 |
p. 1136
|
artikel
|
| 886 |
Chronic Lymphocytic Leukemia (CLL): A Comparative Analysis of Protein Expression Profiles in Peripheral Blood Cells at Diagnosis and upon Disease Progression.
|
Gine, Eva
|
|
|
110 |
11 |
p. 1129
|
artikel
|
| 887 |
Chronic Lymphocytic Leukemia Complicated with Paraneoplastic Pemphigus and Glomerulonephritis in a Patient and Its Treatments: Report of One Case.
|
Xuan, Qian Si
|
|
|
110 |
11 |
p. 4725
|
artikel
|
| 888 |
Chronic Myeloid Leukemia. 15-Years Experience at a Single Institution in Mexico City.
|
Aguayo, Alvaro
|
|
|
110 |
11 |
p. 4557
|
artikel
|
| 889 |
Ciprofloxacin-Induced G2 Arrest and Apoptosis in TK6 Lymphoblastoid Cells Is Not Dependent on Double-Strand Break Formation.
|
Halicka, Dorota
|
|
|
110 |
11 |
p. 4094
|
artikel
|
| 890 |
Ciprofloxacin Inhibits Bortezomib-Mediated Apoptosis in Multiple Myeloma Models in Association with Induction of Heme Oxygenase-1.
|
Chen, Qing
|
|
|
110 |
11 |
p. 2365
|
artikel
|
| 891 |
Circadian Traffic of Hematopoietic Stem Cells Is Orchestrated by the Molecular Clock and Mediated by β3 Adrenergic Signals from the Sympathetic Nervous System.
|
Mendez-Ferrer, Simon
|
|
|
110 |
11 |
p. 219
|
artikel
|
| 892 |
Circulating CD4+CD25+ Regulatory T Cell and Th3 Cell of the Patients with Myelodysplastic Syndromes.
|
Shao, Zonghong
|
|
|
110 |
11 |
p. 4595
|
artikel
|
| 893 |
Circulating Dendritic Cells of the Patients with Myelodysplastic Syndromes.
|
Shao, Zonghong
|
|
|
110 |
11 |
p. 4594
|
artikel
|
| 894 |
Circulating Endothelial Cells as Noninvasive Marker of Angiogenesis in Patients with Chronic Lymphocytic Leukemia.
|
Gora-Tybor, Joanna
|
|
|
110 |
11 |
p. 1124
|
artikel
|
| 895 |
Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations
|
Bonetti, Elisa
|
|
|
110 |
11 |
p. 1535
|
artikel
|
| 896 |
Circulating Leukemic Myeloid Dendritic Cells from Patient with Leukemia Elicit CDK2-Specific CTLs from Allogeneic HLA-A24+ Naive CD8+ T Cells.
|
Kondo, Yukio
|
|
|
110 |
11 |
p. 3228
|
artikel
|
| 897 |
Citrate Anticoagulant Artificially Masks the Hemostatic Effect of Recombinant Factor VIIA in Dilutional Coagulopathy.
|
Fenger-Eriksen, Christian
|
|
|
110 |
11 |
p. 3160
|
artikel
|
| 898 |
c-Jun N-Terminal Kinase (JNK) Activation Failure Confers a New Mechanism of Anthracycline Resistance in Acute Myeloid Leukemia (AML).
|
Lagadinou, Eleni D.
|
|
|
110 |
11 |
p. 2377
|
artikel
|
| 899 |
Cladribine (CdA) Gives Longer Response Duration Than Fludarabine (F) and High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia (CLL). First Results from the International Randomized Phase III Trial.
|
Karlsson, Karin A.
|
|
|
110 |
11 |
p. 630
|
artikel
|
| 900 |
Classification and Survival of 179 Patients with T- and NK-Cell Lymphomas at the Federal Research Hematology Center of Russian Academy of Medical Sciences: A Retrospective Study.
|
Vinogradova, Yulia E.
|
|
|
110 |
11 |
p. 4461
|
artikel
|
| 901 |
Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.
|
Weisdorf, Daniel J.
|
|
|
110 |
11 |
p. 45
|
artikel
|
| 902 |
Classifying Leukemias Based on Epigenetic Alterations.
|
Jelinek, Jaroslav
|
|
|
110 |
11 |
p. 2123
|
artikel
|
| 903 |
Class-II Associated Invariant Chain Peptide (CLIP) Expression on AML Blasts Adversely Affects Alloreactive CD4+ T Cell Recognition.
|
van Luijn, Marvin M.
|
|
|
110 |
11 |
p. 4888
|
artikel
|
| 904 |
Class Prediction Models of Thrombocytosis Using Gene Profiling.
|
Gnatenko, Dmitri V.
|
|
|
110 |
11 |
p. 100
|
artikel
|
| 905 |
Cleaved High Molecular Weight Kininogen (HKa) and Kininostatin (D5) Induce Apoptosis and Inhibit Migration and Invasion of Human Prostate Cancer Cells by Preventing AKT Phosphorylation and Cyclin D1 Synthesis and Disrupting the Interaction of UPAR and EGFR.
|
Liu, Yuchuan
|
|
|
110 |
11 |
p. 405
|
artikel
|
| 906 |
Cleaved Kininogen Inhibits Endothelial Progenitor Cell Differentiation by Interfering with the avb3 Integrin-MMP-2 Pathway.
|
Colman, Robert W.
|
|
|
110 |
11 |
p. 3719
|
artikel
|
| 907 |
Clincial Evidence That Very Small Embryonic Like (VSEL) Stem Cells Are Mobilizaed into Peripheral Blood in Patents after Stroke.
|
Kucia, Magda
|
|
|
110 |
11 |
p. 3705
|
artikel
|
| 908 |
Clinical Activity of Flavopiridol in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) with High-Risk Cytogenetic Abnormalities: Updated Data on 89 Patients (Pts).
|
Heerema, Nyla A.
|
|
|
110 |
11 |
p. 3107
|
artikel
|
| 909 |
Clinical Analysis of Late-Onset Nephrotic Syndrome after Allogenic Hematopoietic Stem Cell Transplantation.
|
Luo, Xiaodan
|
|
|
110 |
11 |
p. 4965
|
artikel
|
| 910 |
Clinical and Haematologic Features of 300 Patients Affected by Hereditary Spherocytosis as a Function of the Type of the Membrane Protein Defect.
|
Barcellini, Wilma
|
|
|
110 |
11 |
p. 1724
|
artikel
|
| 911 |
Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.
|
Bennett, Charles L.
|
|
|
110 |
11 |
p. 2088
|
artikel
|
| 912 |
Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.
|
Tosi, Patrizia
|
|
|
110 |
11 |
p. 4728
|
artikel
|
| 913 |
Clinical and Radiographic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors.
|
Stiff, Patrick J.
|
|
|
110 |
11 |
p. 477
|
artikel
|
| 914 |
Clinical and Virological Responses to Anti-Viral Treatment Correlates with Regulatory T-Cells Evolution in Patients with HCV-Induced Cryoglobulinemia Vasculitis.
|
Landau, Dan Avi
|
|
|
110 |
11 |
p. 3867
|
artikel
|
| 915 |
Clinical-Biomarker Correlations in Adult AML Patients in a Phase I Trial of AVN944 Support Observations of Clinical Effect and Provide Hypotheses for Patient Selection Criteria for Further Clinical Trials.
|
Klisovic, Rebecca B.
|
|
|
110 |
11 |
p. 896
|
artikel
|
| 916 |
Clinical Characteristics and Laboratory Analysis of Patients with Thrombocytopenia and Thrombocytosis.
|
Do, Young-Rok
|
|
|
110 |
11 |
p. 3918
|
artikel
|
| 917 |
Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.
|
Kim, Wan-Seok
|
|
|
110 |
11 |
p. 1954
|
artikel
|
| 918 |
Clinical Characteristics and Outcome of Patients (pts) with F317L BCR-ABL Kinase Domain (KD) Mutation after Therapy with Tyrosine Kinase Inhibitors (TKIs).
|
Jabbour, Elias
|
|
|
110 |
11 |
p. 1949
|
artikel
|
| 919 |
Clinical Characteristics and Outcome of Primary AL Amyloidosis in Greece.
|
Michail, Michalis
|
|
|
110 |
11 |
p. 4729
|
artikel
|
| 920 |
Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.
|
Narimatsu, Hiroto
|
|
|
110 |
11 |
p. 4269
|
artikel
|
| 921 |
Clinical Characteristics of Early and Late Non-Infectious Pulmonary Complications Following Cord Blood Transplantation.
|
Wake, Atsushi
|
|
|
110 |
11 |
p. 4945
|
artikel
|
| 922 |
Clinical Characteristics of Patients with a RBC Fragment Flag on the Advia® 2120 Automated Hematology Analyzer.
|
Ben-Ezra, Jonathan
|
|
|
110 |
11 |
p. 5153
|
artikel
|
| 923 |
Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.
|
Tong, Hongyan
|
|
|
110 |
11 |
p. 3576
|
artikel
|
| 924 |
Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias.
|
Alegre, Adrian
|
|
|
110 |
11 |
p. 2726
|
artikel
|
| 925 |
Clinical Efficacy of Lenalidomide in Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients.
|
Chanan-Khan, Asher A.
|
|
|
110 |
11 |
p. 3108
|
artikel
|
| 926 |
Clinical Evolution to Primary Myelofibrosis - Blast Phase: An International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) Collaborative Retrospective Analysis.
|
Mesa, Ruben A.
|
|
|
110 |
11 |
p. 682
|
artikel
|
| 927 |
Clinical Feature and Prognosis of 60 Patients Presenting Graft Failure (GF) after Allogeneic Stem Cell Transplantation (SCT).
|
Hagihara, Maki
|
|
|
110 |
11 |
p. 4929
|
artikel
|
| 928 |
Clinical Features and Management of Jaw Osteonecrosis in Patients Receiving Bisphosphonate Therapy.
|
Alves, Fabio
|
|
|
110 |
11 |
p. 4775
|
artikel
|
| 929 |
Clinical Features and Prognosis of MDS Patients with Chromosome 5 Abnormalities Other Than ‘5q-Syndrome': Results of Multi-Center Analysis in Korea.
|
Cheong, June-Won
|
|
|
110 |
11 |
p. 4618
|
artikel
|
| 930 |
Clinical Impact of WT1 Mutations in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG).
|
Gaidzik, Verena I.
|
|
|
110 |
11 |
p. 364
|
artikel
|
| 931 |
Clinical Implications of Anemia in Heart Failure (HF) Patients (pts).
|
Puente, Dolores
|
|
|
110 |
11 |
p. 3776
|
artikel
|
| 932 |
Clinical Measurement of Prognostic Immune Signature in Follicular Lymphoma by RT-PCR Based Gene Expression Profiling and Immunohistochemistry Demonstrates Favourable T-Cell and Unfavorable Macrophage Infiltration.
|
Byers, Richard J.
|
|
|
110 |
11 |
p. 359
|
artikel
|
| 933 |
Clinical Molecular Diagnosis of T-Cell Receptor Gene Rearrangement in Thai Patients.
|
Kummalue, Tanawan
|
|
|
110 |
11 |
p. 4396
|
artikel
|
| 934 |
Clinical Outcome by Acute Graft-Versus Host Disease (GVHD) Prophylaxis in Patients Underwent Allogeneic Bone Marrow Transplantation from Unrelated Donors: Nationwide Survey in Japan.
|
Hara, Masamichi
|
|
|
110 |
11 |
p. 1960
|
artikel
|
| 935 |
Clinical Outcomes in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (TTP) Who Received Platelet Transfusions (PT).
|
Swisher, Karen K.
|
|
|
110 |
11 |
p. 1302
|
artikel
|
| 936 |
Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.
|
Chen, Allen R.
|
|
|
110 |
11 |
p. 1896
|
artikel
|
| 937 |
Clinical, Pathological, and Molecular Correlates in Ferroportin Disease. A Study of Two Novel Mutations.
|
Girelli, Domenico
|
|
|
110 |
11 |
p. 706
|
artikel
|
| 938 |
Clinical Presentation, Treatment Response and Survival in Adult Acute Biphenotypic Leukemia: Single Centre Experience.
|
Abdulwahab, Amal S.
|
|
|
110 |
11 |
p. 4330
|
artikel
|
| 939 |
Clinical Profile of Patients with Primary Gastric Lymphoma: A Single Centre Experience.
|
Ambulkar, Indumati B.
|
|
|
110 |
11 |
p. 4451
|
artikel
|
| 940 |
Clinical, Prognostic and Possible Therapeutic Relevance of Angiogenesis in Non-Hodgkin's Lymphoma.
|
Etto, Leina Y.
|
|
|
110 |
11 |
p. 3583
|
artikel
|
| 941 |
Clinical Prognostic Factors in Chemosensitive Multiple Myeloma (MM) Patients Intensified with High Dose Therapy/Stem Cell Support (HDT/SCS): Results of the Spanish Trial (PETHEMA/GEM2000).
|
Mateos, María-Victoria
|
|
|
110 |
11 |
p. 937
|
artikel
|
| 942 |
Clinical Relapses in Follicular Lymphoma Patients Are Preceded by a ≥ 2log Increase of Circulating Lymphoma Cells.
|
Schüler, Frank
|
|
|
110 |
11 |
p. 4131
|
artikel
|
| 943 |
Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Gene Polymorphisms To Predict Response and Resistance to Imatinib Mesylate Therapy in Chronic Myeloid Leukemia.
|
Kim, Dong Hwan (Dennis)
|
|
|
110 |
11 |
p. 737
|
artikel
|
| 944 |
Clinical Significance and Risk Factors of Delayed-Onset Neutropenia (DON) after Autologous Stem Cell Transplantation (ASCT) for B-Cell Non-Hodgkin Lymphoma: A Single-Institute Analysis.
|
Kato, Harumi
|
|
|
110 |
11 |
p. 5111
|
artikel
|
| 945 |
Clinical Significance of Cytocentrifuge Preparation Analysis of Low-Cell-Count Cerebrospinal Fluid Specimens.
|
Lajeunesse-Viens, Guylaine
|
|
|
110 |
11 |
p. 3872
|
artikel
|
| 946 |
Clinical Significance of Hemostatic Parameters in the Patients with Transplantation-Related Complications during Hematopoietic Stem Cell Transplantation.
|
Han, Yue
|
|
|
110 |
11 |
p. 3956
|
artikel
|
| 947 |
Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.
|
Beer, Philip
|
|
|
110 |
11 |
p. 677
|
artikel
|
| 948 |
Clinical Significance of PML/RAR Isoform in Patients of Acute Promyelocytic Leukemia.
|
Kim, Ki-Hyang
|
|
|
110 |
11 |
p. 4218
|
artikel
|
| 949 |
Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.
|
Bashey, Asad
|
|
|
110 |
11 |
p. 1646
|
artikel
|
| 950 |
Clinical Trials Underestimate Age of Chronic Myeloid Leukemia (CML) Patients: Epidemiological Study in a Representative Area in Germany.
|
Rohrbacher, M.
|
|
|
110 |
11 |
p. 2955
|
artikel
|
| 951 |
Clinical Utility and Safety of Methacholine Challenge in Children with Sickle Cell Disease.
|
Brown, Michael S.
|
|
|
110 |
11 |
p. 3797
|
artikel
|
| 952 |
Clinicopathological Analysis of 32 Cases of Extra-Medullary Myeloid Tumour.
|
Todd, Tony
|
|
|
110 |
11 |
p. 4317
|
artikel
|
| 953 |
Clinico-Pathologic Characteristics of Patients with Extra-Nodal Lymphoproliferative Disorders Diagnosed Using Liver Biopsy.
|
El-Sharkawi, D.
|
|
|
110 |
11 |
p. 4453
|
artikel
|
| 954 |
CliniMACS® Cell Enrichment Using NKp46 — A Large Scale, Single-Step NK Cell Isolation Method.
|
Bondzio, Ilka
|
|
|
110 |
11 |
p. 3877
|
artikel
|
| 955 |
CLL Cell Proliferation and IL-6 Production Are Regulated by CD160 - MHC Class I Interactions Offering New Therapeutic Targets.
|
Giustiniani, Jerome
|
|
|
110 |
11 |
p. 1126
|
artikel
|
| 956 |
CLL-Cell Proliferation Measured by In Vivo Deuterium Labeling in Early Stage Patients and Correlation with Other Prognostic Markers.
|
Murphy, Elizabeth J.
|
|
|
110 |
11 |
p. 3088
|
artikel
|
| 957 |
CLL-1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia.
|
Korver, Wouter
|
|
|
110 |
11 |
p. 2839
|
artikel
|
| 958 |
CLL Transcript and Serum Profiling Identifies Distinct Oncogenic Pathways in Rai Stage Progression.
|
Mahadevan, Daruka
|
|
|
110 |
11 |
p. 4688
|
artikel
|
| 959 |
Clofarabine (CLO) Is Active in Patients (pts) with Refractory and/or Relapsed Non-Hodgkin's Lymphoma (NHL): A Phase I/II Study.
|
Nabhan, Chadi
|
|
|
110 |
11 |
p. 4462
|
artikel
|
| 960 |
Clonal Analysis of Progressive Maturation of Erythroid Cells from Human Embryonic Stem Cell-Derived Definitive Hematopoiesis.
|
Ma, Feng
|
|
|
110 |
11 |
p. 2236
|
artikel
|
| 961 |
Clonal Dedifferentiation of Human Myogenic Progenitors into Skeletal Muscle Stem Cells Induced by MAPK Inhibition.
|
Wang, Lei
|
|
|
110 |
11 |
p. 3701
|
artikel
|
| 962 |
Clonal Dominance at the Progenitor Cell Level Defines Clinical Phenotype More Accurately Than the Neutrophil Allele Burden in JAK2V617F-Positive MPD Patients.
|
Moliterno, Alison R.
|
|
|
110 |
11 |
p. 679
|
artikel
|
| 963 |
Clonal Expansion of Graft-Versus-Host Reactive CD8+ T Cells Is Dissociated from Full Effector Differentiation Following Delayed DLI.
|
Chakraverty, Ronjon
|
|
|
110 |
11 |
p. 2170
|
artikel
|
| 964 |
Clonal Heavy and Light Chain Immunoglobulin DNA in Plasma/Serum of AIDS Lymphoma Patients.
|
Wagner-Johnston, Nina D.
|
|
|
110 |
11 |
p. 1579
|
artikel
|
| 965 |
Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy.
|
Mustjoki, Satu
|
|
|
110 |
11 |
p. 2938
|
artikel
|
| 966 |
Cloning and Characterization of the Zebrafish mll Ortholog.
|
Robinson, Blaine W.
|
|
|
110 |
11 |
p. 1249
|
artikel
|
| 967 |
Cloning of AML1-LAF4 Fusion Gene in Childhood T-Cell Acute Lymphoblastic Leukemia with t(2;21)(q11;q22) by Bubble PCR Method for cDNA.
|
Chinen, Yoshiaki
|
|
|
110 |
11 |
p. 983
|
artikel
|
| 968 |
CMV-Associated Expansion of CD8+CD45RA+CD27− T-Cells in Patients with B-Cell Malignancies.
|
Tonino, Sanne H.
|
|
|
110 |
11 |
p. 3592
|
artikel
|
| 969 |
CMV Colitis in a Patient Receiving Dasatinib.
|
Khan, Mudussara A.
|
|
|
110 |
11 |
p. 4567
|
artikel
|
| 970 |
c-Myb Contributes to Normal Human Peripheral Blood T Helper 2 Cell Development through Regulation of GATA-3 Expression.
|
Nakata, Yuji
|
|
|
110 |
11 |
p. 793
|
artikel
|
| 971 |
c-Myb Functions as a Co-Activator of MLL1 through Menin, and More Globally Affects Histone Methylation.
|
Jin, Shenghao
|
|
|
110 |
11 |
p. 827
|
artikel
|
| 972 |
c-Myb Regulates CD9 Gene Expression during Megakaryopoiesis.
|
Mukai, Harumi Y.
|
|
|
110 |
11 |
p. 1245
|
artikel
|
| 973 |
C-MYC Correlates with Expression of Multidrug Transporters ABCC1 and ABCC4.
|
Ho, Lye Lin
|
|
|
110 |
11 |
p. 3467
|
artikel
|
| 974 |
CNS-Disease in Elderly Patients Treated with Modern Chemotherapy (CHOP-14) with or without Rituximab: An Analysis of CNS Events in the RICOVER-60 Trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
|
Boehme, Volkmar
|
|
|
110 |
11 |
p. 519
|
artikel
|
| 975 |
Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
|
Meisel, Roland
|
|
|
110 |
11 |
p. 164
|
artikel
|
| 976 |
Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.
|
Cushman, Mary
|
|
|
110 |
11 |
p. 127
|
artikel
|
| 977 |
Coagulation Factor V-Major Survival Predictor in Patients of Viral Hepatitis Induced Acute Liver Failure.
|
Gupta, Naveen L.
|
|
|
110 |
11 |
p. 3931
|
artikel
|
| 978 |
Coagulation Markers Levels Measured during Acute Infection May Predict the Development of Long Term Cardio- and Cerebro-Vascular Events in Elderly.
|
Winder, Asher
|
|
|
110 |
11 |
p. 3989
|
artikel
|
| 979 |
Coagulation-Related Effect of Bortezomib Treatment in Patients with Relapsed or Refractory Multiple Myeloma.
|
Zangari, Maurizio
|
|
|
110 |
11 |
p. 2733
|
artikel
|
| 980 |
Coalescence of the German-Austrian and IMRAW Cytogenetic MDS Databases: Modification of Patient Risk Groups.
|
Steidl, Christian
|
|
|
110 |
11 |
p. 2468
|
artikel
|
| 981 |
Cobblestone Area-Forming Cell (CAFC) Content of Cord Blood Does Not Predict Engraftment in Double Cord Blood Transplantation.
|
Robinson, Simon N.
|
|
|
110 |
11 |
p. 2243
|
artikel
|
| 982 |
Co-Crystal Structures of 7-Azaindole Inhibitors of Wild-Type and T315I Imatinib-Resistant Mutant Forms of the BCR-ABL Tyrosine Kinase.
|
Lewis, Hal A.
|
|
|
110 |
11 |
p. 1018
|
artikel
|
| 983 |
Co-Culture of Myeloma and Endothelial Cells: Defibrotide Downregulates Heparanase and Pro-Angiogenic Growth Factors.
|
Echart, Cinara
|
|
|
110 |
11 |
p. 2513
|
artikel
|
| 984 |
Co-Delivery of Sleeping Beauty Transposons Encoding FVIII and Indoleamine 2,3-Dioxygenase Attenuate Inhibitor Formation Resulting in Long-Term FVIII Expression.
|
Liu, Li
|
|
|
110 |
11 |
p. 2596
|
artikel
|
| 985 |
Co-Development of Intravital, Laser-Induced Experimental and Computational Models of Thrombogenesis.
|
Kamocka, Malgorzata
|
|
|
110 |
11 |
p. 2683
|
artikel
|
| 986 |
Coexistence of Congenital Red Cell Pyruvate Kinase Deficiency and Hereditary Stomatocytosis.
|
Marcello, Anna P.
|
|
|
110 |
11 |
p. 1738
|
artikel
|
| 987 |
Coexistence of Two Distinct Histological Subtypes of Follicular Lymphoma and Burkitt's-Like Lymphoma in the Single Lymph Node: A Case Report and Literature Review.
|
Nagoshi, Haruhisa
|
|
|
110 |
11 |
p. 4394
|
artikel
|
| 988 |
Coincidence of bcr/abl-Positive Chronic Myeloid Leukemia and bcr/abl-Negative Chronic Myeloproliferative Disorder and Its Relevance to the Course of Disease.
|
Buesche, Guntram
|
|
|
110 |
11 |
p. 2950
|
artikel
|
| 989 |
Coincidence of JAK2V617F and BCR-ABL Is a Very Rare Event: Identification of 4 among 2317 Cases with Suspected CMPD.
|
Schnittger, Susanne
|
|
|
110 |
11 |
p. 2538
|
artikel
|
| 990 |
Collaboration between Activating Mutations in JAK2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS).
|
Ganmore, Ithamar
|
|
|
110 |
11 |
p. LB6
|
artikel
|
| 991 |
Combination Methyltransferase and Histone Deacetylase Inhibition in Elderly Patients with Secondary Acute Myelogenous Leukemia.
|
Thatikonda, Chandanda
|
|
|
110 |
11 |
p. 4387
|
artikel
|
| 992 |
Combination of a Spicamycin Analogue KRN5500 and Chemotherapeutic Agents Synergistically Enhances Their Cytotoxicity in Human Myeloma Cells.
|
Miki, Hirokazu
|
|
|
110 |
11 |
p. 4783
|
artikel
|
| 993 |
Combination of Bortezomib with Tipifarnib (R115777) Induces Synergistic Myeloma Cell Apoptosis Via Down-Regulation of HDAC6 and Inhibition of Aggresome Formation.
|
David, Ebenezer
|
|
|
110 |
11 |
p. 1520
|
artikel
|
| 994 |
Combination of Imatinib with Cisplatin and Nutlin-3: Functional and Molecular Effects on Bcr-Abl Positive Cells.
|
Skorta, Ioanna
|
|
|
110 |
11 |
p. 2954
|
artikel
|
| 995 |
Combination of Proteasome Inhibitors Bortezomib and NPI-0052 Trigger In Vivo Synergistic Cytotoxicity in Multiple Myeloma.
|
Chauhan, Dharminder
|
|
|
110 |
11 |
p. 2524
|
artikel
|
| 996 |
Combination of Rituximab, Bortezomib and Hyper-Fractionated Cyclophosphamide (RBC) in “True” Elderly Patients with Advanced Mantle Cell Lympoma.
|
Guariglia, Roberto
|
|
|
110 |
11 |
p. 4448
|
artikel
|
| 997 |
Combination of Rituximab with Initial Chemotherapy Improves Outcome of Primary Mediastinal B-Cell Lymphoma: A Retrospective Analysis of a Single Institution Cohort
|
Avigdor, Abraham
|
|
|
110 |
11 |
p. 1283
|
artikel
|
| 998 |
Combination of Serum Free Light Chain Analysis with Capillary Zone Electrophoresis Improves Screening for Monoclonal Gammopathies.
|
Holding, Stephen
|
|
|
110 |
11 |
p. 1497
|
artikel
|
| 999 |
Combination Therapy of Bortezomib with Bendamustin in Elderly Patients with Advanced Multiple Myeloma. Clinical Observation.
|
Hrusovsky, Irena
|
|
|
110 |
11 |
p. 4851
|
artikel
|
| 1000 |
Combination Therapy with Lenalidomide, Bortezomib, Liposomal Doxorubicin and Dexamethasone (LBlipDD) May Overcome Resistance to Prior Treatment with Doxorubicin, Lenalidomide, and Bortezomib in High-Risk Multiple Myeloma (MM).
|
Ruckser, Reinhard
|
|
|
110 |
11 |
p. 4838
|
artikel
|
Tijdschrift beschrijving